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ABSTRACT 
 
Background: 
Dental caries is today widely recognised to be a biofilm-mediated disease triggered by dysbiosis in 
the resident oral microbiome. Despite the evolution of caries aetiological theories, disease 
preventive strategies are still largely dependent on the physicochemical effects of fluoride on the 
demineralization-remineralization caries equilibrium. The inability of fluoride to significantly 
influence the cariogenic bacterial challenge and reverse the microbial dysbiosis is one of the reasons 
the disease persists in many high caries-risk individuals and population groups. Countering the 
microbiome dysbiosis with conventional oral microbiocides is not recommended as their broad-
spectrum antimicrobial effects will eliminate even health-associated plaque microflora. 
Comprehensive caries management protocols need to encompass agents that not only influence 
the de-/remineralization balance, but also include measures that can have a beneficial modulating 
effect on the ecology of the dental plaque microbiome. 
 
Objectives: 
The overall aims of this PhD project were to examine whether selected natural products and novel 
remineralizing agents like casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) can 
disrupt key virulence properties of cariogenic bacteria without broadly affecting microbial viability. 
The study also aimed to explore whether any virulence inhibitory effects of cariostatic natural 
products and CPP-ACP could translate into beneficial ecological effects both in in vitro biofilm 
models and in a clinical environment. 
 
Methods: 
A literature review was performed to identify natural products with potential cariostatic effects for 
investigation in this study. Agar diffusion and broth microdilution assays were used to assess 
whether any of the selected natural products could inhibit the growth of planktonic cultures of a 
caries-associated bacteria species (Streptococcus mutans) without affecting the viability of a health-
associated oral commensal bacterial species (Streptococcus sanguinis). Based on the results of the 
planktonic bacterial culture study, specific natural products were further selected to explore their 
effects on cariogenic biofilm virulence properties. The biofilm studies were conducted in an active 
attachment in vitro model using monospecies S. mutans biofilms, dual-species S. mutans-Candida 
albicans biofilms, and saliva-derived polymicrobial biofilms growing in a cariogenic environment. 
The natural products were assessed for their effects on biofilm metabolic activity, acidogenicity, 
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microbial and exopolysaccharide (EPS) biovolumes, structural architecture, microbial counts and 
ecological microbial changes. Besides the natural products, the effect of CPP-ACP on acidogenicity, 
microbial counts and ecology of saliva-derived polymicrobial biofilms was also examined in a 
separate study. Finally, a randomised controlled trial (RCT) was conducted in a high caries-risk 
population group to evaluate the plaque ecological effects of a CPP-ACP dentifrice and a combined 
CPP-ACP – natural product dentifrice with regards to effecting species level changes of caries- and 
health-associated bacteria. 
 
Results: 
1. The planktonic culture study identified several natural products with significant 
antimicrobial effects. However, none of the selected natural products were able to 
selectively inhibit the growth of S. mutans without also affecting the viability of S. sanguinis.  
2. Fruit berry extracts, though they lacked significant growth inhibitory effects, were selected 
for the biofilm virulence studies. This was based on literature reports that suggested 
polyphenols present in dark-coloured berries could exert biological activity against 
cariogenic virulence factors. 
3. A standardized polyphenol-rich cranberry extract was found to be the most effective berry 
extract in disrupting virulence properties of S. mutans biofilms. 
4. The virulence inhibitory effects of the cranberry extract extended to dual-species S. mutans-
C. albicans biofilms, although higher concentrations of the extract were required for 
significant effects. 
5. Twice-daily treatment of saliva-derived polymicrobial biofilms growing in a cariogenic 
environment with the cranberry extract inhibited biofilm virulence factors and drove a 
beneficial ecological change in the biofilm microbial community. 
6. CPP-ACP demonstrated cariogenic virulence-attenuating attributes that influenced 
beneficial microbial ecological changes in saliva-derived polymicrobial biofilms that were 
growing in a cariogenic environment. 
7. The RCT demonstrated that dentifrices containing CPP-ACP and polyphenol-rich cranberry 
extracts were able to effect a species level shift in the ecology of the dental plaque 
microbiome, resulting in a microbial community that had lower levels of bacteria associated 
with dental caries, and elevated levels of bacterial species associated with health. 
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Conclusions:  
The results of this research project confirm the virulence inhibitory and microbial ecological effects 
of a sugar-free polyphenol-rich cranberry extract. This suggests the potential of incorporating the 
commercially available cranberry product into daily use oral care products as a useful strategy for 
better long-term control over dental caries. This study also provides evidence that CPP-ACP has 
beneficial virulence attenuating and ecological effects on saliva-derived polymicrobial biofilms 
growing in a cariogenic environment. Furthermore, a CPP-ACP dentifrice was shown to beneficially 
modulate dental plaque microbial composition in a high caries-risk population group. Thus, the 
effects of CPP-ACP are not limited to its well-established remineralizing effects on tooth surfaces, 
but also extend to having beneficial prebiotic actions on dental plaque biofilms. Although the 
cranberry extract did not appear to significantly enhance the ecological effects of CPP-ACP, 
optimisation of the cranberry extract concentration added to the CPP-ACP dentifrice could result in 
a synergistic ecological effect.  Future studies with the cranberry extract incorporated into a fluoride 
dentifrice without CPP-ACP will be needed to resolve whether the cranberry extracts can have 
clinically useful ecological effects of their own. 
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1. INTRODUCTION TO THE THESIS 
This chapter provides a brief background to the thesis and outlines the flow of the 
thesis chapters.
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1.1 BACKGROUND TO THE THESIS 
Ecological approaches to dental caries prevention is an area of research that is attracting 
increasing attention from investigators around the world. The recent years have seen an explosion 
of exciting developments in this field from Streptococcus mutans-antagonistic probiotic bacteria 
that are natural inhabitants of the oral niche [Huang et al., 2016; Lopez-Lopez et al., 2017], 
prebiotics like arginine incorporated into fluoride dentifrices [Li et al., 2015; Nascimento, 2018], 
antimicrobial peptides that specifically target S. mutans [Guo and Edlund, 2017; Liu et al., 2016], to 
exopolysaccharide matrix degrading free radicals released from pH-responsive catalytic 
nanoparticles [Gao et al., 2016]. The use of cariostatic natural products to modulate the dental 
plaque microbiome and prevent caries lesions is another potential ecological strategy that requires 
further research. Natural products with cariogenic virulence inhibiting properties could supplement 
the remineralizing effects of fluoride and significantly enhance preventive capabilities of daily use 
oral care products. Their natural origin suggest they could find easier acceptance among the general 
public compared to commonly used synthetic microbiocides. This should allow them to be used for 
long-term control over the disease, making them particularly beneficial for high caries-risk groups. 
The research challenge is to identify a natural plant extract or phytochemical that can specifically 
inhibit cariogenic virulence factors without broadly affecting microbial viability. 
 
Ideally, the remineralizing agent itself should be able to reverse any dysbiosis and maintain 
a symbiotic oral microbiome. However, fluoride, regarded as the gold standard among 
remineralizing agents, has minimal to no effects on microbial composition of dental plaque [Adams 
et al., 2017; Koopman et al., 2015; Reilly et al., 2016; Reilly et al., 2014]. The milk protein-based 
remineralizing technology called casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) 
may hold greater promise in effecting a beneficial shift in the dental plaque microbial ecology. 
Several reports in literature suggest that regular use of CPP-ACP products lowered salivary S. mutans 
counts [Emamieh et al., 2015; Plonka et al., 2013; Pukallus et al., 2013; Subramanian and Naidu, 
2009; Yetkiner et al., 2014]. Moreover, recent in vitro studies have shown that treating multi-species 
biofilms growing in a cariogenic environment with CPP-ACP not only reduced the abundance of 
cariogenic bacterial species, but also effected a concomitant increase in the abundance of health-
associated bacterial species [Philip et al., 2019; Dashper et al., 2018]. However, the large majority 
of the CPP-ACP studies have focussed on its remineralizing effects and there is a need for further 
research on its plaque ecological effects. 
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 Recognising the need to develop newer approaches to dental caries prevention, this 
research project aimed to address some of the aforementioned challenges with specific regards to 
virulence attenuating and ecological effects of natural products and CPP-ACP. The long-term aim of 
this research would be to develop an oral care product combining polyphenol-rich natural plant or 
fruit extracts with the milk-derived CPP-ACP for dental caries prevention. 
 
1.2 OUTLINE OF THE THESIS 
The chapters in this thesis are divided into: (i) a broad review of the literature to identify the 
research gaps and define the aims and objectives of the research; and (ii) the experimental studies 
conducted to address the aims of the research.  
The study flow diagram below illustrates the logical flow of thesis chapters relating to the 
literature review performed. 
 
Figure 1. Flow of literature review with corresponding chapters 
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The methodology followed for the experimental studies was based on recommendations by 
the International Conference on Novel Anticaries and Remineralizing Agents (ICNARA) [Maltz and 
Beighton, 2012]. ICNARA suggests the screening process for new agents must involve a variety of 
assay systems of increasing complexity starting from simple tests with planktonic cells to be 
followed by a series of biofilm studies (from mono-species to polymicrobial biofilms) using models 
like the Amsterdam Active Attachment model [Exterkate et al., 2010]. Lastly, a randomised 
controlled trial in a high caries-risk group is recommended to substantiate any in vitro results.  
 
The study flow diagram below illustrates the logical flow of thesis chapters relating to the 
experimental studies conducted for this research project. 
 
Figure 2. Flow of experimental studies and corresponding chapters  
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2. REVIEW OF THE LITERATURE
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2.1 LITERATURE REVIEW: INTRODUCTION 
 
2.1.1  REVIEW PAPER 1 
 
Ecological Approaches to Dental Caries Prevention: Paradigm Shift or Shibboleth? 
 
This paper discusses the rationale for developing alternate methods for dental caries 
control that go beyond the traditional caries preventive measures. The paper further 
reviews the different ecological approaches to dental caries prevention and the current 
status of these ecological caries preventive strategies. 
 
The paper was published on 11th January 2018 in Caries Research, the official publication 
of the European Organisation for Caries Research (ORCA).  
 
Caries Res 2018 52(1): 153-165. 
 
This chapter is comprised of the publication as it stands in print. 
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ABSTRACT 
Contemporary paradigms of dental caries aetiology focus on the ecology of the dental plaque 
biofilm and how local environmental factors can modulate this to cause disease. The crucial role 
that a healthy oral microbiome plays in preventing caries and promoting oral health is also being 
increasingly recognized. Based on these concepts, several ecological preventive approaches have 
been developed that could potentially broaden the arsenal of currently available caries preventive 
measures. Many of these ecological approaches aim for long-term caries control by either disrupting 
cariogenic virulence factors without affecting bacterial viability or include measures that can  
enhance the growth of diverse health-associated microbial communities in the oral microbiome. 
This paper argues for the need to develop ecological preventive measures that go beyond 
conventional caries preventive methods and discusses whether these ecological approaches can be 
effective in reducing the severity of caries by promoting stable, health-associated oral biofilm 
communities. 
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Oral health is integral to general well-being, with profound individual and societal 
implications that extend well beyond the functions of the craniofacial complex. Although largely 
preventable, diseases such as dental caries are major public health concerns, imposing a costly 
burden on health services. Traditional caries epidemiological measures do not adequately reflect 
the social impacts, economic costs, and health care system effects of the disease [Casamassimo et 
al., 2009].  
 
At the individual level, control of dental caries remains largely dependent on twice-daily 
mechanical oral hygiene in the form of tooth brushing with fluoride dentifrices, a preventive 
approach that has been in place for over 50 years. Based on the current understanding of the dental 
caries process, several ecological preventive strategies have been developed or are currently under 
investigation, suggesting a future where caries prevention will not be narrowly focussed on fluoride 
therapies. This review will explore the rationale supporting the need for alternate methods of dental 
caries control, and will discuss the current status of some ecological approaches to biofilm 
modification and caries prevention. 
 
DENTAL CARIES: A BIOFILM-MEDIATED MULTIFACTORIAL DISEASE  
Dental caries belongs to a group of diseases that are considered “complex” or 
“multifactorial,” with no single causation pathway, and therefore, are not amenable to simplistic 
preventive solutions such as the elimination of “one type of organism” or merely enhancing “tooth 
resistance” [Fejerskov, 2004]. Dental caries is now widely recognized to be an endogenous, biofilm-
mediated disease that occurs when acidogenic/aciduric members of resident oral flora obtain a 
selective ecological advantage over other species, disrupting the homeostatic balance of the plaque 
biofilm and initiating the disease process [Marsh and Martin, 1999]. Modern molecular analyses and 
microbial culture techniques have demonstrated that an entire range of bacteria, not just mutans 
streptococci (MS) or lactobacilli (LB), can contribute to the caries process at different stages [Tanner 
et al., 2016], and that even fungi such as Candida albicans can significantly enhance cariogenic 
virulence of plaque biofilms [Koo and Bowen, 2014]. A MS or LB dominated microbiome may be 
found only at the advanced stages of the disease, where the increased severity and frequency of 
biofilm acidification results in the oral microbiome becoming less microbially diverse [Takahashi and 
Nyvad, 2008]. Indeed, it is not the bacterial genotype per se but their shared phenotypic 
characteristics (being acidogenic and aciduric) that are more important for driving the microbial 
ecological shift that leads to dental caries [Takahashi and Nyvad, 2011].  
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While the ionic aspects of the dental caries process have been the focus of research for 
decades, new insights into the aetiology and microbial aspects of this biofilm-mediated disease have 
engendered novel concepts and approaches for its prevention and control [ten Cate and Cummins, 
2013]. A consensus is now emerging that caries preventive measures should aim to not only correct 
the environmental pressures responsible for the plaque biofilm dysbiosis, but also help to maintain 
a healthy, microbially diverse, resident microbiome [Marsh et al., 2015]. These new approaches 
acknowledge the possibility that bacteria yet to be identified and cultured may participate in the 
caries process, and aligns with engaging in a more comprehensive approach towards preventing 
dental caries as a disease at the patient level [Walsh, 2011]. 
 
RATIONALE FOR NEWER METHODS OF DENTAL CARIES CONTROL  
Ecological Strategies 
The historical focus in preventing and managing oral diseases was on eliminating dental 
plaque from teeth. However, contemporary evolving evidence is increasingly highlighting the 
beneficial aspects of a healthy oral microbiome [Kilian et al., 2016]. Commensal plaque microflora 
have a symbiotic relationship with the host, not only acting as a barrier to opportunistic pathogens, 
but also carrying out metabolic processes that benefit the host [He et al., 2011; Schlafer et al., 2017]. 
Acute infections of the oral mucosa are rare because of the interplay between the host immune 
system and microbial symbionts [Zaura et al., 2014]. Likewise, the pro-and anti-inflammatory 
activities of resident bacteria help maintain homeostasis in the oral cavity [Devine et al., 2015]. A 
moderate amount of healthy plaque has also been shown to prevent erosive enamel lesions and 
hypersensitivity [Honorio et al., 2010].   
 
Based on this changed understanding of the importance of a healthy oral microbiome, caries 
preventive strategies should ideally take an ecological approach to the holobiont. Indiscriminate or 
“shotgun” suppression of almost the entire oral biota, without understanding the overall effects on 
plaque ecology, is unlikely to have long-term success in controlling the disease [Caufield et al., 2001]. 
Instead, preventive and curative products should either specifically target cariogenic bacteria 
without affecting other resident microflora, or they should inhibit virulence factors (e.g., glucan 
synthesis or acid production) rather than bacterial viability [ten Cate and Zaura, 2012]. Measures 
that enhance colonization of health-promoting microbial communities can also help in correcting 
the ecological imbalance in cariogenic biofilms. The advantage of such an approach is that the 
impacts of low pH environments generated by acidogenic organisms can be counterbalanced by 
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ammonia production from other bacteria. Following an ecological approach to caries prevention can 
potentially preserve the favourable effects that the host derives from the resident oral microbiome, 
while reducing cariogenic virulence factors that are responsible for plaque biofilm dysbiosis. 
 
Aetiological Factors 
The control and prevention of any disease should preferably focus on the aetiological factors 
involved. For dental caries, this would be the periodic disorganisation of the oral plaque biofilm by 
mechanical oral hygiene, along with dietary modification to reduce exposure to fermentable 
carbohydrates [Cury and Tenuta, 2008]. Unfortunately, individual oral hygiene measures have only 
limited impact in caries prevention [Bellini et al., 1981; Hujoel et al., 2006; Nyvad B, 2003]. It has 
also been suggested that tooth brushing has been effective in preventing caries mainly because it 
brings fluoride into the oral cavity at regular intervals, rather than any particular efficiency in 
disrupting cariogenic plaque biofilms [ten Cate and Zaura, 2012]. Dietary modification, which 
requires individuals to restrict their exposure to sucrose and other fermentable substrates, is 
particularly difficult to achieve in present-day society where cariogenic foods are easily available 
[Duggal and van Loveren, 2001]. Furthermore, restriction of sucrose intake alone is unlikely to 
completely prevent dental caries if frequent intake of other starches persisted [Bradshaw and Lynch, 
2013]. Thus, while minimising the aetiological factors contributing to the disease is critical, 
additional preventive measures commensurate with individual risk status may still be required in 
many segments of the population. 
 
Caries Epidemiology 
For a long time, dental caries was a pandemic that affected children and adults almost 
universally. The landmark discovery of fluoride as an agent that could prevent dental caries, and the 
widespread use of fluoride-based caries preventive programmes, have been responsible for the 
significant reductions seen in caries prevalence of developed countries in the latter half of the 20th 
century [Fejerskov, 2004]. However, the latest Global Burden of Disease report revealed that 
untreated caries in permanent teeth still remains the most common human disease condition 
worldwide [Kassebaum et al., 2015]. Doubts have also been expressed on whether the earlier 
decline in caries prevalence has continued into this new century [Gimenez et al., 2016]. Recent 
caries prevalence studies in United States and Australia indicate tooth decay may in fact be 
increasing again [Chrisopoulos et al., 2016; Dye et al., 2007]. A similar trend has been seen in 
countries such as Norway and Iceland, which had initially shown the biggest improvements, but are 
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now registering increases in caries experience [Agustsdottir et al., 2010; Haugejorden and Birkeland, 
2005]. The flattening of prevalence rates that has occurred even in dentally aware populations 
where individuals commonly brush their teeth with fluoridated dentifrices is concerning and 
underscores the need to develop additional caries preventive measures that are synergistic with or 
complementary to fluoride. 
 
Fluoride Alone may not be Sufficient 
 While fluoride is a highly effective and economical agent for dental caries prevention and 
will remain the mainstay of any caries preventive program, it must be recognised that in many 
situations fluoride alone may not be sufficient. Even with regular fluoride use, carious lesions can 
still develop when there are more than six dietary sugar exposures per day [Ccahuana-Vasquez et 
al., 2007; Duggal et al., 2001]. The ready availability of cariogenic snack foods and drinks in the 
modern consumer culture can overwhelm the benefits of community water fluoridation and daily 
use of a fluoride dentifrice. The limit to the repair potential of fluoride could partly explain the 
reversal of the caries decline being observed in contemporary epidemiological reports from 
developed countries [Agustsdottir et al., 2010; Dye et al., 2017]. 
 
 The cariostatic actions of fluoride are largely attributed to its physiochemical ability to inhibit 
enamel demineralisation and enhance remineralisation [Cury and Tenuta, 2008]. Recent laboratory 
studies have confirmed the notion that under appropriate conditions fluoride ions can also influence 
critical MS virulence factors, significantly reducing acidogenicity, aciduricity, and glucan formation 
[Domon-Tawaraya et al., 2013; Pandit et al., 2015; Pandit et al., 2013]. Metabolome analysis of 
plaque biofilms has demonstrated that fluoride can repress acid production in vivo too [Takahashi 
and Washio, 2011]. However, questions still remain on the extent to which these antibacterial 
mechanisms contribute towards caries preventive effects. A recent study showed that the brief 
fluoride exposure from toothpastes or mouthwashes could not sustain anti-acid production activity, 
with the biofilms recovering acidogenicity over time regardless of the fluoride concentration used 
[Dang et al., 2016]. Concerns have also arisen regarding the emergence of microorganisms that are 
more resistant to the effects of fluoride on microbial metabolism [Liao et al., 2017; Mitsuhata et al., 
2014].  
 
Preventive approaches that combine fluoride with other protective agents have been 
advocated to enhance the ability of fluoride to modify biofilms and diminish the cariogenic bacterial 
challenge [Li et al., 2015]. Fluoride-antimicrobial combinations have been recommended based on 
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the 2-part rationale that fluoride can reduce the critical pH at which dissolution starts, while 
effective antimicrobial agents can decrease the depth of the Stephan curve pH drop following 
consumption of fermentable carbohydrates [Øgaard, 2000]. Randomised controlled trials (RCTs) 
have shown that fluoride-chlorhexidine interventions significantly reduced bacterial load and pH 
drop from glucose metabolism [Giertsen and Scheie, 1995], and most importantly, lowered caries 
increment in high-risk groups [Featherstone et al., 2012]. Sytematic reviews have also found high-
quality evidence that fluoride-triclosan toothpastes give a small improvement in reducing coronal 
caries compared to conventional fluoride dentifrices [Blinkhorn et al., 2009; Riley and Lamont, 
2013]. However, the use of such broad-spectrum antimicrobial agents may not be ideal, as the aim 
of antimicrobial treatment in caries prevention should preferably be to modify the plaque biofilm 
ecology by weakening cariogenic virulence factors rather than eliminating microflora. 
 
An alternative to the fluoride-antimicrobial approach is combining fluoride with agents that 
promote an overall community-wide microbial shift by encouraging the growth of health-associated 
bacteria, thereby beneficially rebalancing the biofilm ecology and potentially resulting in better 
long-term dental caries control. Among such biofilm-modifying oral products, there is now sufficient 
evidence supporting fluoride-arginine combinations as a new standard of care for caries prevention 
[ten Cate and Cummins, 2013; Zheng et al., 2015; Zheng et al., 2017]. Likewise, a dentifrice 
containing enzymes and proteins was shown to significantly shift the ecology of the oral microbiome 
resulting in a community with a stronger association to health [Adams et al., 2017]. 
 
Caries Risk 
Over time, the distribution of caries in the community has changed from a disease that was 
pandemic in society, to now being endemic in specific risk groups. A cross-sectional study concluded 
that 75% of the caries-risk burden tends to reside in 25–40% of the population [Macek et al., 2004]. 
Likewise, there is evidence for genetic differences that exist with respect to caries susceptibility 
[Bretz et al., 2005; Opal et al., 2015], with not everyone in a population group benefiting to the same 
extent from traditional caries preventive programmes [ten Cate, 2013]. The pattern of dental caries 
has also changed over the years, from a rapidly progressing disease of childhood, to a slowly 
progressing disease that can occur or persist throughout adulthood and old age [Lagerweij and van 
Loveren, 2015]. Data from contemporary population studies have revealed that carious lesions are 
also increasingly localized to specific tooth sites [Anderson, 2002]. In children and adolescents, 
occlusal surfaces are the sites most likely to have experienced caries [Carvalho, 2014; Carvalho et 
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al., 2016]. The increasing life expectancy of dentition also means that older adults with exposed root 
surfaces are at greater risk of experiencing root caries during their lifetime [Gati and Vieira, 2011]. 
With fluoride known to exert its cariostatic actions primarily on smooth enamel surfaces, 
susceptible occlusal/root surfaces remain relatively predisposed to acid dissolution [ten Cate, 2009]. 
Caries preventive strategies must therefore go beyond conventional methods (personal oral 
hygiene, fluoride dentifrices, and limiting sugar exposures) to better protect at-risk surfaces in at-
risk patients. 
 
Fluoride Safety 
The U.S Centers for Disease Control and Prevention ranked community water fluoridation as 
one of the 10 great public health achievements of the 20th century. Despite continued broad support 
within the dental profession worldwide, the polarised debate on the safety of fluorides used for 
caries prevention still continues in sections of the popular and scientific press. Recent reports can 
only add to the alarmist picture for sections of the general public who are not informed consumers 
of the scientific literature on this topic. For example, a 2012 systematic review and meta-analysis 
concluded that high fluoride exposure may lower IQ levels in children [Choi et al., 2012], a finding 
which attracted media attention and resulted in the inclusion of fluoride amongst chemicals 
classified as developmental neurotoxicants [Grandjean and Landrigan, 2014]. There are however a 
number of concerns with how the 2012 review was conducted (all selected studies were from China, 
fluoride exposure came from multiple sources not just drinking water, definition of “high” fluoride 
levels varied widely, and the probability of confounding as covariates were not controlled), and the 
authors themselves were extremely conservative, only concluding that  “our results support the 
possibility of adverse effects” advocating future research to evaluate dose-response relations based 
on individual-level measures of exposure over time. However, such caveats are universally 
overlooked when studies are reported in the media, and this fans extremist views on the safety of 
fluoride used for caries prevention.  
 
Additionally, dental fluorosis from excessive intake of fluoride during the period of tooth 
formation is a persisting concern that is raised by anti-fluoride lobbyists. While emphasising that 
fluoride is safe when used at the recommended levels for community water fluoridation or 
dentifrice, behaviours such as swallowing large amounts of dentifrice are not. In modern times there 
are also now opportunities for “halo” exposure from various other sources of fluoride, which has 
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triggered  downward revision of recommended levels for community water fluoridation (from 0.7-
1.2 mg/L to 0.7 mg/L), to ensure that the risk for dental fluorosis does not increase [E.P.A., 2011]. 
 
Ecological caries preventive approaches synergistic with fluoride can potentially allow dental 
products to be designed with lower concentrations of fluoride and these could be useful for caries 
prevention in infants and young children, as well as for patients reluctant to use oral care products 
with high fluoride concentrations. 
 
ECOLOGICAL APPROACHES TO CARIES PREVENTION 
Antimicrobial Peptides (AMPs) 
 AMPs are a heterogeneous group of molecules with unique antimicrobial characteristics that 
have great potential for controlling bacterial infections and modifying biofilms. AMPs have a broad 
range of antibacterial, antiviral, and antifungal activity mediated by selectively interacting 
electrostatically with negatively charged components of cell membrane phospholipids, resulting in 
membrane permeabilization and disruption, leading to cell death [Koczulla and Bals, 2003]. To 
escape the actions of bilayer-disruptive AMPs would entail changing membrane composition and 
organisation, a ‘costly’ process in evolutionary terms, meaning that AMPs have very low resistance 
rates compared to common antibiotics [Zasloff, 2002]. Besides naturally secreted salivary AMPs 
(lactoferrin, cathelicidins, histatins, defensins), a number of AMPs have been synthesized in the 
laboratory, and these include specific anti-caries peptides that have shown the potential to modify 
plaque biofilms and inhibit dental caries.   
 
 The specifically targeted antimicrobial peptide (STAMP) is a synthetic fusion peptide with 
two independent functional domains, consisting of a S. mutans-selective ‘targeting domain’ 
designated as C16, and a ‘killing domain’ designated as G2. C16 is derived from a fragment of the S. 
mutans competence stimulating peptide (CSP), while G2 is derived from a broad-spectrum 
antimicrobial peptide [Eckert et al., 2012]. C16G2 had antimicrobial mechanisms similar to 
traditional AMPs, and critically, its membrane disrupting activity specifically targets S. mutans from 
multispecies biofilms without affecting closely related non-cariogenic oral streptococci [Eckert et 
al., 2006; Kaplan et al., 2011]. More recently, an in vitro study on human saliva-derived 
polymicrobial biofilms was able to demonstrate that treatment with C16G2 not only eliminated S. 
mutans, but also resulted in a more benign oral microbial community with increased populations of 
health associated bacteria and fewer harmful Gram-negative bacteria [Guo et al., 2015].  C16G2 is 
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recognized by the U.S Food and Drug Administration as an investigational new drug for dental caries 
prevention and has successfully completed phase II clinical trials, where it was delivered to patients 
in the form of a dental gel loaded in trays. 
 
Another promising anti-caries AMP is a synthetic α-helical antimicrobial decapeptide 
designated KSL-W, which can selectively destabilize the cell membranes of cariogenic bacteria  
including S. mutans, S. sobrinus, and L. acidophilus [Leung et al., 2015; Na et al., 2007]. This peptide 
resits enzymatic degradation in human saliva for 1 hr, and the potential use of KSL-W as an anti-
biofilm agent in a chewing gum formulation has been suggested [Faraj et al., 2007; Na et al., 2007]. 
More recently, a hydroxyapatite-binding antimicrobial was designed, based on the fusion of specific 
hydroxyapatite-binding heptapeptide with KSL-W, and this bioconjugate was shown to have 
improved oral retention and antibacterial efficacy [Huang et al., 2016b]. Other AMPs that have 
shown in vitro antimicrobial activity against cariogenic bacteria and impaired biofilm formation 
include a synthetic peptide called L-K6 (derived from the naturally occurring peptide temporin-
1CEb), a short synthetic amphiphilic peptide known as 1018, low-cost plant-derived AMPs like 
retrocyclin or protegrin, and a amphipathic α-helical peptide containing only 12 amino acids named 
GH12 [Liu et al., 2016; Shang et al., 2014; Tu et al., 2016; Wang et al., 2015]. 
 
Limitations of AMPs include their potential toxicity, susceptibility to proteases, high cost of 
peptide production, and reduced cationic activity of most AMPs in physiological fluids like saliva. 
With regards to their use for dental caries prevention, questions still remain on whether anti-caries 
AMPs will be able to function against a background of excessive acid production often seen in high 
caries-risk individuals [Maltz and Beighton, 2012].  Before any clinical recommendations can be 
made it will be essential to test such agents in a caries-conducive oral environment, and to evaluate 
whether the desired outcome of reduced caries increment in at-risk population groups can be 
achieved. 
 
Probiotics 
 The term probiotics refers to “live micro-organisms, which, when administered in adequate 
amounts, confer a health benefit on the host” [Teughels et al., 2008], and is based on the Noble-
prize winning pioneering work of Metchnikoff [1907] for maintaining a healthy gut flora. This 
concept of implanting a harmless effector strain into the host’s microflora to maintain or restore a 
natural microbiome by inhibition of pathogenic microorganisms is attractive and has been also used 
to support health-associated microbes or restore diversity in the oral plaque biofilm. The 
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mechanisms by which probiotics re-establish ecological balance in oral biofilms are not fully 
understood, but probiotic bacteria are believed to have both local and systemic effects [Meurman, 
2005]. The local anti-caries effects may include competitive inhibition with cariogenic bacteria for 
nutrition or adhesive surfaces [Terai et al., 2015], selective co-aggregation of MS without disturbing 
other oral flora [Lang et al., 2010; Twetman et al., 2009], and bacteriocin-producing probiotics 
targeting MS [Burton et al., 2013]. The most commonly used and studied probiotics belong to the 
Lactobacillus and Bifidobacterium bacterial genera, although not all their strains have the same 
efficacy in the inhibition of S. mutans growth or biofilm formation [Schwendicke et al., 2017]. 
 
Evidence supporting the application of probiotics for preventing dental caries is 
controversial, with recent reports suggesting potential harmful effects for some probiotic bacterial 
strains [Gruner et al., 2016]. One of the problems identified in using probiotics for caries prevention 
is that the commonly available Lactobacillus and Bifidobacterium probiotic bacteria are themselves 
acidogenic and aciduric, and could contribute to the caries process if such bacteria are allowed to 
colonise the oral cavity [Maltz and Beighton, 2012]. Recent in vitro biofilm studies have confirmed 
this apprehension with different strains such as Lactobacillus salivarius W24 [Pham et al., 2009], 
Lactobacillus rhamnosus GG [Schwendicke et al., 2014a], Bifidobacteria animalis lactis BB12 
[Schwendicke et al., 2014b], Lactobacillus rhamnosus LB21 [Fernandez et al., 2015], and 
Lactobacillus acidophilus LA-5 [Schwendicke et al., 2017] have all been shown to lower biofilm pH. 
In fact, some Lactobacilli and Bifidobacteria strains have greater cariogenic attributes than even MS 
[Beighton et al., 2010]. Thus, while displacing S. mutans from plaque biofilms may in principle be a 
desirable, substituting them for even more cariogenic bacteria will not be useful [Schwendicke et 
al., 2014a]. Some of the non-acidogenic alternatives to Lactobacillus and Bifidobacterium that have 
shown promising early results include Streptococcus salivarius M18 [Burton et al., 2013], heat-
inactivated BB12 [Schwendicke et al., 2014b], and Weissella cibaria CMU [Jang et al., 2016]. 
 
 Another limitation with the traditional use of gut-associated Lactobacillus and 
Bifidobacterium probiotic species to promote oral health, is that these non-oral bacterial strains 
may not efficiently colonise the oral niche, which is vital for the long-term success of probiotics 
[Lopez-Lopez et al., 2017]. Even the use of a bacteriocin-producing strain of S. salivarius may not 
succeed, as S. Salivarius, while a typical member of the oral soft tissue flora, has limited ability to 
colonise tooth surfaces. However, very recently two natural oral commensal species, Streptococcus 
dentisani and Streptococcus A12 that were isolated from the supragingival plaque of caries-free 
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individuals, have demonstrated promising probiotic effects against dental caries. Both these ‘active 
colonisers’ have a double probiotic action, as they can not only inhibit the growth of MS, but also 
moderate plaque pH through their arginolytic actions [Huang et al., 2016a; Lopez-Lopez et al., 2017]. 
 
  The current decade has seen several systematic reviews and meta-analyses evaluating the 
effectiveness of using traditional gut-associated probiotics for caries prevention. A meta-analysis of 
studies with surrogate caries markers (MS and/or LB counts) concluded that these probiotics 
significantly decreased MS counts, but there was insufficient data on whether caries increment was 
reduced as well [Laleman et al., 2014]. A similar inference was also reached by a qualitative 
systematic review of probiotic caries studies, concluding that clinical recommendations would be 
premature without more comprehensive RCTs showing actual reduction in individual caries 
experience [Twetman and Keller, 2012]. Relatively few RCTs of oral probiotics have used clinical 
dental caries indicators to prove the efficacy of probiotics in preventing or treating dental caries 
[Burton et al., 2013; Nase et al., 2001; Stecksen-Blicks et al., 2009; Taipale et al., 2013]. A 
comprehensive systematic review utilizing evidence from these RCTs, concluded that current 
evidence is insufficient for recommending probiotics in controlling dental caries [Gruner et al., 
2016].  
 
Taken together, currently available data indicate that while traditional probiotic bacteria 
may have a beneficial effect on the gut flora and systemic health, a beneficial and clinically 
significant effect on the oral flora is yet to be demonstrated with sufficient rigor. However, 
observations from two major clinical trials in children [Näse et al., 2001; Stecksén-Blicks et al., 2009] 
support the intriguing concept of a ‘metabolic domino effect’, with reductions in caries risk seen to 
be accompanied by improvements in general health. Particularly promising for caries prevention is 
the move away from gut-associated probiotic bacteria to resident oral probiotic strains, such as the 
two S. mutans-antagonistic bacterial species S. dentisani and A12. Further evidence on the ability of 
these oral probiotics to inhibit dental caries is awaited with interest.  
 
Prebiotics 
The prebiotic approach involves feeding resident microbiota with specific nutrients to create 
conditions that favour the growth and dominance of healthy bacteria in the biofilm. The nutritional 
stimulation of endogenous beneficial oral flora to restore microbial balance and promote oral health 
has been validated in mixed species models [Slomka et al., 2017]. Oral prebiotic substrates that are 
especially valuable to prevent caries include arginine, arginine-rich peptides, and urea, as these 
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foods when metabolized create alkalising effects that counteract the acidogenic environment 
created by cariogenic bacteria. Many commensal bacteria are able to use arginine or urea to 
generate ammonia by the arginine deaminase system or urease enzymes respectively [Bradshaw 
and Marsh, 1998; Nascimento et al., 2009]. Multiple studies have shown that bacterial production 
of alkaline metabolites such as ammonia can play a major role in biofilm pH homeostasis and 
beneficially alter the de-/remineralization equilibrium [Burne and Marquis, 2000; Burne et al., 2012; 
Nascimento et al., 2014]. A substantial body of evidence from microbiological, genetic, biochemical 
analyses, and clinical studies has now accumulated confirming that the modulation of the 
alkalinogenic potential of dental biofilms is a promising strategy for caries control [Liu et al., 2012].  
 
The preventive potential of oral alkali production has resulted in the development of 
commercial oral care products that utilize arginine to promote a healthy resident oral microbiome. 
In vitro biofilm experiments found that fluoride-arginine combinations synergistically inhibited S. 
mutans but enriched S. sanguinis growth within multispecies biofilms, while maintaining a 
“streptococcal pressure” against the potential growth of oral anaerobe P. gingivalis in the alkalised 
biofilm [Zheng et al., 2015]. Fluoride-arginine combinations can also supress exopolysaccharide 
(EPS) production, thus targeting another critical virulence factor for cariogenic biofilms [Zheng et 
al., 2015]. Human in situ studies and several double-blinded RCTs using a fluoride dentifrice 
containing 1.5% arginine and an insoluble calcium compound have shown significantly greater 
protection against carious lesions than a fluoride dentifrice alone [Cantore et al., 2013; Kraivaphan 
et al., 2013; Petersen et al., 2015; Srisilapanan et al., 2013; Yin et al., 2013]. A systematic review and 
meta-analysis of the anti-caries effects of arginine-containing dentifrice formulations concluded 
that arginine products provided a superior preventive effect over matched formulations containing 
fluoride alone [Li et al., 2015]. Other authors have been more conservative in their conclusions, 
either citing insufficient evidence in support of a caries preventive effect for arginine, or expressing 
concerns over the higher cost of arginine-fluoride dentifrices versus any additional caries preventive 
effect these may provide [Astvaldsdottir et al., 2016]. However, the preponderance of evidence 
does seem to suggest the arginolysis is an effective approach to improve oral health and balance 
the microbial ecology. 
 
Sugar Polyols  
Sucrose has been designated as the ‘arch criminal’ in the caries process for a long time 
[Newbrun, 1969], and the search for alternative non-fermentable sweeteners has attracted much 
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attention. Data collected from in vitro and in vivo studies indicate that such sugar substitutes can 
exhibit potential anti-caries effects through a number of different mechanisms [Matsukubo and 
Takazoe, 2006]. Xylitol, a naturally occurring five-carbon sugar polyol, is the non-nutritive sweetener 
that has been most extensively researched over the past four decades for its potential cariostatic 
effects. Xylitol inhibits MS growth by disrupting their energy production processes, leading to a futile 
energy cycle and cell death [Marttinen et al., 2012]. Although not all MS strains were inhibited by 
xylitol in this manner, even xylitol-resistant bacteria were found to be less virulent after xylitol 
treatment [Trahan, 1995]. The predominant delivery vehicle for xylitol has been chewing gums, 
although xylitol dentifrices, candies, lozenges, and mouthrinses have also been used with varying 
degrees of success. A substantial body of evidence suggests that 5-6 g of xylitol per day delivered 
over three exposures are needed for worthwhile anti-caries effects [Milgrom et al., 2009]. Among 
other sugar polyols, erythritol, has been attracting increasing attention as it is has been shown to 
be more effective than xylitol and sorbitol, and importantly, its anti-caries effects were shown to 
persist for up to three years [de Cock et al., 2016; Falony et al., 2016; Honkala et al., 2014]. 
 
Despite an immense body of literature, the caries preventive effects of xylitol products 
remain inconclusive because of inconsistent study outcomes. While numerous studies have 
indicated xylitol has beneficial effects on surrogate endpoints (MS levels, plaque pH, acid 
production), evidence for worthwhile reductions in caries experience remains equivocal, and there 
is a need for more double-blind placebo-controlled RCTs, focussing on optimal dosage, delivery 
vehicle, and possible synergism with other preventive agents [Milgrom et al., 2012; Twetman, 2009]. 
In fact, the more recent data is concluding that there is limited evidence to show xylitol is effective 
in the fight against dental caries. A double-blind cluster-RCT using xylitol gummy bears found that 
polyol consumption did not provide any additional benefit over other caries preventive measures 
[Lee et al., 2015]. Recent Cochrane systematic reviews also found only very low to low quality 
evidence on xylitol effectiveness which was not sufficient to determine whether xylitol-containing 
products can prevent caries in infants, children or adults [Duane, 2015; Riley et al., 2015]. Other 
issues that limit the usefulness of sugar polyols include their high costs and low compliance in high-
risk patients because of the need for daily long-term use [Gold, 2016]. 
 
Quorum-sensing Targets 
 Another approach that may maintain and support a healthy oral plaque ecology is to 
interfere with the fundamental cell-cell communications system between biofilm bacteria. This 
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process of quorum sensing (QS) is mediated through small diffusible hormone-like molecules 
(pheromones) and their specific receptors. For MS, the stress-dependent QS system is primarily 
comprised of the competence stimulating peptide and its ComD/ComE two-component signal 
transduction system for communication between biofilm cells of the same species, while 
interspecies signalling is mediated via the autoinducer-2 (AI-2) molecule produced by LuxS 
[Senadheera D and Cvitkovitch DG, 2008]. The CSP-mediated QS system in S. mutans affects biofilm 
formation, acidogenicity, aciduricity, genetic transformation, bacteriocin production, stress 
response, and ability to produce persister phenotypes [Leung et al., 2015]. Targeting QS signalling 
pathways could provide a promising avenue in the development of novels therapeutics to alter 
cariogenic biofilms. As QS is not directly involved in processes essential for bacterial growth, 
targeting QS will allow less virulent bacteria to remain in the biofilm, and also will not impose 
selective pressures that can lead to development of antibiotic resistance [Rasmussen and Givskov, 
2006]. 
 
Interfering with CSP signalling systems has been shown to inactivate a wide range of 
bacteriocins and mutacins that play an important role in the sustained existence of S. mutans in the 
dental plaque [Cvitkovitch et al., 2003; Qi et al., 2004]. The addition of an exogenous CSP can disrupt 
signalling events of S. mutans and induce cell death [Qi et al., 2005]. Another novel QS-modifying 
compound 3-Oxo-N, was seen to significantly minimise lactic acid accumulation without affecting 
biofilm growth even in the presence of fermentable sugars, representing a promising agent for 
maintaining a healthy, non-cariogenic microbial ecology in dental plaque [Janus et al., 2016]. 
  
Natural Products 
Natural products include secondary metabolites or phytochemicals derived from plants, 
fruits, herbs or spices. They offer a rich source of structurally diverse molecules with a wide range 
of biological activities and could prove useful as alternative or adjunctive anti-caries agents [Jeon et 
al., 2011]. Potential cariostatic mechanisms identified include inhibition of bacterial growth, 
adhesion, acidogenicity, aciduricity, and glucan synthesis [Ferrazzano et al., 2011; Jeon et al., 2011]. 
 
Polyphenols from propolis (apigenin and tt-farnesol) and cranberry proanthocyanidins have 
been shown to exert useful ecological effects on the plaque biofilm. Apigenin is a potent inhibitor 
of water-insoluble glucan synthesis, while tt-farnesol disrupts S. mutans membrane permeability 
and acid production [Koo and Jeon, 2009]. An animal study found a combination of these two 
phytochemicals with fluoride suppressed dental caries without affecting the viability of oral flora, 
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being as potent as a fluoride-chlorhexidine control in caries inhibition, but without the broad 
antibacterial action of the control [Koo et al., 2005]. Similarly, cranberry proanthocyanidins, which 
lack significant biocidal activity, can modify plaque biofilms by reducing acidogenicity, aciduricity, 
and glucan synthesis [Duarte et al., 2006; Gregoire et al., 2007], and this translated into cariostatic 
effects in vivo [Koo et al., 2010]. A number of other polyphenol compounds have been found to be 
effective in killing S. mutans, with the minimal inhibitory concentrations of some bioactive 
molecules like xanthorrrhizol (from Javanese turmeric, Curcuma xanthorrhiza) or macelignan (from 
nutmeg, Myristica fragrans) almost comparable to chlorhexidine [Chung et al., 2006; Hwang et al., 
2000]. While most of the tested anti-caries phytochemicals showed growth inhibitory or anti-
adhesive effects, a potentially interesting natural agent in caries prevention is Galla Chinensis, which 
was uniquely able to beneficially regulate the de-/remineralization balance of dental hard tissues 
[Cheng et al., 2015].  
 
An analysis of how phytochemical research has impacted oral care in the period from 2000-
2015 found that despite many in vitro, in vivo, and clinical studies testing natural products derived 
from plants, only 11% of studies were in phase IV clinical trials [Freires and Rosalen, 2016]. Similar 
conclusions were reached in a systematic review of the anti-caries effects of essential oils and their 
isolated constituents, which found that most studies were conducted in the laboratory and did not 
provide botanical characterization or compositional data on the natural product being tested 
[Freires et al., 2015]. The emphasis in caries research using natural products has mostly focussed on 
microbial aspects of the disease process, but effects on de-/remineralization processes also need to 
be explored [Jeon et al., 2011]. Natural products remain a largely unexplored source of effective 
and non-toxic anti-biofilm molecules that could potentially be used in combination with fluoride as 
useful alternatives to broad-spectrum biocides like chlorhexidine or triclosan. However, future 
research needs to focus on translational approaches to advance the development of effective anti-
caries products containing phytochemicals or essential oils. 
 
Replacement Therapy with “Designer” Bacteria 
 Modifying dental plaque by replacing S. Mutans, a member of the normal microbiota, with 
a less virulent effector strain has been an established concept for many years [Hillman, 1978].  The 
rationale for bacterial replacement therapy against dental caries is that relatively avirulent strains 
of MS are most likely to occupy the same ecological niche in plaque as their more cariogenic 
counterparts thereby reducing the overall cariogenicity of the plaque biofilm [Sun et al., 2009]. 
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A number of “designer” bacteria have been studied for bacteriotherapy against cariogenic 
biofilms including a glucan synthesis-defective mutant of S. mutans, variants of S. salivarius (TOVE-
R), and a recombinant alkali-generating ureolytic S. mutans strain [Clancy et al., 2000; Tanzer et al., 
1974; Tanzer et al., 1985].The most extensive research in using genetically modified bacteria for 
preventing dental caries used a wild-type S. mutans strain that naturally produces an antibiotic 
called mutacin 1140 capable of killing all other strains of S. mutans [Hillman, 2002]. This strain was 
genetically modified by deleting the open reading frame for lactate dehydrogenase, to yield a viable 
strain called BCS3-L1, that still produced wild-type levels of mutacin 1140, but notably produced no 
lactic acid [Hillman et al., 2000]. In laboratory and animal models, the BCS3-L1 strain proved to have 
significantly reduced cariogenic potential. It persistently and pre-emptively colonized tooth sites 
normally occupied by wild-type S. mutans strains, with no reported adverse effects [Hillman et al., 
2000]. To overcome safety issues and to enable the altered strain to be implanted into human oral 
biofilms for clinical trials, additional genetic modifications of BCS3-L1 was done to facilitate its rapid 
elimination should an adverse event manifest itself. This strain was designated as A2JM and was 
extensively tested to assure its safe use in Phase I clinical trials [Hillman et al., 2007].  
 
It has also been suggested that hypocariogenic strains exhibiting only defects in acid 
production are unlikely to compete successfully with wild-type strains for initial plaque locations, 
and on this principle, a S. mutans strain that was deficient in the gcrR gene was genetically 
engineered for bacterial replacement therapy [Pan et al., 2013; Sun et al., 2009]. The gcrR gene 
functions as a negative transcriptional regulator of the gbpC gene, which encodes the Glucan-
binding lectin (GBL), an adhesin that is ubiquitous on S. mutans surfaces, and plays an important role 
in initial bacterial aggregation and adhesion to tooth surfaces. The MS-gcrR-def mutant bacteria 
showed reduced acid production, out-competed wild S. mutans strains with its strong early 
colonization ability, and lowered caries incidence in vivo [Pan et al., 2013].  
 
 Modulation of oral plaque biofilms with genetically engineered “designer” bacteria has great 
potential through fostering a healthy oral environment, which prevents the dominance of cariogenic 
bacteria. A single treatment regimen could lead to persistent colonization by the effector strain 
affording lifelong protection, with minimal need for patient compliance. Whilst there have been 
encouraging results with genetically modified strains, the concept of replacement therapy needs to 
be tested for effectiveness in highly cariogenic environments. Even if successful, the widespread 
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acceptance of genetically-engineered “designer” bacteria may prove to be difficult for emotional, 
ethical, and legal reasons. 
 
Other Approaches 
          In addition to the strategies discussed above, several other approaches for modifying plaque 
biofilm ecology are currently under investigation including using compounds that specifically affect 
bacterial virulence proteins [Horst et al., 2012], free radicals released from pH-responsive catalytic 
nanoparticles that can degrade the EPS matrix [Gao et al., 2016], calcium phosphate-osteopontin 
particles that can inhibit biofilm formation and reduce the fall in pH without affecting bacterial 
viability [Schlafer et al., 2017], graphene oxide [He et al., 2015] and ceramic water [Nomura et al., 
2017]. 
 
CONCLUSIONS 
 There is no doubt that fluoride will continue to be the mainstay of any caries prevention 
protocol as it still remains the most effective and economical protective agent against dental caries. 
However, fluoride alone may not offer complete protection against the disease, and it is generally 
recognized that the effectiveness of fluoride could be enhanced when combined with additional 
cariostatic agents [NIH, 2001]. Moreover, current paradigms emphasise the importance of 
maintaining a healthy and stable oral plaque biofilm for long-term disease control. One way to do 
this is to limit or exclude refined sugars from the diet. However, within the constraints of present-
day consumer culture behavioural dietary changes are difficult to achieve and sustain. Adopting 
ecological preventive measures can help in correcting the disturbed plaque ecology and drive the 
advent and persistence of a symbiotic oral microbiome. These could be valuable tools in achieving 
long-term dental caries control, allowing the clinician to shift to a biological model for the 
management of the disease. 
 
 It is imperative that the effectiveness of ecological preventive approaches be evaluated for 
success in individuals who consume a conventional diet containing a fairly high level of sugars before 
any clinical recommendations are made [Beighton, 2009]. Furthermore, rather than surrogate 
endpoints like lower MS levels or reduced acid production, the critically important outcome for all 
new caries preventive measures will be whether they can ensure a significant reduction in individual 
caries experience.  
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ABSTRACT 
Aetiological concepts of dental caries have evolved over the years from being considered as a 
disease initiated by nonspecific microorganisms, to being regarded as an “infectious” disease caused 
by specific bacteria, to the current paradigms that emphasise a “mixed bacterial-ecological 
approach” as being responsible for lesion initiation and pathogenesis. These aetiological paradigms 
are not just intellectual concepts but have important implications on how clinicians manage this 
age-old disease in the twenty-first century. Despite evidence-backed recommendations for 
adopting more biological measures to counter the disease, a significant proportion of dentists 
continue following traditional caries management guidelines in their daily clinical practice. This 
paper will review the evolving dental caries aetiological concepts and highlight the current evidence 
for adopting a more ecological approach to caries prevention, risk assessment, and treatment. 
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Dental caries remains the most common chronic disease in children (being five time as 
common as asthma), and is a major contributor to tooth loss in adults [Benjamin, 2010]. In fact, the 
most recent Global Burden of Disease report revealed that untreated caries in permanent teeth was 
the most prevalent human disease condition worldwide, with untreated caries in primary teeth 
being the tenth most prevalent disease [Kassebaum et al., 2015]. Dental caries is now recognised to 
belong to a group of diseases like cancer or diabetes that are considered “complex” or 
“multifactorial” with no single causation pathway [Fejerskov, 2004]. There have been important 
paradigm shifts in the aetiological concepts of the disease and it is now widely recognized that the 
earlier singular focus on Streptococcus mutans to assess caries risk status or success of preventive 
measures and treatment interventions is no longer a viable strategy. This article highlights the 
evolution of dental caries aetiological theories over the years and how this continues to have 
important implications for caries prevention, risk assessment, and treatment. 
 
EVOLVING PARADIGMS OF DENTAL CARIES AETIOLOGY 
The role of microbes in the development of caries lesions was suggested as early as 1890 
with the chemoparasitic theory of Miller [1973], and by the end of the nineteenth century it was 
commonly accepted that dental diseases were caused by the non-specific overgrowth of bacteria in 
dental plaque [Black, 1899]. According to this non-specific plaque hypothesis (NSPH) it was the 
quantity of plaque that determined levels of pathogenicity without discriminating between different 
levels of bacterial virulence. Applying the NSPH, it was recommended that the best way for 
preventing caries would be the mechanical removal of as much plaque as possible by tooth brushing 
or flossing [Rosier et al., 2014]. By the mid-twentieth century, Keyes and Fitzgerald’s famous animal 
model experiments revolutionised caries aetiological concepts by demonstrating that dental caries 
was an “infectious and transmittable” disease [Keyes, 1960; Tanzer, 1995]. In 1976, Loesche 
announced the specific plaque hypothesis (SPH), postulating that dental caries was an “infection” 
caused by specific bacteria within dental plaque [Loesche, 1976]. The specific bacteria that have for 
long been the cause célèbre for caries initiation and progression belonged to a group of Gram-
positive acidogenic and aciduric bacterial species, now designated as mutans streptococci (MS), of 
which Streptococcus mutans and Streptococcus sobrinus are the most common in humans. For 
decades most diagnostic, preventive and therapeutic interventions were directed against these 
microorganisms. For example, the SPH proposed the use of antibiotics against specific bacterial 
species as a method to prevent and treat dental caries [Loesche et al., 1977]. 
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However, it is now acknowledged that Robert Koch’s postulates on infectious diseases that 
focussed on specific pathogens as causative agents of disease are not applicable for microbial 
community-based diseases like dental caries or periodontitis. The bulk of the data that supports a 
relation between MS and dental caries can be considered associative rather than causative 
[Beighton, 2005]. There is also evidence showing that individuals with high MS levels do not 
necessarily develop caries lesions, while lesions have been detected even in the absence of MS 
[Galaviz et al., 2005; Kleinberg, 2002]. Furthermore, the specific bacteria suggested to be 
responsible for caries are actually part of the indigenous microflora and unlike foreign pathogens 
cannot be eliminated for long from the oral cavity by use of antibiotics. Thus, while dental caries is 
of course microbially induced, the important point is that it is caused by endogenous bacteria that 
are normal part of the resident microbiome, and not by specific exogenous bacteria acquired from 
outside the host, as in other infectious diseases [Fejerskov, 2004]. 
 
The Bacterial-Ecological Approach 
Contemporary concepts of dental caries aetiology and pathogenesis emphasise a “mixed 
bacterial-ecological approach” as being responsible for lesion initiation and progression [Kleinberg, 
2002]. Rather than being considered as an “infectious disease” caused by a specific organism, dental 
caries is now understood to be a biofilm-mediated polymicrobial disease [Marsh, 1994]. Caries 
lesions develop due to a catastrophic ecological shift in the plaque biofilm microbial flora, instigating 
an imbalance in the physiologic equilibrium between tooth mineral and biofilm fluid, and ultimately 
tipping the caries balance towards demineralization and lesion formation [Marsh, 2003]. According 
to this ecological plaque hypothesis (EPH), the critical factors that trigger an upsurge in the 
acidogenic/aciduric component of the oral microbiome are local environmental conditions like 
frequent dietary sugar exposures or salivary dysfunction. Dental caries can thus be considered to be 
an endogenous infection which may occur when members of resident flora obtain a selective 
ecological advantage over other species, disrupting the homeostatic balance of the biofilm, and 
thereby initiating the disease process [Marsh and Martin, 1999]. 
 
Takahashi and Nyvad proposed an extension of the caries EPH to explain the relation 
between the dynamic changes in the phenotypic/genotypic properties of plaque bacteria and the 
de-/remineralization equilibrium of the caries process [Takahashi and Nyvad, 2008, 2011]. They 
suggested that the oral plaque biofilm is a dynamic microbial ecosystem with different microbial 
communities associated with the three reversible stages of the caries process (dynamic stability 
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stage, acidogenic stage, and aciduric stage). Mutable bacterial ecological succession takes place in 
the plaque biofilm at each stage of the caries process, depending on the severity and frequency of 
biofilm acidification [Takahashi and Nyvad, 2011]. It is only when the acidogenic environment is 
prolonged that highly aciduric bacteria like MS or lactobacilli, begin to dominate and replace the 
“low pH” non-MS, Actinomyces spp., or Veillonella spp. that are the main species populating the 
plaque microflora in the early stages of incipient (non-cavitated) carious lesions. Even at the highly 
aciduric stage, microbial composition and mineral loss can be reversed provided the 
acidogenic/aciduric properties of the biofilm are modified by adopting effective preventive 
measures such as restricting dietary sugar exposures [Takahashi and Nyvad, 2008]. The significance 
of the extended EPH model is that it is not the bacterial genotype per se, but the phenotypic 
characteristics (acidogenic and aciduric properties) and their regulatory parameters that are more 
relevant for causing a microbial ecological shift leading to caries [Takahashi and Nyvad, 2011]. There 
is now a consensus that any bacterial species can participate in the caries process as long as they 
are aciduric and dominant [Bowden, 1984]. 
 
These caries ecological concepts have been confirmed by recent DNA- and RNA-based 
molecular studies that have uncovered an extraordinarily diverse microbial ecosystem, where S. 
mutans accounts for a very small fraction (0.1% -1.6%) of the bacterial community implicated in the 
caries process [Simon-Soro and Mira, 2015]. Oral microbiologists have now expanded the principal 
bacterial species in caries-associated microbiomes from the traditional culture-isolated cariogenic 
bacteria like S. mutans, S. sobrinus, Lactobacillus, and Actinomyces to include bacterial species like 
non-MS, Bifidobacterium, Scardovia wiggsiae, Prevotella spp., Selenomonas, Olsenella spp., 
Atopobium spp., Capnocytophaga and many more [Aas et al., 2008; Gross et al., 2012; Tanner et al., 
2016]. In addition, bacterial-fungal associations can also synergistically enhance cariogenic biofilm 
virulence, with Candida albicans frequently detected in high numbers in plaque biofilms of children 
with early childhood caries (ECC) [de Carvalho et al., 2006; Raja et al., 2010]. This was an intriguing 
observation as Candida does not normally associate well with S. mutans, nor colonise teeth or 
metabolise sucrose effectively on its own [Koo and Bowen, 2014]. However, recent studies have 
demonstrated a symbiotic relationship exists between S. mutans and C. albicans, mediated through 
the influence of bacterially-derived glucosyltransferases, contributing to the increased severity of 
ECC [Falsetta et al., 2014; Gregoire et al., 2011; Kim et al., 2017]. These findings prompt the 
possibility of incorporating anti-Candida therapy also in the treatment of virulent ECC [Koo and 
Bowen, 2014]. 
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The polymicrobial nature of carious lesions implies that consortia formed by multiple 
microorganisms act collectively, probably synergistically, to initiate and advance the disease [Simon-
Soro and Mira, 2015]. The 16S RNA-based estimates of microbial diversity over carious lesions also 
show different microbial consortia are formed in the dental plaque of different individuals. These 
microbial combinations have essentially the same functional profile, indicating that focussing on 
metabolic output of microbial communities would be more useful in controlling the disease 
regardless of the specific microbial compositions involved in the process [Simon-Soro and Mira, 
2015; Takahashi and Nyvad, 2011]. 
 
Health-associated Microbial Communities 
Another evolving paradigm in our understanding of the caries-associated microbiome is the 
role that health-promoting oral microbial communities can play in mitigating acid produced by 
cariogenic bacteria [Dewhirst, 2016].  Many oral commensal bacteria can counter the low pH 
produced by acidogenic organisms by using arginine or urea to generate ammonia [Nascimento et 
al., 2009]. Such alkaline metabolites produced by “healthy” bacteria can play a major role in 
maintaining biofilm homeostasis to beneficially alter the de-/remineralisation equilibrium. Research 
has also shown microbial biodiversity to be crucial to health, with plaque and saliva of healthy 
individuals revealed to be much more diverse than originally hypothesized [Filoche et al., 2010]. 
Results from clinical studies have shown that oral microbiomes of children with ECC were 
significantly less diverse than those of children without ECC, confirming that diversity in plaque 
microbial communities is essential for maintaining oral health [Kanasi et al., 2010]. From the applied 
viewpoint, the use of broad-spectrum biocides like chlorhexidine for long-term caries control may 
not be desirable as they would cause an indiscriminate suppression of the entire oral microbiota 
[Caufield et al., 2001]. 
 
Genetic Factors 
 Genetic factors can also be responsible for microbial ecological shifts that lead to disease. 
An individual’s genotype can potentially prevent the existence of certain beneficial bacteria or allow 
pathogenic species to reside and contribute to its unique microbiome [Turnbaugh et al., 2007]. The 
criticism of the caries EPH is that it does not consider host genetic susceptibility to caries [Rosier et 
al., 2014]. A salient observation from the unethical Vipeholm study was that about 20% of the 
individuals who received high frequency cariogenic snacks for two years did not develop dental 
caries, and this genetic resistance to caries was further supported by the observation that parents 
30 
 
and siblings of these individuals also showed lower caries prevalence than the rest of the population 
[Böök and Grahnén, 1953; Gustafsson et al., 1954]. There is now additional recent evidence that 
certain at-risk individuals and population groups are genetically more susceptible to dental caries 
[Bretz et al., 2005; Opal et al., 2015; Wang et al., 2013], implying that hereditary factors should also 
be considered while planning individual caries management protocols. 
 
In summary, the current ecological model of dental caries presents a complex picture of a 
multifactorial, pH-driven disease whose onset and progression is influenced by multiple pathogens, 
systemic effects, and hereditary components layered on interactions of diet, behavioural, 
environmental, socioeconomic, and physiological risk factors. The caries process can be considered 
as a model system of dynamic amphibiosis, where under normal environmental conditions the 
biofilm microorganisms live in a symbiotic relationship with the host, characterised by 
commensalism and mutualism.[Ruby and Goldner, 2007] The nature of this symbiosis may shift 
under changing local environmental conditions with mutualism becoming parasitism, and this 
dynamic adaptation is the basic principle that underlines our current understanding of endogenous 
disease processes like dental caries.  
 
ORAL CARE IMPLICATIONS 
 The current aetiological paradigms of the dental caries have important consequences for 
oral care. Complex diseases like dental caries that arise from the concerted action of biofilm-
embedded polymicrobes, risk-conferring behaviours, environmental influences, and genes present 
clinical challenges on how these multiple contributing factors can be assessed in a way that can be 
translated into effective approaches for caries prevention, risk assessment, and therapy. 
Contemporary evidence-backed recommendations for management of dental caries, based on the 
ecological-biofilm concepts of the disease, have revolutionised many conventional caries 
management philosophies, and clinicians need to be aware of the emerging evidence with regards 
to prevention, risk-assessment and treatment of dental caries. 
 
Dental Caries Prevention  
With the mechanism of dental caries now well established, new strategies are being sought 
for better targeted caries prevention based on a scientific understanding of the processes involved. 
The earlier focus on determining the specific causative agents is giving way to ecology-based 
propositions where the disease is seen as the output of a skewed microbial community caused by 
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environmental changes. While fluoride will remain the cornerstone of any dental caries preventive 
protocol, a consensus is emerging that preventive measures should also focus on remediation of 
environmental pressures responsible for the plaque biofilm dysbiosis, while maintaining the 
resident microbiota at levels compatible with health [Marsh et al., 2015]. 
 
Advising patients to reduce dietary exposure to fermentable carbohydrates is clearly the 
most effective approach to prevent acidification and the detrimental ecological shift of the plaque 
biofilm. However, requiring individuals to modify their dietary behaviour as part of caries 
prevention, is usually the most difficult advice for patients to adhere to [Duggal and van Loveren, 
2001]. Additional preventive measures that are synergistic with fluoride have thus been advocated 
for high caries-risk groups [NIH, 2001]. Ecological caries preventive approaches are probably the 
next frontier in the long-standing attempts to obtain control over this ubiquitous disease. These 
preventive measures are based on the current caries aetiological paradigms, where an ecologically 
balanced and diverse microbiome is seen as the key to long-term control over the disease. Ecological 
preventive approaches can broadly be divided into measures that either enhance the growth of 
health-promoting microbial communities within the plaque biofilm, or antimicrobial strategies that 
can weaken cariogenic biofilm virulence properties without eliminating the entire microbiome. 
Examples include prebiotics, probiotics, antimicrobial peptides (AMP), sugar polyols, 
phytochemicals, quorum-sensing (QS) targets, and genetically-modified designer bacteria. 
 
The ecological preventive approach that is probably the most evidence-backed is the use of 
prebiotics like arginine or urea. Prebiotics are nutritional substrates that commensal bacteria can 
breakdown to alkalise the biofilm, thus preventing the overgrowth of acidogenic/aciduric bacteria. 
The nutritional stimulation of endogenous oral flora to restore microbial balance and promote oral 
health has been validated in mixed species models [Slomka et al., 2017]. A substantial body of 
evidence from microbiological, genetic, and biochemical analyses suggests that alkali generation in 
dental biofilms contributes to inhibition of dental caries [Liu et al., 2012]. Additionally, human in situ 
studies, double-blinded RCTs, and systematic reviews have demonstrated that a 1.5% arginine-
containing fluoride toothpaste (Colgate Maximum Cavity Protection plus Sugar Acid Neutraliser™) 
provided significantly greater protection against caries than a fluoride dentifrice alone [Cantore et 
al., 2013; Kraivaphan et al., 2013; Li et al., 2015; Petersen et al., 2015; Srisilapanan et al., 2013]. 
Although other reviews have questioned the dentifrice’s preventive efficacy and its comparative 
higher costs [Astvaldsdottir et al., 2016; Shaw et al., 2015], the preponderance of evidence does 
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seem to suggest that arginine-fluoride dentifrices offer a new standard of care for caries prevention 
in high-risk patients [ten Cate and Cummins, 2013]. An alternative to arginine dentifrices may be a 
toothpaste containing enzymes and proteins (Zendium™), that was recently shown to boost oral 
defences by promoting a beneficial shift in the oral microbial ecology [Adams et al., 2017]. However, 
more comprehensive randomised controlled trials (RCTs) regarding its caries preventive effects are 
required before firm clinical recommendations can be made. 
 
The use of probiotic bacteria (lactobacilli and bifidobacteria) to support health-associated 
microbes or restore diversity in the oral plaque biofilm is enjoying growing popularity as an 
ecological method to control dental caries. However, while probiotics may indeed improve 
surrogate caries markers (e.g. reduced MS counts) [Laleman et al., 2014], there are doubts on 
whether this actually results in any reduction in individual caries experience [Twetman and Keller, 
2012]. Another drawback of using traditional probiotics for caries prevention is the potentially 
harmful acidogenic effects of many commonly used oral probiotic bacterial strains. [Gruner et al., 
2016] Furthermore, the traditional use of gut-associated lactobacilli and bifidobacteria probiotic 
species to promote oral health may not succeed as these non-oral bacterial strains cannot efficiently 
colonise the oral niche, which is vital for the long-term success of probiotics. A more promising 
breakthrough in the use of oral probiotics for caries prevention is the recent identification of two S. 
mutans-antagonistic oral probiotic strains, Streptococcus dentisani and Streptococcus A12. Both 
these bacteria are natural oral commensal species having double probiotic action, as they not only 
inhibit the growth of major oral pathogens but can also moderate plaque pH through their 
arginolytic actions [Huang et al., 2016; Lopez-Lopez et al., 2017]. However, clinical 
recommendations would be premature at this stage without evidence from RCTs showing significant 
reductions in caries increment on using these oral probiotics.  
 
Another long-standing approach to promote healthy biofilms is the use of non-fermentative 
sugar polyols (e.g. xylitol, sorbitol, erythritol) that are believed to inhibit virulent bacteria allowing 
healthy bacteria to dominate in the biofilm. Despite an immense body of literature, the caries 
preventive effects of xylitol oral products remain inconclusive, with more recent data concluding 
that there is limited evidence to show that xylitol provided any additional benefit beyond other 
preventive measures [Duane, 2015; Lee et al., 2015; Riley et al., 2015]. Among the sugar polyols, 
erythritol may be the one that hold most promise, as new studies indicate that it may be more 
effective than xylitol and sorbitol, and critically, its anti-caries effects were shown to persist for up 
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to three years after the intervention ended [de Cock et al., 2016; Falony et al., 2016; Honkala et al., 
2014]. 
 
 The other side of the ecological preventive approach is to use antimicrobial agents to modify 
the plaque biofilm. It is logical to assume that caries prevention can potentially be improved by 
combining fluoride, which predominantly has physiochemical effects on the hard dental tissues, 
with biological agents that can reduce the severity of the bacterial attack on teeth.  However, many 
of the commonly available toothpastes and mouthwashes use broad-spectrum antimicrobials which 
can cause an undesirable suppression of even the healthy plaque microflora. There is now a 
consensus that antimicrobials used for dental caries prevention should be more subtle in their anti-
plaque actions, aiming to undermine bacterial virulence properties (e.g. glucan synthesis or acid 
production) rather than bacterial viability [ten Cate and Zaura, 2012]. Promising antimicrobial 
measures with biofilm-modifying cariostatic action include specifically targeted antimicrobial 
peptides (STAMP) [Kaplan et al., 2011], natural phytochemicals [Koo et al., 2010; Koo et al., 2005], 
genetically-engineered S. mutans strains [Hillman et al., 2007; Pan et al., 2013], and QS-targeting 
compounds [Janus et al., 2016; Qi et al., 2005]. Although promising, the ultimate success of these 
antimicrobial ecological approaches will depend on their ability to effectively act in the highly 
cariogenic oral environments, often found in high-risk individuals, where there is frequent biofilm 
acidification due to multiple sugar exposures.  
 
The changed paradigms of dental caries has implications for dental public health 
programmes too. A consequence of dental caries being a multifactorial disease is that a particular 
preventive program that is successful in one population group, need not be so in another population 
group with different cultural and behavioural habits.  The complexity of the disease also implies that 
dental caries can never be 100% preventable at the individual or societal level [Fejerskov, 2004]. 
What this implies is that a well-trained dentist should regularly monitor patients for any change in 
their oral environmental conditions to avoid new lesions. 
 
Caries-risk Assessment 
 Caries-risk assessment (CRA) is fundamental to modern caries management protocols, 
assisting the clinician in making decisions regarding the type of diagnostic procedures, 
preventive/treatment interventions, and recall intervals required for each patient. When high 
caries-risk patients are effectively identified, more resources and intensive preventive interventions 
can be directed towards them, while avoiding redundant diagnostic procedures and therapy in 
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patients at low-risk of developing caries lesions. Past caries experience has been demonstrated to 
be the best risk predictor of the disease in every age group [Mejare et al., 2014; Powell, 1998]. 
However, this metric does not provide an explanation for the heightened risk, and thus may not 
suggest the best avenue for prevention. 
 
 Microbiological tests on the levels of MS or lactobacilli in plaque or saliva have traditionally 
been used to predict an individual’s risk of developing caries lesions. However, with an entire 
consortium of acidogenic/aciduric bacterial species now known to be involved in the caries process 
such microbial tests have limited applicability in assessment of caries activity and in risk prediction 
[Bowden, 1997]. For instance, eating habits and socio-economic status of children and their 
caregivers have been shown to be better predictors of ECC than MS titre levels [Nunn et al., 2009]. 
The high MS levels detected in patients with severe ECC can be considered an incidental 
consequence of the frequent acidification of plaque by poor eating habits, rather than an early risk 
predictor [Takahashi and Nyvad, 2011].  The fact that S. wiggsiae has been shown to have the same 
prevalence as S. mutans in ECC lesions, or that Bifidobacterium dentium was found in cavitated 
lesions but never in healthy plaque, suggests that assessing combined levels of several indicator 
aciduric bacterial taxa may be more useful for risk prediction [Henne et al., 2015]. Microbiological 
tests should only be considered as one component of the patient’s caries risk history, establishing a 
norm for the individual patient, with any deviations from this indicating a change in the oral 
environment [Bowden, 1997]. 
 
The recognition of the multifactorial aetiology of dental caries has led experts and 
professional bodies to develop multivariate CRA systems accounting for each of the disease-
associated factors, assessing them not in isolation but with regards to their unique and dynamic 
interactions. Examples of some of the currently recommended CRA protocols include the cariogram 
model [Petersson et al., 2002], the caries management by risk assessment (CAMBRA) system 
[Featherstone et al., 2007; Ramos-Gomez et al., 2007], the American Academy of Paediatric 
Dentistry’s caries-risk assessment tool (CAT) [AAPD, 2013], systems of the American Dental 
Association [ADA, 2009, 2011], the Traffic Light Matrix system (TLM) [Ngo and Gaffney, 2005], and 
the Dundee caries risk assessment model (DCRAM) [MacRitchie et al., 2012]. 
 
The clinical utility of these protocols to guide the design of precise personalised care has 
been questioned with a systematic review finding that the validity of some the commonly used CRA 
protocols (cariogram, CAMBRA, CAT, and ADA) to accurately predict caries risk is limited [Tellez et 
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al., 2013]. This has been confirmed with the cariogram model shown to be not “particularly useful 
in identifying high caries risk patients in a low-caries community” [Holgerson et al., 2009], while the 
CAMBRA protocol was not able to significantly distinguish between the low and moderate caries-
risk groups [Tellez et al., 2015]. A more recent critical review suggested that it was fallacious to 
transfer and apply population risk estimates to assess individual caries risk [Divaris, 2016]. For 
example, ECC risk factors shown to be consistently correlated with caries prevalence in large 
population studies are poor predictors of individual lesion occurrence. 
 
 However, many of these CRA tools still have excellent pedagogical value, facilitate 
communication with patients, and have the potential to enhance oral care by identifying the specific 
causes for the caries activity, allowing the clinician to customise the treatment plan according to 
individualised needs of patients [Divaris, 2016; Domejean et al., 2017].  For a more comprehensive 
risk assessment and personalised caries care plan, clinicians may be advised to adopt the 
international caries classification and management system (ICCMS) [Pitts and Ekstrand, 2013], or 
the system for total environmental management (STEM) protocol [Walsh, 2008], as these include 
explicit patient-level assessments as part of the overall disease management. 
 
Dental Caries Treatment 
 Caries treatment approaches have progressed over an extended timeframe from the early 
extractive phase to the commonly practiced restorative phase through to the currently 
recommended preventive/preservative phase [Pitts, 2004]. The evidence for the evolution of caries 
management philosophies from a restorative-only approach to a preventive/preservative approach 
has now been available for at least a couple of decades [Elderton, 1993; Mertz-Fairhurst et al., 
1998]. Unfortunately, caries management continues to be skewed to “drilling” and “filling”, with a 
recent systematic review and meta-analysis finding that a significant proportion of dentists continue 
to intervene invasively (restoratively) on carious lesions where clinical recommendations indicate 
less invasive therapies should be used [Innes and Schwendicke, 2017]. The largely technical and 
mechanistic approaches to tooth restoration ignores the emerging evidence strongly 
recommending more biological approaches to controlling disease causative factors and the need for 
clinicians to adopt the principles of minimum intervention dentistry (MID) for treating non-cavitated 
and cavitated lesions [Pitts and Zero, 2016]. The overarching approach to caries management in the 
21st century should be to “preserve the tooth structure and restore only when necessary” [Ismail et 
al., 2013]. 
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 The rationale underpinning many of the current recommendations for managing caries 
lesions are based on the aetiological paradigms of EPH. Fundamental to the EPH is that unless there 
is an attempt to interfere with the environmental factors driving the biofilm dysbiosis, the patient 
is likely to suffer from repeated episodes of the disease and the clinician will encounter frequent 
failure of any restorative or preventive treatment rendered. Most restoration failure is due to 
secondary caries associated with restorations and sealants (currently referred to as CARS), 
highlighting that patient risk factors should be regularly monitored and actively managed 
[Domejean et al., 2017]. While repairing cavitations (the end result of the disease process) is 
important, these are merely symptoms of the disease, and alleviating symptoms by restorations 
alone cannot proffer a “final solution” to the disease [Walsh, 2008]. It is wrong to assume that 
drilling out a caries lesion and placing a restoration eliminates bacteria and stops the disease process 
[Featherstone, 2000]. With the extended EPH establishing a firm association between plaque 
microbiome diversity and the de-/remineralization caries equilibrium, a biological understanding of 
the disease process and its associated microbiome is vital for successful clinical management of 
dental caries. 
 
 There are now excellent papers detailing the contemporary guidelines for operative 
management of caries lesions in permanent and primary teeth based on the recommendations of 
the International Caries Consensus Collaboration (ICCC) [Banerjee et al., 2017; Schwendicke et al., 
2016]. These consensus recommendations underscore the pathological basis of dental caries as a 
biofilm disease and emphasise that both the prevention of new lesions and management of existing 
lesions should primarily focus on biofilm management rather than tissue removal. Although some 
of these recommendations may seem counterintuitive to decades of clinical practice and dental 
training, they are in keeping with our current understanding of the dental caries disease process. 
For instance, in teeth with deep cavitated lesions, it is recommended that carious tissue be removed 
only to create conditions for long-lasting, tightly sealed restorations, and all the bacterially 
contaminated (soft/infected dentine) or demineralised tissue close to the pulp need not be removed 
[Schwendicke et al., 2016]. This makes sense once it is accepted that dental caries is tissue 
destruction caused by bacterial metabolism in the biofilm – if the disease process can be arrested 
by modifying the biofilm, the symptoms of the disease (demineralised dentine) is removed purely 
to create a sufficiently large surface to bond to and optimise the longevity of a restoration. Once 
bacteria are sealed into the tooth, the biofilm is physically prevented from accessing nutrition and 
an actively carious lesion becomes an arrested lesion. 
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A number of studies have clearly shown that the microbiological load in infected dentine is 
progressively reduced when it is sealed off from the oral environment [Bjorndal et al., 1997; Mertz-
Fairhurst et al., 1998; Paddick et al., 2005; Weerheijm et al., 1999]. The gradual reduction in lesion 
activity allows time for the pulp-dentine complex to lay down tertiary and peri-tubular dentine 
providing further protection to the pulp complex and reducing risk of pulp exposure [Ricketts et al., 
2013]. Multiple RCTs and systematic reviews have not found any detrimental effects to the pulp by 
sealing in bacteria [Bjorndal et al., 2010; Hesse et al., 2014; Innes et al., 2007, 2011; Mertz-Fairhurst 
et al., 1998; Orhan et al., 2010; Ricketts et al., 2013]. These include the classical studies of the Mertz-
Fairhurst group which showed that bonded and sealed composite restorations placed over frank 
cavitations arrested the clinical progress of these lesions even at 10 years, profoundly changing our 
concepts of how much demineralised dentine may be left during cavity preparation [Kidd, 2016]. A 
similar rationale supports the use of the Hall technique, where preformed stainless steel crowns are 
placed directly over asymptomatic carious primary molar teeth without removing any carious tissue 
(and hence not requiring any local anaesthesia or tooth preparation). This radical treatment option 
gave rise to a great deal of controversy and questions in the past [Croll et al., 2015; Nainar, 2012], 
but as authors of a recent seminal paper on the Hall technique assert “emotion, misinformation, 
and outdated ideas have been used in arguments against Hall crowns rather than logic, 
understanding or evidence” [Innes et al., 2017]. There is now robust evidence showing that the Hall 
technique, when appropriately used in indicated teeth (clear band of dentine between carious 
lesion and pulp), has success rates superior to comparator treatment [Boyd et al., 2017; Innes et al., 
2007, 2011; Innes et al., 2015; Santamaria et al., 2014]. Given the high success rate and patient 
acceptability of the Hall technique, clinicians still reluctant to offer this treatment option, need to 
examine why they are treating a child more invasively when a less invasive option is available [Innes 
and Manton, 2017]. 
 
Many of the core principles of MID elucidated by Walsh and Brostek [2013] are also in 
keeping with the current aetiological and preventive/preservative paradigms of dental caries. These 
MID principles include: recognition (of disease contributory factors); re-orientation (of the 
contributory lifestyle factors); remineralisation (of both cavitated and non-cavitated lesions); repair 
(only when other solutions are not possible); and review (to ensure healthy oral and life 
environment is maintained) [Innes and Manton, 2017; Walsh and Brostek, 2013]. The chance for 
MID to be successful is increased if dental caries is not considered as an infectious disease but rather 
a behavioural disease with a bacterial component.  
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By approaching the clinical situation of caries from a biological standpoint, the vicious cycle 
of treatment and retreatment of CARS can be terminated. This is done most effectively by evaluating 
and tackling the risk factors that fuel the disease process and adopting one of the several biological 
management options available. These contemporary caries management philosophies are 
consistent with the ICCMS or STEM, whose intergral aims are to preserve tooth structure with non-
operative biological care at the initial stages, and conservative tooth-preserving operative care at at 
more extensive stages of the carious lesion. 
 
CONCLUSIONS 
 About 700-800 bacterial species have been identified from the human oral microbiome 
making the mouth the most microbiologically diverse environment in the body. Both traditional as 
well as newly identified bacterial species have an important role in the caries process, and from an 
ecological point of view it may be more important to describe what the bacteria are doing in the 
biofilm community rather than which bacteria are present [Takahashi, 2015]. Given the 
polymicrobial nature of dental caries, it is predicted that diagnostic, preventive, and treatment 
strategies directed toward specific bacterial species will not be universally effective [Simon-Soro 
and Mira, 2015]. Another important change in perspective is the realisation that there are beneficial 
members of the oral microbiome and an understanding of health and disease requires knowledge 
of all microorganisms, not just a select few pathogens.  
 
Dental caries affects all age groups, and can have particularly devastating, life-long 
consequences in young children, while in the elderly it can compromise an individual’s ability to eat 
leading to malnutrition and expediting mortality. It is thus critical that dentists recognize the 
evolving aetiological paradigms of the dental caries process and its clinical implications. Oral health 
care professionals need to incorporate contemporary evidence-based guidelines into their routine 
practice for the benefit of their patients.  Further education and training for dental practitioners, 
coupled with fairer remunerative schemes, would encourage a change in favour of the provision of 
more biological approaches towards prevention and treatment of dental caries [Suga et al., 2014]. 
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2.2 LITERATURE REVIEW: NATURAL PRODUCTS 
 
2.2.1  REVIEW PAPER 3 
 
Potential Role for Natural Products in Dental Caries Control 
  
This paper presents the emerging evidence on the anti-cariogenic properties of natural 
products and the rationale for their use in controlling dental caries. The paper also 
discusses the challenges and future research directions needed to translate the 
cariostatic potential of natural products into clinically relevant oral care products. 
 
The paper was published in Oral Health and Preventive Dentistry, the official publication 
of the European Society for Preventive Dentistry. 
 
Oral Health Prev Dent; DOI: 10.3290/j.ohpd.a42741. 
 
This chapter is comprised of the publication as it stands in print.  
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ABSTRACT 
Dental caries is today recognised as a polymicrobial biofilm-mediated behavioural disease resulting 
from an unfavourable ecological change in the oral microbiome. In addition to fluoride-based 
preventive measures, the importance of adopting ecological approaches to dental caries prevention 
is being increasingly highlighted. This has resulted in renewed interest in the anti-cariogenic 
properties of a number of natural products, especially those that have the ability to inhibit 
cariogenic virulence properties or bacterial adhesion without disrupting the key health benefits of 
the resident oral microbiome. Other cariostatic mechanisms identified for natural products include 
phytochemicals that can inhibit demineralization and enhance remineralization thereby beneficially 
rebalancing the caries equilibrium, and natural non-fermentable dietary sweeteners that can reduce 
the acidogenic challenge posed by sugar-laden foods or beverages. There are however a number of 
significant challenges to which future research needs to be directed in order to translate the 
potential of cariostatic natural products into clinically relevant oral care products for dental caries 
control. 
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The term “natural products” is generally used to refer to secondary metabolites or 
phytochemicals derived from plants, herbs, spices, and fruits. While not essential nutrients, these 
bioactive chemicals are believed to be responsible for much of the disease protection conferred by 
diets rich in plant-based products [Arts and Hollman, 2005]. The influence of diet on oral health is 
indisputable, as can be clearly observed in populations consuming high quantities of polyphenol-
rich foods [Signoretto et al., 2010; Taylor et al., 2005]. Both Eastern and Western civilisations have 
used natural products to prevent or treat oral maladies, from recipes of herbal mouthwashes and 
dentifrices mentioned in the Ebers Papyrus, to the use of plant-based products to cure bad breath 
by Greek and Roman physicians. The advent of the “Antibiotic Era” in the mid-20th century did shift 
the emphasis away from natural product-based formulations. However, the emergence of 
antibiotic-resistant bacterial strains and other adverse effects of synthetic chemotherapeutics have 
rekindled interest in the search for biocompatible natural antimicrobial agents, including those with 
activity against cariogenic biofilms. 
 
Dental caries results from a deleterious shift in the microbial ecology of the resident oral 
microbiome, rather than from any exogenous “infection” acquired from outside the host [Fejerskov, 
2004]. Under normal oral environmental conditions, the dental plaque biofilm has a symbiotic 
relationship with the host characterised by commensalism and mutualism [Ruby and Goldner, 
2007]. However, deleterious lifestyle factors (e.g. frequent exposure to fermentable carbohydrates) 
can alter local environmental conditions, causing biofilm dysbiosis, resulting in the 
acidogenic/aciduric members of resident oral flora gaining a selective ecological advantage over 
other commensal species. This disrupts the homeostatic balance of the biofilm and initiates the 
dental caries disease process [Marsh, 2003]. While dental caries is undoubtedly a microbial disease, 
it is imperative not to perturb or lose the beneficial functions delivered by the resident oral 
microbiome by non-specific mechanical plaque removal or application of broad-spectrum 
antimicrobials [Philip et al., 2018; Yoo et al., 2011]. Consumer oral care products should ideally focus 
on maintaining the composition and activity of healthy plaque microflora rather than eliminating 
them completely [Marsh et al., 2015]. Natural products have exhibited the potential to maintain the 
delicate balance needed to control oral microflora at levels compatible with health and could be 
valuable adjuncts to control biofilm-mediated oral diseases like dental caries. 
 
Various antimicrobial agents have been recommended for caries control in high-risk 
individuals, from biocides like chlorhexidine [Ribeiro et al., 2007], triclosan [Chen et al., 2010], and 
42 
 
cetylpyridinium chloride [Holbeche et al., 1976] to antibiotics like vancomycin [De Paola et al., 
1974], based on their ability to reduce levels of mutans streptococci (MS). However, most of these 
chemotherapeutic agents exert a broad-spectrum of antimicrobial action, suppressing even the 
health-associated commensal microflora. Randomised controlled trials (RCTs) and systematic 
reviews have indicated that their long-term effectiveness in preventing new lesions in highly caries-
active patients is limited [Plonka et al., 2013; Twetman, 2004]. Natural products that can specifically 
target bacterial adherence, glucan synthesis, or biofilm matrix acidification without killing beneficial 
microbes are an attractive alternative to traditional broad-spectrum microbicides [Jeon et al., 2009]. 
Furthermore, oral products containing synthetic antimicrobials can cause a number of adverse 
effects making their long term use impractical [Eley, 1999; Marsh, 1991]. Natural antimicrobials, on 
the other hand, generally have excellent biocompatibility allowing for the improved compliance and 
public acceptance of oral care products containing them. 
 
Cariostatic natural agents acting in concert with the anti-caries effects of fluoride could be a 
promising strategy for long-term dental caries prevention [Jeon et al., 2011]. Animal model caries 
studies have shown that fluoride-phytochemical combinations were as potent as fluoride-
chlorhexidine controls in caries inhibition, with the added benefit that the resident oral microbiota 
were not affected [Koo et al., 2010; Koo et al., 2005]. Evidently, the emerging field of phytodentistry 
can be particularly promising for the prevention of biofilm-mediated oral diseases like dental caries 
[Chenicheri et al., 2017].  This paper discusses the cariostatic mechanisms of some of the most 
promising natural products and the research directions that are needed to translate the potential 
of natural products into commercial oral care products for dental caries control. The search strategy 
for this narrative review involved performing a comprehensive literature search to capture all 
published studies (up to December 2017) specifically related to natural products with anti-caries 
effects. The databases searched were MEDLINE (via PubMed), EMBASE, and Web of Science using a 
combination of controlled vocabulary and text words. The reference list of all selected studies were 
also hand searched for additional relevant studies. 
 
NATURAL PRODUCTS: CLASSIFICATION AND CARIOSTATIC MECHANISMS 
Naturally occurring bioactive compounds possess structures that have high chemical 
diversity and biochemical specificity that make them attractive candidates for drug discovery and 
development [Koehn and Carter, 2005]. Phytochemicals from natural sources have been classified 
into three broad groups based on their chemical structure [Chinou, 2008]: (i) polyphenols, which 
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are the most widely distributed phytochemicals in the plant kingdom, (e.g. flavonoids, Fig. 3); (ii) 
terpenoids, which include the essential oils used in some anti-plaque mouthwashes (e.g. thymol and 
eugenol); and (iii) alkaloids, which are nitrogen-containing compounds (e.g. sanguinarine). 
 
 
Figure 3. Different classes of flavonoids and their food sources 
 
Three potential antimicrobial mechanisms have been identified for natural products to 
inhibit dental caries: (i) antibacterial activity through the inhibition of bacterial growth and 
metabolic activity; (ii) inhibition of glucan synthesis through suppressing glucosyltransferase (Gtf) 
activity; and (iii) inhibition of bacterial adherence [Jeon et al., 2009].  In addition to these 
antimicrobial properties, other proposed modes of cariostatic action include modulation of the 
demineralization-remineralization caries equilibrium, and natural products that provide a source of 
non-fermentable sugar substitutes. A summary of selected key natural products, their reported anti-
caries mechanisms, and the bioactive phytochemicals believed to be responsible for these 
cariostatic actions is presented in Table 1 below. 
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Table 1. Natural products with anti-caries activity 
 
 
Natural Product Source Studies 
[authors, year] 
Bioactive 
phytochemicals 
Cariostatic Effects 
Cacao bean husk Matsumoto et al., 2004; 
Ooshima. et al., 2000; 
Osawa et al., 2001; 
Venkatesh et al., 2011 
Oleic acid, linoleic acid 
and epicatechins 
Oleic & linoleic acids have 
bactericidal actions at 
concentrations of 30 µg/mL. 
Epicatechins displayed anti-Gtf 
activity. 
 
Cinnamon (Cinnamomum 
camphora) 
Chaudhari et al., 2012; 
Gupta et al., 2011 
 
Cinnamaldehyde and 
eugenol 
Anti-bacterial action against 
MS. 
Cranberry (Vaccinium macrocarpon) Duarte et al., 2006; 
Gregoire et al., 2007; Koo 
et al., 2010 
Polyphenols like PACs, 
flavonols, phenolic 
acids and anthocyanins 
Inhibits acidogenicity and 
aciduricity.  
Disrupts glucan synthesis with 
anti-Gtf activity. 
Reduces caries lesion 
development in vivo 
 
Crustacean shells Busscher et al., 2008; 
Hayashi et al., 2007; Tarsi 
et al., 1997 
 
Low molecular-weight 
chitosans 
Inhibitory effects on S. mutans 
adhesion to tooth surfaces. 
Galla chinensis Cheng et al., 2011; Cheng 
et al., 2008, 2010; Xie et 
al., 2008 
Gallic acid and other 
polyphenols 
Inhibits demineralization, 
enhances remineralization and 
fluoride effects. 
Inhibits polymicrobial biofilm 
development. 
 
Ginger (Zingiber officinale) Hasan et al., 2015 Flavonoids and 
gingerols 
Inhibits multiple S. mutans 
virulence factors including 
glucan synthesis, adherence, 
F1F0-ATPase activity and 
acidogenicity. 
 
Guava (Psidium guajava) Jain et al., 2014; Prabu et 
al., 2006 
Guaijaverin Bacterial growth inhibitory 
activity with MICs 
against S. mutans between 2-4 
mg/mL. 
 
Hop bracts (Humulus lupulus) Shinada et al., 2007; 
Tagashira et al., 1997 
Not known Inhibitory effects against 
cellular adherence, Gtf activity 
and plaque accumulation. 
 
Javanese Turmeric (Curcuma 
xanthorrhiza) 
Hwang et al., 2000; 
Hwang et al., 2000a 
Xanthorrrhizol Growth inhibition of S. mutans 
with MIC of 2 µg/mL 
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Table 1. Continued 
Natural Product Source Studies 
[authors, year] 
Bioactive 
phytochemicals 
Cariostatic Effects 
Liquorice (Glycyrrhiza uralensis) Ahn et al., 2012; Ahn et 
al., 2015; Sela et al., 
1987 
Glycyrrhizin, 
licorisoflavan A, 
methoxyficifolinol  and 
diprenylgenistein 
 
Dose-dependent inhibition of 
bacterial adherence, Gtf 
activity and biofilm 
development. 
Mulberry (Morus alba) Islam et al., 2008 Deoxynojirimycin Anti-adhesion effects against 
S. mutans. 
 
Neem (Azadirachta indica) Pai et al., 2004; Wolinsky 
et al., 1996 
Gallotannins Inhibited glucan synthesis and 
reduced dental plaque 
formation/MS counts. 
 
Nutmeg (Myristica fragrans) Chung et al., 2006; Yanti 
et al., 2008 
Macelignan MIC against S. mutans and 
Lactobacilli of 3.9 µg/mL and 
2 µg/mL respectively. 
 
Peppermint (Mentha piperita) Rasooli et al., 2008 Menthol and 
menthone 
 
Anti-MS and anti-biofilm 
effects 
Propolis from Apis mellifera Koo et al., 2005; Koo et 
al., 2006 
Apigenin and  
tt-farnesol 
Apigenin displays potent anti-
Gtf activity. 
tt-farnesol disrupts S. mutans 
membrane permeability.  
 
Rosemary (Rosmarinus officinalis) Bernardes et al., 2010; 
Tsai et al., 2007 
Oxygenated 
monoterpenes 
Antibacterial effects with 
MICs against S. sobrinus of 16 
mg/mL. 
Anti-Gtf activity. 
 
Sanguinaria canadensis 
(Bloodroot) 
Dzink and Socransky, 
1985] 
Sanguinarine Antimicrobial activity against 
various oral pathogens 
including S. mutans 
 
Stevia rebaudiana 
(Sweetleaf) 
Brambilla et al., 2014; 
Das et al., 1992; Gamboa 
and Chaves, 2012] 
 
Stevioside and 
rebaudioside A 
Non-fermentable natural 
sweetener. 
Impairs plaque biofilm 
metabolism. 
 
Sweet orange (Citrus sinensis) 
Lemon (Citrus limon) 
 
Hiraishi et al., 2011; 
Islam et al., 2012] 
Hesperidin Beneficially shifts the de-
/remineralisation caries 
equilibrium. 
Tea (Camellia sinensis) 
Green tea 
Oolong tea 
Black tea 
Hirasawa et al., 2006; 
Nakahara et al., 1993; 
Ooshima et al., 1994; 
Ooshima et al., 1998; 
Otake et al., 1991; Touyz 
and Amsel, 2001 
Catechins, theaflavins 
and tannins 
Inhibits bacterial growth, 
aggregation, acidogenicity 
and Gtf activity 
PAC: proanthocyanidin; MIC: minimum inhibitory concentration; MS: mutans streptococci; Gtf: glucosyltransferase 
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Several naturally derived bioactive compounds have demonstrated strong growth inhibitory 
effects against MS. It has been reported that the minimum inhibitory concentrations of 
xanthorrrhizol from Javanese turmeric, [Hwang et al., 2000] or macelignan from nutmeg [Chung et 
al., 2006] against planktonic Streptococcus mutans are almost comparable to that for chlorhexidine. 
However, it is not known whether the bacterial growth inhibitory effects of these antimicrobial 
phytochemicals would be selective for cariogenic bacterial species without affecting growth of 
health-associated bacterial species. Natural antimicrobials with broad-spectrum of action may still 
have a role to play in oral conditions where broad antimicrobial action is required and could be 
incorporated into oral care products instead of synthetic chemical microbiocides. 
 
More relevant for caries prevention are polyphenols that can inhibit lesion development by 
targeting the unique virulence properties of cariogenic bacteria without affecting the viability of the 
oral commensal microbial communities. Such an ecological approach is more likely to succeed 
compared to bactericidal methods as it inhibits disease pathogenesis without stimulating the 
evolution of resistant bacteria or disrupting the resident microbiome [Cegelski et al., 2008]. Tea 
(Camellia sinensis), one of the most widely consumed beverages, is a rich source of polymeric 
polyphenols with well-documented strong evidence of anti-Gtf activity [Hirasawa et al., 2006; 
Nakahara et al., 1993; Ooshima et al., 1998; Otake et al., 1991]., This could be the reason why 
Japanese tea drinkers have been observed to have reduced incidence of dental caries compared to 
other population groups [Taylor et al., 2005]. The slow release of catechins, theaflavins and tannins 
from tea leaves is likely to contribute to the caries preventive effects of the non-fluoride component 
of tea that has been demonstrated in several human clinical trials and animal studies [Elvin-Lewis 
and Steelman, 1986; Onisi et al., 1981; Ooshima et al., 1994]. Besides tea phenolics, flavonoids 
found in cranberry, beehive propolis, parsley, and red wine grapes (proanthocyanidins, apigenin, 
and myricetin), gallotannins present in Neem (Azadirachta indica), and epicatechins derived from 
cacao bean husk also possess potent anti-Gtf activity [Jeon et al., 2009; Koo et al., 2010; Koo et al., 
2006; Matsumoto et al., 2004; Osawa et al., 2001; Wolinsky et al., 1996]. Inhibition of bacterial Gtf 
enzymes will reduce the synthesis of insoluble glucans, which are key virulence factors for cariogenic 
biofilms as they provide specific binding sites for bacterial adhesion and co-aggregation, support 
biofilm bulk and stability, and serve as a reserve carbohydrate source for enhanced acid production 
[Bowen and Koo, 2011]. 
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Acidogenicity, aciduricity, and adhesion are other key cariogenic virulence factors that have 
been found to be affected by specific phytochemicals. Cranberry phenolics (especially the A-type 
proanthocyanidins) have been shown to reduce the acid production induced glycolytic pH drop in 
biofilms, besides disrupting the F1F0-ATPase proton-translocating pumps responsible for 
maintaining the aciduric properties of S. mutans [Duarte et al., 2006b; Gregoire et al., 2007]. Natural 
products have also demonstrated the ability to inhibit sucrose-dependent and sucrose-independent 
bacterial adhesion to tooth surfaces [Badet and Quero, 2011; Islam et al., 2008; Steinberg et al., 
2004; Tarsi et al., 1997].  The anti-adhesion effects of natural products are believed to be mediated 
through the reduction of cell surface hydrophobicity, which is an important factor in the initial 
attachment of bacteria to the pellicle-coated tooth surface [Yamanaka et al., 2004]. Anti-adhesion 
natural agents can thereby reduce the total mass of biofilm without significantly affecting bacterial 
viability. A good example of natural anti-adhesion agents are the low molecular-weight chitosans 
(obtained from marine crustacean shells), that have been found to reduce initial bacterial adhesion 
to salivary pellicle coated surfaces [Busscher et al., 2008; Tarsi et al., 1997]. The excellent 
biocompatibility of chitosans has already seen their inclusion in some dentifrices, mouth rinses, and 
chewing gums [Busscher et al., 2008; Hayashi et al., 2007].  
 
 Besides antimicrobial cariostatic effects, some natural extracts also appear to be adept at 
shifting the demineralization-remineralization caries balance. Galla chinensis, formed when Chinese 
sumac aphids parasitise Rhus chinensis leaves, has been found to be effective in inhibiting 
demineralization and enhancing remineralization, increasing the efficacy of fluoride, besides 
inhibiting biofilm development [Cheng et al., 2008, 2010; Cheng et al., 2011; Cheng et al., 2015; Xie 
et al., 2008]. Hesperidin, a citrus flavonoid, is another phytochemical that suppresses acid-
dependent demineralization and enhances remineralization even under fluoride-free conditions 
[Hiraishi et al., 2011; Islam et al., 2012]. While fluoride will continue to remain the cornerstone of 
dental caries prevention, natural products with remineralizing ability could potentially be used to 
design oral care products with lower fluoride concentrations, intended for use in young children to 
minimize their risk of developing dental fluorosis. 
 
Natural products can also contribute to caries prevention by offering a source of non-
cariogenic natural sweeteners. With sucrose recognised as the “arch criminal” in the carious process 
[Newbrun, 1969], reducing sugar intake and replacing it with non-fermentable sweeteners is an 
useful approach to caries prevention. Although some commercially available non-nutritive artificial 
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sweeteners are considered safe for teeth (e.g. aspartame or acesulfame potassium), these synthetic 
compounds have been associated with other health issues. Recent research is oriented towards the 
discovery of non-cariogenic natural sweeteners, with over 100 plant-derived sweet compounds 
being reported [Kim and Kinghorn, 2002]. Among them, the extracts of Stevia rebaudiana 
(sweetleaf) have been approved for use in sweetening foods and beverages in several countries, 
where they are used as sugar substitutes for caries-active and diabetic patients [Ferrazzano et al., 
2015]. There is now robust evidence showing that bioactive Stevia phytochemicals (stevioside and 
rebaudioside A), besides being non-fermentable highly intense sweeteners (200-400 times sweeter 
than sucrose), also have the ability to interfere with biofilm metabolism [Brambilla et al., 2014; Das 
et al., 1992; Gamboa and Chaves, 2012; Giacaman et al., 2013]. 
 
NATURAL PRODUCTS: CHALLENGES AND RESEARCH DIRECTIONS 
 From the literature, there appears to be considerable promise for the use of therapeutically 
relevant natural products for dental caries control and prevention. However, a number of challenges 
have to be overcome for the potential of natural products to be translated into clinically relevant 
anti-caries agents. To start with, it will be important to ascertain how the cariostatic effects of 
natural products can be applied clinically through daily-use products such as dentifrices or 
mouthwashes.  A key challenge is the formulation of lipophilic natural products, to address issues 
such as phase separation and stability. Many phytochemicals are water insoluble and highly volatile, 
making them difficult to formulate into aqueous vehicles, while others are not chemically stable, 
degrading in the presence of heat, humidity, light, or oxygen, negatively impacting their clinical 
utility [Turek and Stintzing, 2013]. Likewise, some natural products have bitter or alkaloid tastes or 
aftertastes, which means they must be balanced with intense sweeteners. There is little point using 
a phytochemical whose effective concentration is either unpalatable, astringent or irritant, since 
compliance will be poor [Walsh, 2013]. 
 
Another key challenge is to improve the retention time of natural agents that are applied 
into the oral cavity. Dental plaque biofilms have to be exposed to effective concentrations of the 
chemoprophylactic agent for a sufficiently long time for them to be able to alter the microbial 
ecology and/or the demineralization-remineralization balance. Micellar drug delivery systems and 
various polymeric delivery systems have been shown to increase retention times [Chen et al., 2010; 
Gaffar et al., 1997], and could possibly be used for oral care products containing natural products. 
Nanotechnology can also be a useful tool for this purpose with nano-sized calcium phosphate 
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particles incorporating tea polyphenols having shown potential as a caries preventive agent [He et 
al., 2015]. Cariostatic natural products could also be delivered using varnishes, wafers, gums, or 
even confectionery. 
 
When considering using natural products for caries control, one must also take into account 
the effect geographic location and seasonal influences have on phytochemical composition [Jeon et 
al., 2011]. The variability often associated with natural products makes it essential that natural 
agents used for caries prevention have well-documented origins and composition, and that the 
active compounds are known and standardized, as much as that is possible [Freires et al., 2015a]. It 
is necessary to have reproducible, consistent, and optimised botanical sources from which to isolate 
cariostatic bioactive phytochemicals, if they cannot be manufactured more conveniently by 
chemical synthesis. 
 
An additional issue that is often ignored is the safety profile of oral care natural products. 
While many food-derived phytochemicals have been classified as GRAS (Generally Recognised as 
Safe) compounds and are not expected to have acute toxicological problems [Bakkali et al., 2008; 
Freires et al., 2015b], this does not mean that all natural products are completely safe for human 
use. For example, the use of sanguinarine in dentifrices and mouthwashes was discontinued after 
controversy over its association with oral leucoplakia [Vlachojannis et al., 2012]. Among the natural 
products suggested for use in dentistry, there is very limited information on issues such as their 
product quality, safety, and possible interactions with other medicines [Groppo et al., 2008]. 
Comprehensive animal and human safety studies, evaluating acute, sub-chronic, and chronic 
toxicity, especially with regards to brief daily exposures in topical applications, are needed before 
the widespread use of natural products for oral care can be recommended. 
 
The ultimate success of therapeutic products containing cariostatic natural products will 
depend on them being able to clearly show an appreciable reduction in individual caries increment. 
Well-designed RCTs are needed to establish the effectiveness of natural products in preventing 
dental caries. As seen in Table 1, most of the cariostatic effects of natural products have been shown 
in in vitro studies, rather than in clinical trials. Recent reviews indicate that just over a tenth of the 
studies of natural products are in Phase IV clinical trials, while even fewer have led to commercially 
successful products [Freires et al., 2015a; Freires and Rosalen, 2016]. Further research is also 
required to know the precise cariostatic mechanisms of action of natural products and to establish 
their most effective dosing regimen. 
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In conclusion, phytochemicals hold considerable potential for use as caries preventive 
agents, once the technical issues outlined above are resolved. With traditional antimicrobial 
measures increasingly falling out of favour, virulence-targeted therapies are gaining increased 
interest. From an ecological perspective, cariostatic natural products that inhibit bacterial adhesion, 
glucan synthesis, acidogenicity, and aciduricity could potentially be more beneficial for caries 
prevention than agents with broad growth inhibitory effects. Future research on cariostatic natural 
products needs to focus on cross-disciplinary approaches, using well-characterized agents and 
testing them in relevant laboratory and clinical models, both alone and in combination with fluoride 
and other agents, to ensure that any synergistic or antagonistic interactions are recognised. 
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 LITERATURE REVIEW: NATURAL PRODUCTS 
 
2.2.2  REVIEW PAPER 4 
 
Cranberry polyphenols: Natural Weapons against Dental Caries 
 
This paper presents an overview of the oral health benefits of cranberry polyphenols 
with particular focus on dental caries prevention. The paper details the cariogenic 
virulence properties that can be potentially targeted by specific cranberry flavonoids. 
 
The paper was published on 1st March 2019 in Dentistry Journal. 
 
Dent J 2019; 7(1): 20-24. 
 
This chapter is comprised of the publication as it stands in print. 
  
52 
 
ABSTRACT 
Bioactive polyphenol components of cranberry (Vaccinium macrocarpon) are known to have 
virulence attenuating effects against several cariogenic virulence properties responsible for dental 
caries pathogenesis. In particular, the unique cranberry A-type proanthocyanidins and flavonols 
have demonstrated potent inhibitory effects against cariogenic virulence targets such as bacterial 
acidogenicity, aciduricity, glucan synthesis, and hydrophobicity. Cranberry phenols have the ability 
to disrupt these cariogenic virulence properties without being bactericidal, a key quality essential 
to retain the benefits of the symbiotic resident oral microbiome and prevent emergence of resistant 
microbes. This review discusses the cariostatic mechanisms of specific cranberry phytochemicals 
and their potential use as therapeutic agents against cariogenic bacteria in the prevention and 
control of dental caries. 
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There has been an increasing global interest in the potential therapeutic uses of plant-
derived natural products to prevent oral diseases. Phytodentistry is based on long-standing 
evidence showing population groups that habitually consume polyphenol-rich diets have 
significantly better oral and dental health [Yoo et al., 2011]. Traditional chemotherapeutic 
approaches to oral diseases using synthetic oral biocides like chlorhexidine are becoming less 
popular because of the growing concerns of allergic reactions and the emergence of microbial 
resistance [Kampf, 2016; Moka et al., 2015]. Furthermore, the realization of the key health benefits 
of having an oral microbiome that is in a symbiotic relationship with the host has resulted in 
virulence-targeted therapies being preferred over broad-spectrum antimicrobials. This is especially 
vital for biofilm-mediated diseases like dental caries, where reversing the microbiome dysbiosis 
responsible for caries development is crucial for long-term disease control rather than simply 
eliminating the dental plaque biofilm [Philip et al., 2018]. 
 
The Global Burden of Diseases report highlighted that dental caries is the most common 
human disease condition worldwide [Kassebaum et al., 2015]. Newer and more effective preventive 
measures that go beyond using fluoride dentifrices and conventional mechanical plaque removal 
are clearly needed to tackle this ubiquitous human disease. In this regard, a number of cariostatic 
natural products have shown the potential to be useful for dental caries prevention [Jeon et al., 
2011]. Phytochemicals present in the cranberry fruit are particularly promising, having been shown 
to exert biological effects against critical virulence properties of cariogenic bacteria, besides having 
other well-established benefits to human health.  
 
ORIGIN AND HEALTH BENEFITS OF CRANBERRY 
 Cranberry is a small red fruit that is cultivated almost exclusively in the cooler climes of the 
American Northeast, Canada, and Chile. Four species have been described: Vaccinium macrocarpon 
(large cranberry, American cranberry), Vaccinium microcarpom (small cranberry), Vaccinium 
oxycoccus (common cranberry or northern cranberry), and Vaccinium erythrocarpum (southern 
mountain cranberry) [Feghali et al., 2012]. The American cranberry has received the most attention 
for its beneficial effects on human health, dating back to the 17th century. Native Americans used 
cranberries as a meat preservative and a medicine to relieve diverse ailments from scurvy to 
stomach and liver problems. Today, cranberry is commonly recognized as having a preventive effect 
on urinary tract infections and gastric ulcers because its high-molecular weight phytochemicals 
inhibit the adhesion of uropathogenic P-fimbriated Escherichia coli to the mucosa of the urinary 
54 
 
tract and Helicobacter pylori to the gastric mucosa [Burger et al., 2000; Howell et al., 2005]. These 
anti-adhesive properties of cranberry phenols are unique and are not found with the polyphenols 
present in other fruits like grapes, apples and oranges [Johnson-White et al., 2006]. Other purported 
health benefits of cranberry include lowering cardiovascular and neurological disease risk, 
modulation of inflammatory responses, and inhibiting cancer cell proliferation [Pappas and Schaich, 
2009; Shabrova et al., 2011]. 
 
 With regards to oral health, in vitro studies have shown cranberry constituents can exert 
beneficial effects on gingival and periodontal health by inhibiting the host inflammatory response, 
suppressing bacterial biofilm formation, and reducing the activity of periopathogenic proteolytic 
enzymes [Bodet et al., 2008; Feghali et al., 2012; Labrecque et al., 2006]. Specific flavonoids present 
in cranberry were also shown to disrupt key virulence factors responsible for dental caries 
pathogenesis [Duarte et al., 2006; Feng et al., 2013; Gregoire et al., 2007]. This narrative review will 
explore the potential therapeutic targets and the specific cranberry phenols reported to be involved 
in disrupting virulence traits of cariogenic bacteria. 
 
POTENTIAL CARIOGENIC VIRULENCE TARGETS 
 Dental caries is a polymicrobial multifactorial disease that develops when the acidogenic and 
aciduric members of the resident oral flora obtain a selective ecological advantage over other 
commensal microorganisms, disrupting the homeostatic balance of the plaque biofilm, and initiating 
the disease process [Marsh, 2003]. While the disease is polymicrobial in nature, mutans streptococci 
(MS) function as keystone pathogens, as they are principally responsible for the initial assembly of 
exopolysaccharide (EPS) glucan-rich scaffold matrix. The ability of MS (predominantly Streptococcus 
mutans and Streptococcus sobrinus) to synthesize copious amounts of insoluble glucans is critical 
for caries pathogenesis [Hajishengallis et al., 2017]. The first part of this review discusses the 
cariogenic virulence traits that cranberry flavonoids can potentially target in order to reverse the 
dental plaque dysbiosis responsible for caries development. 
 
Glucan synthesis 
 The S. mutans glucosyltransferases (Gtfs) are exoenzymes that are primarily responsible for 
orchestrating the virulent plaque biofilm matrix. In the presence of sucrose, different Gtfs (i.e. B, C 
and D) synthesize extracellular carbohydrate polymers called glucans. These glucans confer 
structural integrity and bulk to plaque biofilms, enhance bacterial adhesion and accumulation, and 
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provide a readily metabolizable carbohydrate source for sustained acid production [Paes Leme et 
al., 2006]. The glucan-rich EPS matrix also creates a diffusion limiting barrier that not only protects 
plaque microflora from topical antimicrobial agents, but also helps maintain acidic 
microenvironments critical to enamel dissolution [Bowen and Koo, 2011]. As the different Gtfs 
acting in concert are a primary virulence property of S. mutans, targeting Gtf enzyme activity should 
significantly disrupt the development of dental caries [Koo and Bowen, 2014]. 
 
Acidogenicity 
 An important attribute of cariogenic microorganisms is their proficiency to produce large 
amounts of organic acids as a by-product of carbohydrate metabolism. These acids (particularly 
lactic acid) lower the pH of the plaque fluid, causing demineralization of the tooth structure and 
lesion initiation. Sustained low pH within the plaque biofilm will favour the survival and growth of 
acidogenic and aciduric bacteria, which start to dominate the plaque microbial community, 
displacing many of the health-associated commensal oral microflora [Philip et al., 2018]. Disrupting 
bacterial metabolism and acid production is thus key to not only preventing tooth demineralization, 
but also to restoring the ecological balance of dental plaque. 
 
Aciduricity 
 The ability to survive and thrive in low pH environments is a key characteristic of MS. Proton 
translocating F1F0-ATPases play a major role in protecting the bacterial glycolytic and sugar transport 
system enzymes from the environmental stress caused by biofilm acidification. Inhibiting the F1F0-
ATPase proton pump can result in cytoplasmic acidification and thus affect the optimal functioning 
of the intracellular acid-sensitive glycolytic enzymes. 
 
Bacterial Adhesion 
 The S. mutans-derived Gtfs (particularly GtfC) are adsorbed onto salivary pellicle-coated 
tooth surfaces and rapidly generate an amorphous glucan layer that facilitates initial bacterial 
adhesion. Gtf exoenzymes (particularly GtfB) also have great affinity for cell surfaces of other 
microorganisms, converting them into de facto glucan producers in the presence of sucrose.  The 
glucans formed in situ provide enhanced binding sites for MS, resulting in further bacterial 
aggregation, and favouring cohesive microcolonies [Xiao and Koo, 2010]. While the Gtf-derived 
glucans are mainly responsible for MS adhesion and accumulation, cell hydrophobicity can also play 
a role in the initial bacterial adhesion to the salivary pellicle. The hydrophobicity of S. mutans is 
believed to be mainly associated with its cell surface proteins [McBride et al., 1984]. Targeting Gtf 
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exoenzymes and bacterial surface hydrophobicity could therefore impede microbial adhesion and 
lower the virulence of dental plaque. 
 
CARIOSTATIC EFFECTS OF CRANBERRY POLYPHENOLS 
 The cranberry fruit is a unique and rich source of bioactive polyphenol compounds. Among 
the different classes of polyphenols, the flavonoid family has the largest variety of compounds with 
pharmacological activity. The three major flavonoids found in whole cranberries are the flavonols, 
anthocyanins, and the flavanols that include monomeric flavan-3-ols and the polymeric flavan-3-ols 
called proanthocyanidins [Cunningham et al., 2004]. Very minute quantities of other polyphenols 
may also be found in cranberries including flavanones (e.g. prunin), non-flavonoids such as phenolics 
acids (e.g. benzoic acid), and anti-oxidant stilbenes (e.g. resveratrol) [Pappas and Schaich, 2009]. 
Table 2 summarizes the bioactive phytochemicals in cranberry fruit and their reported cariostatic 
effects. The role specific cranberry flavonoids play in disrupting cariogenic virulence is discussed 
further below. 
 Table 2. Cranberry polyphenols and their cariostatic effects 
Polyphenol class Cariostatic effects 
Flavonoids 
1. Flavonols  
• e.g. quercetin, myricetin, kaempferol 
 
Inhibits Gtf, F1F0-ATPase enzyme activity and 
acid production 
2. Flavanols 
     (a) Monomeric flavan-3-ols 
• e.g. catechin, epicatechin, epigallocatechin,          
                   epigallocatechin gallate 
      (b) Polymeric flavan-3-ols 
• e.g. A-linked proanthocyanidins 
 
 
No reported effects 
 
 
Inhibits Gtf, F1F0-ATPase enzyme activity and 
acid production 
3. Anthocyanins 
• e.g. cyanidin, peonidin, malvidin, delphinidin 
 
Insignificant effects against cariogenic 
virulence factors 
4. Flavanones 
• e.g. prunin 
 
No reported effects 
 
Nondialyzable Material Interferes with bacterial hydrophobicity and 
initial stages of plaque development 
 
Phenolic acids 
• e.g. benzoic acid, ellagic acid 
 
No reported effects 
Stilbenes 
• e.g. resveratrol 
 
No reported effects 
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Flavonols 
 Cranberry flavonols occur mainly as glycosylated forms of quercetin, myricetin, and 
kaempferol [Vvedenskaya et al., 2004]. The total flavonols in cranberry has been quantified to be 
approximately 300-500 mg/kg of the fruit [Wang et al., 2017]. The content and nature of cranberry 
flavonols are unique in character and are not usually seen in flavonols of other fruits. Cranberry 
flavonols are believed to be responsible for many of the systemic health benefits associated with 
cranberry consumption [Pappas and Schaich, 2009]. 
 
Cranberry flavonols, especially the most abundant quercetin glycosides, were found to be 
significant inhibitors of GtfB, GtfC, F1F0-ATPase, and of cytoplasmic glycolytic enzymes within S. 
mutans [Duarte et al., 2006; Gregoire et al., 2007]. Flavonol-mediated Gtf inhibition appears to be 
related to its unsaturated double bond between C2 and C3, as anthocyanins that lack the C2–C3 
double bond exhibited only modest inhibitory activity against glucan synthesis [Duarte et al., 2006]. 
Quercetin is also known to be a non-competitive inhibitor of the proton-translocating F1F0-ATPase 
activity that is critical to the survival of acidogenic bacteria in the low pH biofilm environment they 
create [Zheng and Ramirez, 2000]. 
 
Proanthocyanidins (PACs) 
 PACs (also referred to as condensed tannins) are oligomers or polymers of flavan-3-ols that 
are distinctive in terms of their size, high molecular weight, and free hydroxyl groups.  These 
structural properties determine their bioactivity, including the ability to precipitate or denature 
polypeptides and proline-rich proteins [Bennick, 2002]. Binding of PACs to salivary proteins is 
responsible for the astringent taste of cranberries and other tannin-rich foods. PAC subunits 
(catechin, epicatechin, epigalloatechin, epigalloatechin gallate) are linked most often via a single B-
type bond, and less often by a double interflavan A-type linkage (Fig. 4). The A-linked PACs (A-PACs) 
are found in high concentrations in cranberry and can also be found in peanut skins and cinnamon 
[Foo et al., 2000; Singh et al., 2009]. The cranberry A-PACs are mainly composed of epicatechin 
monomer subunits with at least one A-type interflavan bond and the type of PAC linkage is closely 
related to its biological effects. The A-PACs appear to be more biologically active than B-type PACs 
due to the conformational rigidity afforded by the double interflavan linkages [Foo et al., 2000; 
Howell et al., 2005]. For instance, A-PACs demonstrated significant anti-adhesion effects against E. 
coli and H. pylori, whereas B-type PACs were devoid of anti-adhesion properties. 
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Figure 4. Structure of cranberry proanthocyanidins with A-linkage 
 
Among the different cranberry flavonoids, the A-PACs have exhibited the most potent 
effects against bacterial glycolytic, Gtf and F1F0-ATPase enzymes [Duarte et al., 2006; Koo et al., 
2010]. The ability of PACs to form protein-polyphenol complexes possibly affects the enzyme activity 
by irreversibly binding to the catalytic and glucan-binding domains once complexed [Koo et al., 
2010]. The precise mechanisms by which cranberry A-PACs inhibit S. mutans enzyme activity are 
likely to be related to their unique rigidity conferring A-type linkages, as PACs from non-cranberry 
fruits that lacked A-type linkages did not affect these enzymes [Feng et al., 2013; Gregoire et al., 
2007; Koo et al., 2010]. 
 
The PACs in cranberry are predominantly found in oligomeric forms (up to 13 monomeric 
units), although smaller PAC dimers are also seen. The bioactivity of the A-PACs are also strongly 
associated with their degree-of-polymerization (DP). A-PACs with DP 4 and DP 8 to 13 are optimal 
for interaction and inhibition of Gtfs and glucan-mediated adhesion [Feng et al., 2013]. On the other 
hand, inhibitory activity against bacterial acid production is mostly related to a low molecular weight 
A-PAC dimer called procyanidin A2 [Gregoire et al., 2007]. It is unlikely that the larger PAC oligomers 
can directly affect intracellular bacterial glycolytic enzymes, though they may still have deleterious 
effects on membrane components of the glycolytic pathway [Yoo et al., 2011]. 
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Cranberry A-PACs have been shown to significantly reduce incidence and severity of smooth 
surface caries in an animal caries model, suggesting they may have value as a supplement to fluoride 
for dental caries prevention [Koo et al., 2010]. Overall, the evidence does indicate that A-PACs have 
the most effective cariostatic properties amongst the different cranberry flavonoids, with the 
potential to be developed as natural agents for dental caries prevention. 
 
Anthocyanins (ACYs) 
 ACYs such as cyanidin and peonidin are present at concentrations of approximately 100-900 
mg/kg of the fruit and are responsible for the distinctive red colour of the fruit [Vorsa et al., 2003]. 
While ACYs may a have a number of systemic health benefits, their ability to inhibit bacterial 
cariogenic virulence properties are relatively low. A study comparing the effects of different 
cranberry fractions on virulence traits of S. mutans found that A-PACs exhibited the greatest 
biological activity, followed by the flavonols, while the ACY extract did not have any significant 
effects [Duarte et al., 2006]. 
 
Nondialyzable Material (NDM)  
 A number of studies have reported beneficial effects from a high molecular weight fraction 
of cranberry that remains after dialysis of concentrated cranberry juice using membranes with a 
molecular weight cut off of 12000-15000 [Pappas and Schaich, 2009]. Chemical analysis of the NDM 
fraction suggests it is a heterogeneous mixture of phenols containing about 65% PACs and trace 
amounts of ACYs [Bodet et al., 2006]. 
 
A mouthwash supplemented with NDM has been found to significantly reduce salivary MS 
counts following 6 weeks of usage [Weiss et al., 2004]. In vitro experiments have revealed that NDM 
inhibits adhesion of S. mutans and S. sobrinus, and promotes desorption of the bacteria from 
biofilms [Steinberg et al., 2005; Weiss et al., 2004; Yamanaka et al., 2004]. This is likely because 
NDM components may interact with bacterial cell surface hydrophobic proteins, reducing 
hydrophobicity and thus initial bacterial adhesion to tooth surfaces [Yamanaka et al., 2004]. 
Cranberry juice itself may not be suitable for dental caries prevention as it has a high content of 
enamel eroding organic acids (e.g. quinic, citric and malic acids) compared to juices from apple, 
grape or blueberry. However, the potential of using the non-fermentable NDM fraction from 
cranberry juice concentrate in oral care products needs to be explored [Bodet et al., 2008]. 
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Cranberry vs. other natural products 
 Cranberry polyphenols may have a number of advantages over other suggested cariostatic 
natural products. A comparison of three dark-coloured berries (cranberry, wild blueberry, and 
strawberry) showed that cranberry extracts had the greatest effects against S. mutans biofilm 
virulence properties [Philip et al., 2019a]. While tea (Camellia sinensis) also contains high levels of 
biologically active phenolic compounds, studies have shown cranberry polyphenols have the ability 
to effect a more powerful disruption of cariogenic virulence factors [Yoo et al., 2011]. The greater 
cariostatic effects of cranberry could partly be attributed to the presence of the unique cranberry 
A-PACs that are not present in other polyphenol-rich plants. 
 
 Isolated phytochemicals like xanthorrrhizol from Javanese turmeric (Curcuma 
xanthorrhizha) and macelignan from nutmeg (Myristica fragrans) have also shown significant 
growth inhibitory effects against oral bacteria [Chung et al., 2006; Hwang et al., 2000; Philip et al., 
2019c]. However, they lack the ability to discriminate between health- and disease-associated 
plaque microorganisms, which is key for long-term control over biofilm-mediated oral diseases like 
dental caries [Philip et al., 2019c]. Cranberry polyphenols, while lacking bactericidal effects, have 
the potential to modulate cariogenic virulence allowing them to possibly reverse the microbiome 
dysbiosis responsible for dental caries, and still retain the key benefits of the resident oral 
microbiome. 
 
 A common problem with using natural products as therapeutic agents is their compositional 
variability. In this regard, cranberry is a particularly feasible and sustainable source of standardized 
bioactive compounds, as it is a chemically and genetically well-characterized fruit, with highly 
standardized methods for extracting the biologically active components [Koo et al., 2010]. 
 
CONCLUSIONS 
 Cranberry polyphenols have enormous potential for development as adjunctive anti-caries 
agents. However, the cariostatic effects of cranberry have mostly been demonstrated in laboratory 
studies. There is a need for well-designed clinical trials to evaluate whether the proposed cariostatic 
effects of cranberry phenols can actually translate into preventing dental caries in high-risk 
individuals and population groups. The combination of virulence-attenuating standardized 
cranberry extracts and remineralizing agents in a single oral care product could hold great promise 
in the global fight against dental caries. 
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2.3  LITERATURE REVIEW: NON-FLUORIDE REMINERALIZING AGENTS 
 
2.3.1  REVIEW PAPER 5 
 
State of the Art Enamel Remineralization Systems: The Next Frontier in Caries 
Management 
 
This paper discusses the rationale for using non-fluoride remineralization systems like 
CPP-ACP in caries management and the mechanisms and evidence behind the latest 
advances in enamel remineralization technologies. 
 
The paper was published on 8th October 2018 in Caries Research, the official publication 
of the European Organisation for Caries Research (ORCA).  
 
Caries Res 2019 53(3): 284-295. 
 
The paper was made Open Access with funding from ORCA based on the 
recommendation of the Editor of Caries Research. 
 
This chapter is comprised of the publication as it stands in print. 
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ABSTRACT 
The principles of minimally-invasive dentistry clearly recommend the need for clinically effective 
measures to remineralize enamel caries lesions. While fluoride-mediated remineralization is the 
cornerstone of current caries management philosophies, a number of new remineralization 
strategies have been commercialized or are under development that claim to promote deeper 
remineralization of lesions, reduce the potential risks associated with high-fluoride oral care 
products, and facilitate caries control over a lifetime. These non-fluoride remineralizing systems can 
be broadly categorized into biomimetic enamel regenerative technologies and the approaches that 
repair caries lesions by enhancing fluoride efficacy. This paper discusses the rationale for non-
fluoride remineralization and the mechanism of action, challenges, and evidence behind some of 
the most promising advances in enamel remineralization therapies.  
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Dental caries pathophysiology is not simply a continual cumulative loss of tooth minerals, 
but rather a dynamic process characterized by alternating periods of demineralization and 
remineralization. Lesion progression or reversal depends on the equilibrium between 
demineralization-favouring pathological factors (cariogenic bacteria, fermentable carbohydrates, 
salivary dysfunction) and the protective factors (antibacterial agents, sufficient saliva, remineralizing 
ions) that tip the balance towards remineralization [Featherstone and Chaffee, 2018]. 
Remineralization can occur as a natural repair process where plaque/salivary calcium (Ca2+) and 
phosphate (PO43-) ions are deposited into crystal voids of the demineralized tooth structure, 
resulting in net mineral gain. The presence of free fluoride (F-) ions in the oral environment can drive 
the incorporation of Ca2+ and PO43- ions into the crystal lattice, with the ensuing fluorapaptite 
mineral significantly more resistant to a subsequent acid challenge [ten Cate, 1999].  
 
A better understanding of regenerative and physiochemical mechanisms has influenced the 
development of a number of innovative remineralization technologies that go beyond fluoride-
mediated remineralization. While traditional fluoride-based remineralization remains the 
cornerstone for caries management with the highest level of supporting evidence, additional 
remineralizing agents to enhance fluoride effects are often needed in high caries-risk individuals 
and population groups [Amaechi and van Loveren, 2013; Fontana, 2016]. The first International 
Conference on Novel Anticaries and Remineralizing Agents (ICNARA) had suggested that the broad 
aim of new remineralization therapies should be to “facilitate caries control over a lifetime using 
evidence-based, clinically effective, multifactorial prevention to keep the caries process in balance” 
[Pitts and Wefel, 2009].  This paper discusses the rationale for using non-fluoride remineralization 
systems and the mechanisms, challenges, and evidence underpinning some of the technological 
advances in enamel remineralization therapies.  
 
NON-FLUORIDE REMINERALIZATION SYSTEMS: ARE THEY NEEDED? 
Natural remineralization alone is not sufficient 
The remineralization potential of saliva is well-documented [Stookey, 2008], having evolved 
to deliver Ca2+ and PO43- ions in a bioavailable form for hard tissue development and maintenance 
throughout life [Cochrane and Reynolds, 2012]. At physiological pH, saliva is supersaturated with 
phosphoprotein-stabilized Ca2+ and PO43- ions, ensuring that the ions remain bioavailable to diffuse 
into mineral deficient lesions [Cochrane et al., 2010]. However, longitudinal studies that followed 
the natural progress of white spot lesions (WSL) found that although some WSL get smaller, the 
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majority are largely unaffected even after two years [Mattousch et al., 2007; van der Veen et al., 
2007]. Moreover, net salivary remineralization is a slow process [Dowd, 1999], with a tendency for 
mineral gain only on the surface of the WSL due to the low ion concentration gradient from saliva 
into the lesion [Silverstone, 1972]. Fluoride-mediated salivary remineralization is also seen to be 
restricted to the outer 30 μm of the tooth [Schmidlin et al., 2016]. This surface-only remineralization 
neither improves the aesthetics or the structural properties of the subsurface lesion [Cochrane et 
al., 2010]. The presence of additional extrinsic sources of stabilized Ca2+ and PO43- ions could 
augment the natural remineralization potential of saliva by increasing diffusion gradients favouring 
faster and deeper subsurface remineralization.  
 
Fluoride – Improving its efficacy and safety 
The pivotal discovery of fluoride as an agent that could prevent dental caries was one of the 
most important landmarks in dentistry [ten Cate, 2015]. The dramatic decline in caries prevalence 
rates of developed countries from the latter half of the 20th century has been largely attributed to 
the widespread use of oral care products containing fluoride [Fejerskov, 2004]. Fluoride remains the 
gold standard for arresting caries lesions with multiple systematic reviews confirming the role of 
fluoride products in preventing dental caries [Benson et al., 2013; Marinho et al., 2016; Marinho et 
al., 2003; Marinho et al., 2015; Shahid, 2017]. However, emerging epidemiological data are showing 
a worrying trend, with caries experience plateauing or even increasing in some population groups, 
despite the regular use of fluoride dentifrices in these countries [Agustsdottir et al., 2010; AIHW, 
2018; Dye et al., 2017; Haugejorden and Birkeland, 2005]. This raises questions on whether the 
earlier reduction in caries prevalence rates has continued into this century [Gimenez et al., 2016]. 
The reported pause in the decline of dental caries has been attributed to the fact that diets across 
the world are changing to include more processed and sugar-laden foods, limiting the repair 
potential of fluoride [Duggal et al., 2001]. While under normal physiological conditions, fluoride and 
salivary homeostatic mechanisms are often enough to remineralize early lesions, these are often 
not adequate in highly cariogenic oral environments. Other at-risk population groups (xerostomia 
patients, elderly individuals at risk of root caries) can also benefit from boosters to improve the 
remineralizing and preventive efficacy of fluoride [Fontana, 2016].  
 
An obvious approach to increase the remineralizing potential of fluoride would be to just 
add more fluoride to oral care products. Dentifrices with 5000 ppm fluoride have been found to be 
more efficacious for remineralization of root caries lesions than 1000-1500 ppm fluoride dentifrices 
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[Wierichs and Meyer-Lueckel, 2015]. A dose-response relationship of decreasing caries incidence 
with increasing dentifrice fluoride concentration has also been observed [Walsh et al., 2010]. 
However, the recent classification of fluoride as a chemical nuerotoxicant could raise safety 
concerns among the general public regarding the use of high concentration fluoride products 
[Grandjean and Landrigan, 2014]. More pertinent, are the growing concerns that children today are 
exposed to fluoride from multiple sources, potentially increasing their risk of developing dental 
fluorosis [Zohoori and Maguire, 2018].  This “halo” effect of fluoride probably accounts for the 
increased prevalence of permanent teeth mottling being seen in western countries [McGrady et al., 
2012; Pendrys, 2000]. The increased risk of dental fluorosis has led the World Health Organisation 
(WHO) to recommend the need to assess total fluoride exposure of the population before 
introducing any additional fluoridation for caries prevention [Baez and Marthaler, 2014]. Besides 
fluorosis in children, the surface-only remineralization that often occurs in the presence of high 
topical fluoride concentrations can increase the incidence of occult caries (“fluoride syndrome”) 
across all age groups [Ball, 1986]. Considering the narrow “dose-gap” between caries reduction 
benefit and fluoride side-effects, regulatory authorities have limited the fluoride concentration in 
non-prescription toothpastes to within 1000-1500 ppm, while for children below 6 years this dose 
is even lower and probably suboptimal for effective remineralization of early lesions.  
 
Evidently, there is a need for new-age remineralization technologies with an ability to 
complement fluoride, close the gap in its remineralizing efficacy, and effect a fuller consolidation of 
carious lesions [Lynch and Smith, 2012]. Effective non-fluoride remineralization systems can also 
potentially allow dental products to be designed with lower fluoride concentrations, to allay the 
safety concerns associated with consumer oral care products containing high fluoride 
concentrations.  
 
Modern caries management 
 Enamel caries presents as a progressive subsurface demineralization that if not reversed will 
result in mechanical failure and cavitation, often leading to a vicious restoration cycle. Despite long-
standing recommendations for adopting a biological approach to caries management [Pitts, 2004], 
a significant proportion of dentists continue with the restorative-only model that has failed both 
clinically and economically [Innes and Schwendicke, 2017; Pitts and Zero, 2016]. There is a global 
consensus that principal approach to modern-day caries management should be to “preserve the 
tooth structure and restore only when necessary” [Ismail et al., 2013]. New remineralization 
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systems that either regenerate lesion body structure (e.g. biomimetic peptide scaffolds) or provide 
ions favouring subsurface mineral gain (e.g. calcium phosphate systems), can significantly reduce 
the need for traditional restorations and preserve tooth structure. 
 
Disease detection is also increasingly shifting from the conventional decayed missing filled 
teeth criteria of the WHO to the use of the International Caries Detection and Assessment System 
(ICDAS), where non-cavitated enamel lesions (ICADS 1 and 2) are also included. This has increased 
the proportion of individuals diagnosed with dental caries, providing a significant opportunity for 
secondary prevention and non-operative care using regenerative medicine-based dental 
approaches. Modern-day dentistry clearly needs such minimally-invasive remineralization 
measures, not just to enhance clinical outcomes, but also to improve patient experience and well-
being [Pitts and Wright, 2018].  
 
NON-FLUORIDE ENAMEL REMINERALIZING SYSTEMS 
 The development of novel enamel remineralization systems has significantly progressed in 
the recent years with many of them already in clinical use, while others are in various stages of 
development. These remineralizing technologies are briefly summarized in Table 3, and can be 
broadly classified into: (i) biomimetic regenerative systems; and (ii) approaches that synergize 
fluoride efficacy. The mechanisms, advantages and challenges of these remineralizing technologies 
are discussed further below. 
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Table 3. Non-fluoride enamel remineralizing technologies 
 
A.  Biomimetic Remineralization 
Oral care products containing fluoride are effective in remineralizing enamel but do not have 
the potential to promote formation of organized apatite crystals [Ruan and Moradian-Oldak, 2015]. 
Presently, there is an attempt to shift from reparative to regenerative biomineralization therapies, 
wherein diseased dental tissues are replaced with biologically similar tissues [Alkilzy et al., 2018a]. 
Enamel regeneration is however particularly challenging as mature enamel is acellular and does not 
resorb or remodel itself unlike bone or dentin [Moradian-Oldak, 2012]. Advances in tissue 
engineering methods has yielded biomimetic methods that have demonstrated a strong potential 
for regenerating the hierarchical enamel microstructure.  
Technology                                                                                                      Commercial Product 
 
A. Biomimetic Systems 
1. Dentin phosphoprotein 8DSS peptides                                                                                     Not available 
2. P11-4 peptides                                                                                                                               Curodont Repair/ Curodont Protect  
3. Leucine-rich amelogenin peptides                                                                                             Not available 
4. Poly(amido amine) dendrimers                                                                                                  Not available 
5. Electrically accelerated and enhanced remineralization                                                       Not available                                                                             
6. Nanohydroxyapatite                                                                                                                    Apagard/ Desensin 
 
B. Fluoride Boosters 
1. Calcium phosphate systems 
             Stabilized calcium phosphates  
• Casein phosphopeptide-amorphous calcium phosphate                                                Tooth Mousse/ MI Paste crèmes   
                                                                                                                                                      Recaldent/ Trident White gum 
                                                                                                                                                      MI Paste One toothpaste 
 
              Crystalline calcium phosphates 
• Functionalized β-tricalcium phosphate                                                                             ClinPro toothpaste 
• Calcium sodium phosphosilicate                                                                                         Oravive toothpaste 
                  (NovoMin™ technology) 
 
            Unstabilized calcium phosphates 
• Amorphous calcium phosphate                                                                                          Enamelon toothpaste      
(Enamelon™ technology) 
 
2. Polyphosphate systems                                                                                                              Oral-B Pro Expert toothpaste                                                                                 
• Sodium trimetaphosphate  
• Calcium glycerophosphate 
• Sodium hexametaphosphate 
 
3. Natural Products                                                                                                                          Not available 
• Galla chinensis  
• Hesperidin 
• Gum Arabic 
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Dentin Phosphoprotein-derived 8DSS Peptides 
 Dentin phosphoprotein (DPP) is the most abundant non-collagenous extracellular matrix 
component in dentin and is known to play a critical role in tooth mineralization [Hsu et al., 2011]. 
Human DPP contains numerous repetitive aspartate-serine-serine (DSS) nucleotide sequences that 
are believed to promote hydroxyapatite (HA) formation, with studies showing that DPP can 
generate HA crystals in calcium phosphate solutions [George et al., 1996; Prasad et al., 2010]. 
Several short functional peptides based on DPP have been designed as they offer a number of 
advantages over full-length DPP such as higher purity and better conformational fit on enamel, while 
avoiding allergies and immunogenicity often associated with animal proteins [Hsu et al., 2011]. 
Among the DPP-derived peptides, the octuplet repeats of aspartate-serine-serine (8DSS) are the 
most active in promoting biomineralization [Yarbrough et al., 2010]. 
 
 8DSS peptides have essentially two mineral-binding surfaces and can strongly bind not only 
to free Ca2+ and PO43 ions but also to the HA surface [George et al., 1996; Yarbrough et al., 2010]. 
Applying these peptides to enamel can prevent dissolution of Ca2+ and PO43 ions into the 
surrounding medium while promoting the capture of these ions from solution. 8DSS peptides thus 
appear to have a dual mechanism in the mediation of biologically directed mineral deposition. First, 
they limit the dissolution of Ca2+ and PO43 ions from demineralized dentin, and second, they 
promote the capture of these ions to form new mineral deposits on demineralized enamel [Hsu et 
al., 2011; Yang et al., 2014]. The newly grown mineral had uniform deposition of small apatite 
crystals with significantly improved properties such as reduced surface roughness, and higher 
hardness and elastic modulus [Chung et al., 2012; Hsu et al., 2011]. A recent in vitro study also 
provided strong evidence that the biomimetic 8DSS peptide, besides inhibiting enamel 
demineralization on its own, could significantly potentiate the ability of fluoride to do the same 
[Yang et al., 2016]. This synergistic interaction can be useful to lower fluoride concentration for 
caries prevention in young children reducing their risk of dental fluorosis. 
 
 To date, the proof of concept of 8DSS peptides have been shown only in vitro systems and 
is likely to present some challenges when used clinically. For example, it is not known whether these 
peptides can survive enzymatic action in the oral cavity, although being short peptides should make 
them relatively difficult targets for hydrolytic enzymes. Another drawback is that because 8DSS 
binds calcium strongly it could lead to calculus formation if not controlled. However, if future in vivo 
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studies can confirm the clinical promise of 8DSS and overcome the challenges, it holds great promise 
as non-fluoride biomineralizing agent [Yang et al., 2014]. 
 
Self-assembling P11-4 Peptides 
 An ideal enamel regenerative approach would involve substituting the degraded enamel 
matrix with a biomimetic matrix that favours in-depth remineralization of enamel lesions [Alkilzy et 
al., 2018]. An exciting development in this field is a monomeric peptide consisting of 11 amino acids 
called P11-4. This rationally-designed peptide self-assembles into hierarchical 3D fibrillar scaffolds 
in response to local conditions such as high ionic strength and acidic pH found in the lesion body 
[Kirkham et al., 2007]. The P11-4 fibrillar matrix has a high affinity for Ca2+ ions and acts as a 
nucleator for de novo HA formation resulting in remineralization of the lesion body [Kind et al., 
2017; Kirkham et al., 2007]. Analysis of in vitro data showed that the presence of P11-4 fibers in the 
lesion body resulted in faster HA formation, yielding tangentially arranged needle-shaped crystals, 
with increased microhardness of the remineralized subsurface lesion [Schmidlin et al., 2016; Sousa 
et al., 2017; Takahashi et al., 2016]. 
 
 P11-4 has shown promising results as a biomimetic mineralization agent in in vivo and clinical 
trials. This includes the ability to reverse early occlusal and proximal lesions that are more resistant 
to fluoride remineralization than smooth surface lesions [Alkilzy et al., 2018; Alkilzy et al., 2015; 
Brunton et al., 2013; Schlee et al., 2014; Schlee et al., 2018]. The low viscosity isotropic P11-4 when 
applied on the initial carious lesion rapidly diffuses into the lesion body, where it transforms to an 
elastomeric nematic gel in the presence of cations and pH<7.4, leading to the 3D fiber matrix 
assembly and subsequent biomineralization of the lesion [Brunton et al., 2013]. The P11-4 treated 
carious lesions showed significantly improved visual appearance and increased radiographic 
opacity, remaining stable even 6-12 months after treatment [Schlee et al., 2014; Schlee et al., 2018]. 
A recent randomised controlled trial (RCT) demonstrated that biomineralization facilitated by P11-
4 in combination with fluoride is safe and more effective than the present clinical gold standard of 
fluoride treatment alone [Alkilzy et al., 2018a]. 
 
 As P11-4 relies on natural remineralization driven by saliva, its effectiveness will depend on 
the individual’s quality of saliva especially its mineral content, pH, and flow rate [Schlee et al., 2018]. 
This could reduce its efficacy in xerostomia patients. Undoubtedly, P11-4 therapy is a significant 
step towards the elusive goal of guided enamel regeneration, but more long-term controlled studies 
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are needed to confirm and quantify these findings, as well as to identify additional factors that can 
potentiate the repair process.  
 
Amelogenin 
The amelogenin-rich enamel organic matrix plays a critical role in regulating the growth, 
shape and arrangement of HA crystals during enamel mineralization. However, mature enamel lacks 
matrix proteins and cannot regenerate the mineral loss caused due to dental caries or erosion [Ruan 
and Moradian-Oldak, 2015]. Recently, several promising strategies have been proposed to replicate 
the complex enamel microstructure using synthetic amelogenin-based systems. Recombinant 
porcine amelogenin (rP172) was found to stabilize calcium phosphate clusters and promote the 
growth of hierarchically-arranged enamel crystals on acid-etched lesions, significantly improving its 
hardness and elastic modulus [Fan et al., 2009; Ruan et al., 2016; Ruan et al., 2013]. This biomimetic 
regrowth of HA crystals also generated a robust interface between the newly formed layer and 
native enamel ensuring efficacy and durability of restorations. 
 
 An excellent low-cost and safer alternative to the full-length amelogenin is a leucine-rich 
amelogenin peptide (LRAP) that is comprised of only 56 amino acids. The non-phosphorylated LRAP 
contains only the N- and C-terminal domains of the parent amelogenin, with these domains known 
to be responsible for directing mineral growth and binding [Le Norcy et al., 2011]. In vitro studies 
have shown treatment of enamel lesions with LRAP reduced lesion depth and allowed biomimetic 
reconstruction of enamel by promoting linear growth of mature enamel crystals along the c-axis 
[Bagheri et al., 2015; Mukherjee et al., 2016; Shafiei et al., 2015]. The addition of mineralization 
inhibitors such as inorganic pyrophosphate or matrix metalloproteinase to synthetic amelogenin 
assemblies was able to better regulate size, shape, and orientation of a strongly adherent new 
mineral layer, while preventing undesirable protein occlusion within newly formed crystals [Kwak 
et al., 2017; Prajapati et al., 2018].  
 
A disadvantage of amelogenin-mediated enamel regeneration is that not only is the protein 
difficult to extract and store, but the growth of the repaired enamel layer also takes an extended 
amount of time, making it potentially unsuitable for clinical use. Furthermore, while amelogenin has 
been seen to promote apatite nucleation in vitro, there is as yet no direct evidence that similar 
biomineralization occurs in vivo [Ruan and Moradian-Oldak, 2015].  
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Poly(amido amine) (PAMAM) Dendrimers  
 PAMAM dendrimers are highly branched polymers characterized by the presence of internal 
cavities, a number of reactive end groups, and well-defined size and shape [Chen et al., 2013]. These 
amelogenin-inspired dendrimers have been referred to as “artificial proteins” as they can mimic the 
functions of organic matrices in modulating the biomineralization of tooth enamel. Several in vitro 
studies have demonstrated that amphiphilic, carboxyl-terminated, and phosphate-terminated 
PAMAM dendrimers exhibited strong tendency to self-assemble into hierarchical enamel crystal 
structures [Chen et al., 2013; Chen et al., 2015; Chen et al., 2014; Wu et al., 2013; Yang et al., 2011]. 
The new crystals created by the PAMAM organic templates had the same structure, orientation and 
mineral phase of the intact enamel, with the HA nanorods closely paralleling the original prisms 
[Chen et al., 2013]. 
 
 The synthetic PAMAM dendrimers have the potential to act as amelogenin analogues for 
biomineralization, overcoming the difficulty associated with extracting, purifying, and storing the 
natural protein. However, they are still far from clinical translation with in vivo studies so far limited 
to only animal experiments. Furthermore, like amelogenin, PAMAM-mediated enamel 
remineralization is also a time consuming process and unless this can be potentiated their clinical 
application may not be practical. Recently, there have been suggestions that lasers could be used 
to speed up the biomineralization process and control the crystal growth precisely where needed 
[Sun et al., 2017]. 
 
Electrically Accelerated and Enhanced Remineralization (EAER) 
 EAER is a recently developed remineralization technology targeted at initial and moderate 
enamel lesions with the treatment objectives of preserving all healthy tissue, restoring the full depth 
of the caries lesion, and improving mechanical properties of the treated enamel [Pitts and Wright, 
2018]. It utilizes iontophoresis to accelerate the flow of remineralizing ions into the deepest part of 
the subsurface caries lesion. This creates an environment that favours remineralization of the lesion 
that then matures to give the repaired lesion optimal hardness and mineral density. Unlike the 
biomimetic peptides, EAER does not “regenerate” lost enamel via matrix proteins or the organic 
capture of Ca2+ and PO43 ions. However, the developers claim that the EAER-treated lesions have a 
very similar appearance to healthy enamel, with no broken rods or degraded prisms visible under 
scanning electron microscopic examination [Pitts and Wright, 2018]. An advantage that the EAER 
technology will have over synthetic biomimetic peptides is that it proposes to utilize tools and 
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chemicals commonly available in most dental practices. The early in vitro results using the EAER 
technology are promising, although a thorough evaluation of its remineralization potential will 
depend on results from in vivo studies, as well as studies independent of the technology developers.  
 
Nanohydroxyapatite (nHA) 
 Synthetic nHA is considered one of the most biocompatible and bioactive materials having 
similar morphology, structure, and crystallinity to the apatite crystal within enamel [Hanning and 
Hanning, 2010]. The nano-sized particles can strongly bind to enamel surfaces and with fragments 
of plaque and bacteria. The small size of the particles that compose nHA considerably increase its 
surface area for binding as well as allowing it to act as a filler to repair small holes and depressions 
on the enamel surface [Pepla et al., 2014]. In vitro dynamic pH-cycling experiments have shown that 
nHA had the potential to remineralize initial enamel lesions with a comparable or even superior 
efficacy to that of fluoride [Huang et al., 2011; Huang et al., 2009; Najibfard et al., 2011; Tschoppe 
et al., 2011]. Another in vitro study found that nHA gel had significant potential for enamel 
remineralization around restoration margins [Juntavee et al., 2018]. The mechanism of nHA 
biomimetic function is not clear with some researchers suggesting that it promotes remineralization 
through the creation of a new layer of synthetic enamel around the tooth or by depositing apatite 
nanoparticles in the enamel defects [Li et al., 2008; Pepla et al., 2014]. However, others have 
proposed that nHA acts as calcium-phosphate reservoir maintaining a state of supersaturation with 
respect to enamel minerals, thereby inhibiting demineralization and enhancing remineralization 
[Huang et al., 2011]. 
 
 Although nHA products have been available since the 1980s, there are as yet no well-
designed RCTs that prove its superior efficacy to fluoride toothpastes. Moreover, under neutral 
conditions, nHA is seen to promote preferential remineralization of the outer enamel caries lesion, 
with full remineralization of the lesion not observed [Huang et al., 2011]. Further evidence is 
required before clinicians can recommend nHA oral products as a substitute to fluoride dentifrices 
or mouthwashes. 
 
B. Fluoride Boosters 
1. Calcium Phosphate systems 
 Biomimetic guided enamel regeneration could well be the future of non-fluoride 
remineralization, however, their widespread clinical application is still a few years away. Presently, 
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the need to enhance the remineralizing efficacy of fluoride in high caries-risk patients is largely met 
by calcium-phosphate systems. The bioavailability of Ca2+ and PO43- ions is often the limiting factor 
for net remineralization to occur on topical fluoride application, and this is especially exacerbated 
under hyposalivation conditions [Reynolds et al., 2008; Vogel et al., 2008]. The presence of extrinsic 
sources of Ca2+ and PO43- ions can increase diffusion gradients and augment the F- ion-mediated 
remineralization. A number of unique calcium-phosphate remineralization systems have been 
commercialized in recent years and Cochrane et al. [2010] categorized them into three types: (i) 
stabilized amorphous calcium-phosphate systems; (ii) crystalline calcium-phosphate systems; and 
(iii) unstabilized amorphous calcium-phosphate systems (Table 3).  
 
Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) 
 This remineralization system was developed based on the idea that the tryptic digestion of 
milk caseinate produced multi-phosphorylated casein phosphopeptides (CPP), substantially 
increasing the milk protein’s solubility and ability to stabilize Ca2+ and PO43- ions [Reynolds, 1987]. 
CPP is a saliva biomimetic but with a significantly greater calcium-stabilizing capacity than salivary 
proteins due to the higher content of its phosphoseryl residues [Cochrane and Reynolds, 2012]. CPP-
amorphous calcium phosphate (ACP) nanocomplexes are readily soluble in saliva, creating a 
diffusion gradient that allows them to localize in supragingival plaque. Low pH conditions that arise 
during a cariogenic attack facilitate the release of Ca2+ and PO43- ions, inhibiting demineralization 
and favouring the remineralization of the incipient lesion by precipitation of the released ions 
[Reynolds, 2009]. The subsurface remineralization pattern produced by CPP-ACP has been shown 
to significantly improve the aesthetics, strength, and acid resistance of the remineralized WSL 
[Cochrane et al., 2010; Mayne et al., 2011].  
 
 CPP-ACP is probably the most studied non-fluoride remineralizing agent, although there is 
considerable variability in the reported results. Many RCTs have demonstrated significantly better 
remineralizing and anti-caries effects for CPP-ACP products compared to a placebo or a fluoride 
containing product [Bailey et al., 2009; Guclu et al., 2016; Heravi et al., 2018; Juarez-Lopez et al., 
2014; Krithikadatta et al., 2013; Llena et al., 2015; Morgan et al., 2008; Rao et al., 2009; Robertson 
et al., 2011]. However, other RCTs contradict the above studies as they did not report any superior 
added effect for CPP-ACP [Beerens et al., 2010; Brochner et al., 2011; Huang et al., 2013; Plonka et 
al., 2013; Singh et al., 2016; Sitthisettapong et al., 2015; Sitthisettapong et al., 2012]. Published 
literature and systematic reviews also reach conflicting conclusions, with some reviews suggesting 
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that CPP-ACP had significant remineralizing and caries preventive effects [Llena et al., 2009; Wang 
et al., 2017; Yengopal and Mickenautsch, 2009], while others conclude that the evidence to support 
its long-term remineralizing or synergistic effect with fluoride is limited [Azarpazhooh and Limeback, 
2008; Fontana, 2016; Li et al., 2014; Raphael and Blinkhorn, 2015; Zero, 2009].  
 
The reasons for the conflicting results from CPP-ACP remineralization studies can partly be 
due to a poor understanding of CPP-ACP technology. Many RCTs that concluded that CPP-ACP did 
not provide any superior remineralization to fluoride have not accounted for the fact that 
remineralization patterns produced by CPP-ACP and fluoride are different. CPP-ACP enhanced 
remineralization of enamel subsurface lesions compared to predominantly surface-only 
remineralization produced by fluoride alone products [Shen et al., 2011]. Fully remineralized WSL 
not only have better aesthetics and strength, but are more resistant to a subsequent acid challenge. 
Furthermore, the ability of CPP-ACP to provide high concentrations of stabilized Ca2+ and PO43- ions 
could be especially important in highly cariogenic environments (e.g. xerostomia, >6 sugar 
exposures/day), where fluoride and salivary homeostatic mechanisms alone will not be enough to 
repair developing lesions. Reasons for inconsistent conclusions from systematic reviews can be 
attributed to inclusion of studies with inadequate statistical power and possible conflict of interest 
between competing product manufacturers. Clearly, there is a need for more independent long-
term longitudinal studies focussing on high-risk population groups to demonstrate whether CPP-
ACP therapy can effect superior remineralization of early lesions compared to fluoride-based 
products [Gonzalez-Cabezas and Fernandez, 2018].  
 
Functionalized β-Tricalcium Phosphate (fTCP) 
 Crystalline β-tricalcium phosphate (β-TCP) was modified by coupling it with carboxylic acids 
and surfactants to yield fTCP [Karlinsey et al., 2010]. The purpose of functionalizing β-TCP was to 
create barriers preventing premature fluoride-calcium interactions, thereby allowing it to act as a 
targeted low-dose delivery system when applied to teeth via dentifrices or mouthwashes [Karlinsey 
and Pfarrer, 2012]. It was designed primarily to boost F- ion activity on the tooth surface, with 
remineralization driven mostly by salivary Ca2+ and PO43- ions.  
 
 Although already available as a commercial product, data on its remineralizing efficacy is 
sparse, and limited to in vitro studies that do not fully reflect the complex biological process involved 
in lesion remineralization. Purely based on the mechanisms involved, it does seem that CPP-ACP will 
have a significant advantage over fTCP in remineralizing early lesions. While the pH-responsive CPP-
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ACP nanocomplexes can deliver stabilized Ca2+ and PO43- ions over an extended time, fTCP appears 
to supply only a small amount of unbound ions during the short period of brushing before being 
expectorated from the mouth [Walsh, 2009]. Clinical recommendation on using fTCP products will 
be premature without evidence from well-designed RCTs. 
 
Calcium Sodium Phosphosilicate (CSPS) 
 CSPS is a bioactive glass material originally developed as a biocompatible bone regenerative 
agent. When introduced into the aqueous oral environment, it releases Na+, Ca2+ and PO43- ions, 
which then interact with saliva and deposit crystalline hydroxycarbonate apatite layer that is 
structurally and chemically similar to tooth mineral [Burwell et al., 2009]. CSPS was initially 
incorporated into a dentifrice for the treatment of dentin hypersensitivity but there have been 
suggestions it could be useful for enamel remineralization too [Wefel, 2009]. However, evidence 
from in vitro and in situ data is weak and contradictory [Parkinson et al., 2017; Wang et al., 2016], 
while there is no clinical data from RCTs to prove its remineralizing efficacy. 
 
Amorphous Calcium Phosphate (ACP) 
 ACP is an unstabilized calcium-phosphate system that has been incorporated into a dual-
chamber fluoride toothpaste with the intention of separately delivering Ca2+ and PO43- ions into the 
mouth [Tung and Eichmiller, 2004]. On brushing, the intraoral mixing of Ca2+ and PO43- ions results 
in the immediate precipitation of ACP or amorphous calcium fluoride phosphate (ACFP). Both ACP 
and ACFP are unstable and rapidly transform into more stable HA or fluorhydroxyapatite. Before 
their phase transformation, the Ca2+ and PO43- ions should be transiently bioavailable for subsurface 
lesion remineralization [Cochrane et al., 2010]. 
 
 Evidence for the ACP technology is available only from a single RCT in radiation patients 
where it was found to be superior to a conventional fluoride dentifrice in lowering root caries 
increment, although there were no significant differences in its ability to control coronal caries 
[Papas et al., 2008]. One of the main concerns with using an unstabilized calcium-phosphate system 
is that it can promote dental calculus deposition on teeth. Moreover, ACP also tends to rapidly 
sequester free F- ions in the oral environment, reducing their availability for lesion remineralization. 
Considering the limited evidence and better alternatives available, oral products based on the ACP 
remineralization technology have limited clinical applicability. 
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2. Polyphosphates 
Sodium Trimetaphosphate (STMP) 
 One way to reduce the potential risk of fluorosis while maintaining the anticaries efficacy of 
conventional dentifrices is to partly replace fluoride with polyphosphate salts like STMP, calcium 
glycerophosphate, or hexametaphosphate [da Camara et al., 2016; Takeshita et al., 2016; Zaze et 
al., 2014]. Among the polyphosphates, STMP is seen to be the most effective anticaries agent with 
an ability to not only inhibit demineralization but also enhance remineralization [Freire et al., 2016; 
Takeshita et al., 2011].  
 
STMP (Na3P3O9) is a condensed inorganic phosphate that is able to strongly bind to 
phosphate sites on enamel surface and remain adsorbed for a longer time compared to other 
phosphates [McGaughey and Stowell, 1977]. This leads to the formation of a protective layer on the 
enamel surface that limits acid diffusion of ions during a cariogenic challenge [McGaughey and 
Stowell, 1977]. The fact that STMP can minimize mineral loss even in the presence of low fluoride 
concentrations has been confirmed in several in vitro and in situ studies [Danelon et al., 2014; 
Favretto et al., 2013; Takeshita et al., 2015; Takeshita et al., 2011]. The protective barrier against 
acid diffusion created by the adsorption of STMP on enamel does not seem to hinder the diffusion 
of Ca2+ and F- ions into the enamel. In situ models have shown that supplementation of a low-
fluoride product with STMP produced similar remineralization effects to 1100 ppm fluoride 
formulation [Danelon et al., 2013; Takeshita et al., 2016], while the addition of STPM to 
conventional fluoride dentifrices and varnishes significantly enhanced their remineralization of 
artificial caries lesions [Danelon et al., 2015; Manarelli et al., 2015].  
 
While earlier clinical trials evaluating caries preventive effects of STMP produced conflicting 
results [O'Mullane et al., 1997; Stadtler et al., 1996], a recent 18-month double-blinded RCT showed 
that a 500 ppm low-fluoride dentifrice supplemented with STMP was significantly superior to a 1100 
ppm fluoride dentifrice in lowering the caries increment of children [Freire et al., 2016]. There is a 
need for additional clinical studies to ascertain whether STMP can influence the reversal of non-
cavitated lesions. 
 
3. Natural Products 
 An interesting addition to remineralizing agents are plant-derived natural products that have 
demonstrated the ability to beneficially shift the de-/remineralization caries equilibrium. Among the 
most promising is Galla chinensis, a leaf gall produced by parasitic aphids, which has been found to 
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be effective in inhibiting demineralization, enhancing remineralization, and increasing the efficacy 
of fluoride [Cheng et al., 2008, 2010]. The mechanisms are still not fully clear, but it is hypothesized 
that polyphenols present in Galla chinensis interact with and stabilize the organic matrix remnants, 
thereby blocking the ion diffusion pathways, and slowing demineralization [Huang et al., 2017; 
Zhang et al., 2015]. Galla chinensis remineralization is believed to be mediated through different 
polyphenol compounds that act as a Ca2+ ion carriers into the lesion body [Cheng et al., 2015]. 
Hesperidin, a citrus flavonoid, and Gum arabic, an Acacia exudate, are other natural products that 
have been found to suppress acid-dependent demineralization and boost remineralization even 
under fluoride-free conditions [Islam et al., 2012; Onishi et al., 2008].  
 
Natural remineralizing agents could find greater acceptability among the general public 
compared to fluoride-based remineralizing systems. However, chemical characterisation and 
standardization of the natural products will be required before further application in clinical trials. 
 
CONCLUSIONS 
 The era of preventive and minimally-invasive dentistry clearly dictates the need for 
developing newer approaches to remineralize enamel caries lesions. While fluoride-mediated 
natural repair of early lesions can occur by influencing oral hygiene and diet, this is dependent on 
variables such as saliva quality and patient compliance. Non-fluoride remineralization systems are 
less reliant on such factors and can also significantly improve the structure, aesthetics, and acid 
resistance of the remineralized lesion. Furthermore, effective non-fluoride remineralizing strategies 
can prevent a non-cavitated lesion from being subjected to a “death spiral of restorations” due to 
secondary caries at the enamel-restoration interface [Qvist, 2008]. Currently, most commercially 
available non-fluoride remineralizing systems are aimed at enhancing fluoride efficacy and 
minimizing the potential risks associated with fluoride. However, a biomimetic strategy for enamel 
regeneration may well be the future, where organized enamel apatite crystals with robust 
attachment to the tooth surface is grown to replace demineralized tissue. Guided enamel 
regeneration is the holy grail of remineralizing therapeutic approaches and some of the biomimetic 
technologies discussed here are bringing us a step closer to the reality of growing artificial enamel.  
 
 Although highly promising, the currently available clinical evidence for most of the non-
fluoride enamel remineralizing systems is either poor, equivocal, or limited to a few early studies. 
Well-designed RCTs are vital to clarify whether these new-age remineralizing approaches provide 
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any additional benefit over traditional fluoride remineralization, and these studies are especially 
needed for the products already in the market. 
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 LITERATURE REVIEW: NON-FLUORIDE REMINERALIZING AGENTS 
 
2.3.2  REVIEW PAPER 6 
 
The Potential Ecological Effects of Casein Phosphopeptide-Amorphous Calcium 
Phosphate in Dental Caries Prevention 
 
This review principally discusses the proposed ecological mechanisms of CPP-ACP and 
presents the current evidence for its effects on the oral microbiome ecology. 
 
The paper was published on 21st February 2019 in Australian Dental Journal, the official 
publication of the Australian Dental Association (ADA).  
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This chapter is comprised of the publication as it stands in print. 
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ABSTRACT 
Contemporary caries prevention protocols recommend not only effective remineralizing agents but 
also ecological measures to reverse the dental plaque dysbiosis responsible for the disease 
pathogenesis.  There is a high-level of evidence supporting the remineralizing efficacy of casein 
phosphopeptide-amorphous calcium phosphate (CPP-ACP) from studies around the world. Evidence 
is also emerging that CPP-ACP may also have a beneficial influence on the dental plaque microbial 
ecology and homeostasis. The ecological cariostatic effects of CPP-ACP are believed to be mediated 
predominantly through its anti-adhesion, buffering, and biofilm disrupting actions. This review 
principally discusses the ecological mechanisms of CPP-ACP and presents the current evidence for 
its effects on the oral microbiome ecology. 
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The progress of dental caries lesions to cavitation depends on the equilibrium between 
demineralization, caused by dental plaque dysbiosis, and remineralization, which is contingent on 
the presence of calcium, phosphate, and fluoride in the oral environment [Featherstone et al., 
2018]. Ever since the cariostatic effects of fluoride were discovered, caries prevention has largely 
relied on the ability of fluoride ions to inhibit enamel dissolution and enhance remineralization of 
incipient lesions. More recently, several calcium-phosphate remineralization technologies have 
been developed aiming to further boost the remineralizing efficacy of fluoride [Fontana, 2016; 
Philip, 2019]. However, one consequence of accepting the ecological plaque hypothesis is the 
recognition that current approaches to caries management do not necessarily challenge the 
underlying aetiology of the disease [Burne, 2018; Philip et al., 2018a]. Caries lesions develop due to 
a catastrophic ecological shift in the plaque biofilm microflora, triggering an imbalance in the 
physiologic equilibrium between tooth mineral and biofilm fluid. This ultimately tips the caries 
balance towards demineralization and lesion formation [Kleinberg, 2002; Marsh, 2003]. 
Environmental pressures (e.g. frequent sugar exposures, xerostomia etc.) can create an extended 
period of low pH in dental plaque, favouring acidogenic/aciduric bacteria over commensal resident 
species, and thereby increase caries-risk [Marsh, 2018]. The pH-driven shifts in composition and 
metabolism of oral microflora have been shown to be responsible for enamel demineralization and 
caries initiation [Bradshaw and Marsh, 1998; Bradshaw et al., 1989]. The need to reverse this 
microbiome dysbiosis has prompted suggestions to include ecological measures to complement the 
physiochemical preventive effects of fluoride [Philip et al., 2018]. 
 
Ideally, the remineralizing agents themselves should be able to influence the cariogenic 
virulence traits responsible for the microbial plaque dysbiosis. Several studies have shown that 
under appropriate conditions fluoride ions can inhibit the acidogenicity, aciduricity, and glucan 
synthesis of cariogenic bacteria [Domon-Tawaraya et al., 2013; Pandit et al., 2015; Pandit et al., 
2013; Takahashi and Washio, 2011]. However, it is unclear as to how much the antimicrobial 
mechanisms of fluoride contribute to its caries preventive effects. A recent study demonstrated that 
the brief fluoride exposure from toothpastes or mouthwashes could not sustain anti-acid 
production activity, with the biofilms recovering acidogenicity over time, even when high fluoride 
concentrations were used [Dang et al., 2016]. 
 
In this regard, a naturally derived protein-based remineralizing technology called casein 
phosphopeptide-amorphous calcium phosphate (CPP-ACP) has been shown to not only significantly 
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improve remineralization of enamel subsurface lesions but may also hold great promise in effecting 
a beneficial shift in the dental plaque microbial ecology. CPP-ACP is probably the most studied non-
fluoride remineralizing technology with a large number of randomised controlled trials (RCTs) and 
systematic reviews from across the globe having assessed its remineralizing efficacy [Philip, 2019]. 
However, the literature is relatively sparse on the ecological influences of CPP-ACP on dental plaque. 
This brief overview aims to discuss the proposed mechanisms and the evidence for its effects on the 
oral microbiome ecology. 
 
CPP-ACP: DEVELOPMENT AND CARIOSTATIC MECHANISMS 
The caries protective effects of milk and milk products like cheese have for long been 
attributed to casein phosphoproteins and the calcium and phosphate components present in them 
[Harper et al., 1986; Reynolds and del Rio, 1984]. The tryptic digestion of milk caseinate has been 
shown to produce multi-phosphorylated casein phosphopeptides (CPPs), substantially increasing its 
ability to stabilize calcium phosphate in solution, through the binding of amorphous calcium 
phosphate (ACP) clusters with their multiple phosphoserine residues [Reynolds, 1987]. CPP acts as 
a salivary protein biomimetic but with significantly greater calcium-stabilizing capacity due to the 
higher content of its phosphoseryl residues [Cochrane and Reynolds, 2012]. Moreover, CPP exhibits 
ten times greater anti-cariogenicity on a weight basis than the intact milk protein, without the 
associated problems of unpalatability or allergenicity [Reynolds and Walsh, 2005]. This natural 
process of calcium stabilization, transport, and delivery was used to develop the CPP-ACP 
remineralisation technology. Both CPP-ACP and a fluoride-incorporated version (CPP-ACFP) are now 
used globally in a number of oral care products like chewing gums, topical crèmes, and toothpastes. 
 
 CPP-ACP nanocomplexes are readily soluble in saliva creating a diffusion gradient that allows 
them to localize in dental plaque. CPP-ACP can thus act as biological calcium phosphate delivery 
vehicles that significantly boost levels of bioavailable calcium and phosphate ions in saliva and 
plaque fluid without causing indiscriminate precipitation of the calcium salts [Reynolds et al., 2003]. 
Low pH conditions that arise during a cariogenic attack facilitate the release of calcium, phosphate, 
and fluoride ions from the CPP-ACP/CPP-ACFP complexes, inhibiting demineralization and favouring 
remineralization by precipitation of the released ions [Reynolds, 2009]. The ability of CPP-ACP to 
readily provide supersaturated concentrations of stabilized calcium and phosphate ions significantly 
augments the remineralisation potential of saliva/plaque and enables deeper subsurface lesion 
remineralisation. The remineralization pattern produced by CPP-ACP is considered superior to the 
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predominantly surface-only remineralization mediated by fluoride [Shen et al., 2011]. Fully 
remineralized enamel lesions not only have better aesthetics and strength but are also more 
resistant to a subsequent acid challenge [Cochrane et al., 2008; Mayne et al., 2011]. 
 
CPP-ACP: ECOLOGICAL EFFECTS ON DENTAL PLAQUE 
 The majority of the studies on the cariostatic effects of CPP-ACP have focussed on its 
remineralization capabilities. However, there is growing awareness that the daily application of CPP-
ACP can have beneficial effects on the ecology of the oral plaque microflora. The existing evidence 
on its possible dental plaque effects are summarized in Table 4 and the proposed mechanisms 
underpinning the ecological influences of CPP-ACP are detailed further below. 
 
Table 4. Scientific evidence for the ecological effects of CPP-ACP/CPP-ACFP 
Author [year] Study Design Test Agent Results/Conclusions 
Anti-adhesion Effects 
   
Schüpbach et al. [1996] In vitro incubation of bovine enamel 
discs with unstimulated saliva 
 
CPP/CGMP 
 
Significant reduction in adherence of S. 
mutans 
 
Guggenheim et al. [1999] 
 
In vivo animal caries model study 
 
CPP/micellar 
casein 
 
Inhibition of caries lesions and S. sobrinus 
Rose [2000a,b] 
 
In vitro calcium binding 
experiments 
 
CPP-ACP Binds to streptococcal plaque with twice 
the affinity of free Ca2+ ions and lowers the 
degree of calcium bridging between the 
pellicle and adhering bacteria 
 
Reynolds et al. [2003] 
 
Immunolocalization in plaque CPP-ACP Strong affinity of to bacterial cell surface 
molecules and plaque extracellular matrix 
 
Subramanian and Naidu 
[2009] 
RCT in children aged 13-18 years CPP-ACFP Reduced plaque S. mutans counts more 
than a fluoride-chlorhexidine gel 
 
Beerens et al. [2010] RCT in orthodontic patients CPP-ACFP Lowered dental plaque numbers of S. 
mutans and Lactobacillus but not 
significantly more than a fluoride-free 
control paste 
 
Pukallus et al. [2013] Longitudinal RCT in infants from 
birth to 24 months 
CPP-ACP Fewer MS-positive infants at 24 months in 
the CPP-ACP group with a dose-response 
effect observed with CPP-ACP usage 
 
Plonka et al. [2013] Longitudinal RCT in infants from 
birth to 24 months 
CPP-ACP Fewer MS-positive infants at 12 months in 
the CPP-ACP group 
 
Yetkiner et al. [2014] RCT in children with white spot 
lesions 
CPP-ACP Salivary S. mutans counts decreased at 
end of3-month experimental period 
 
Emamieh et al. [2015] RCT in students aged 20-25 years CPP-ACP CPP-ACP chewing gums significantly 
reduced salivary S. mutans counts even 
more than a xylitol chewing gum 
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Table 4. Continued 
Author [year] Study Design Test Agent Results/Conclusions 
Buffering Effects 
   
Reynolds and Riley 
[1989] 
In vitro protein dissimilation study CPP Enzymatic breakdown of CPP elevated 
plaque pH rise through production of NH3 
 
Caruana et al. [2009] Randomised cross-over trial CPP-ACP Application of CPP-ACP crème reduced 
plaque pH drop after a sucrose challenge 
 
Marchisio et al. [2010] RCT in orthodontic patients  Significantly increased salivary pH levels 
but plaque pH changes were equivocal 
 
Heshmant et al. [2014a] Randomised cross-over trial CPP-ACFP Clinically beneficial in increasing plaque pH 
but no effect on salivary pH 
 
Heshmant et al. [2014] RCT in teenage patients CPP-ACP/ 
CPP-ACFP 
Prior application of CPP-ACFP kept plaque 
pH high for up to 96 h after a sugar 
challenge compared to 48 h for CPP-ACP 
 
Biofilm Effects    
Rahiotis et al. [2008] In situ biofilm study CPP-ACP Delayed intraoral biofilm formation 
 
Dashper et al. [2016] In vitro biofilm study CPP-ACP Inhibited S. mutans biofilm development 
and disrupted architecture of established 
biofilms 
CPP-ACP: casein phosphopeptide-amorphous calcium phosphate; CPP-ACFP: casein phosphopeptide-amorphous calcium fluoride 
phosphate; CGMP: caseinoglycomacropeptide; RCT: randomised controlled trial; MS: mutans streptococci 
 
Inhibition of Bacterial Adhesion 
 Early in vitro studies have reported a rapid saturation of saliva-coated hydroxyapatite 
surfaces by casein complexes inhibiting the adherence of Streptococcus mutans and Streptococcus 
sobrinus [Reynolds and Wong, 1983; Schüpbach et al., 1996; Vacca-Smith et al., 1994]. This was 
confirmed in an experimental animal caries model study where rats fed cariogenic diets containing 
micellar casein/CPP showed a significant reduction in caries lesions and numbers of S. sobrinus 
colonizing the teeth of these animals [Guggenheim et al., 1999]. Further studies by Rose revealed 
that CPP-ACP binds both to dental plaque (with a strong affinity for S. mutans) and to pellicle 
macromolecules adsorbed on the tooth surface [Rose, 2000a; Rose, 2000b]. This was corroborated 
by electron micrographs of immunocytochemically stained sections of dental plaque showing CPPs 
bound to bacterial cell surfaces as well as to the extracellular matrix [Reynolds et al., 2003]. It has 
been suggested that major bonds localizing the CPP-ACP on bacterial cell surfaces are not mediated 
by the acid-labile calcium ions or ACP cross-linking but were predominantly between the peptides 
and cell surface molecules [Reynolds et al., 2003]. 
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 The exact anti-adhesion mechanisms for CPP-ACP are not clearly defined but it has been 
shown that CPP-ACP competes with free calcium for plaque calcium binding sites, reducing the 
degree of calcium bridging between the pellicle and adhering cells and between the bacterial cells 
themselves [Rose, 2000a]. In addition, CPP molecules have hydrophilic and hydrophobic regions that 
can mask the bacterial cell surface hydrophobic proteins and thereby impede the initial bacterial 
adhesion to pellicle-coated tooth surfaces. Furthermore, localization of CPP-ACP on bacterial 
surfaces and plaque could prevent bacterial co-aggregation and accumulation in dental plaque. This 
interference with microbial attachment may prevent deleterious ecological shifts in dental plaque 
thereby inhibiting caries development. 
 
 Several clinical trials have shown that regular use of CPP-ACP/CPP-ACFP oral care products 
reduced mutans streptococci levels in saliva [Emamieh et al., 2015; Plonka et al., 2013; Pukallus et 
al., 2013; Subramanian and Naidu, 2009; Yetkiner et al., 2014]. Another RCT reported that while 
CPP-ACFP caused a reduction in percentages of S. mutans and aciduric lactobacilli in dental plaque 
samples, the plaque composition was not significantly different from that effected by a fluoride-free 
control paste [Beerens et al., 2010]. The authors of this study suggested that poor compliance of 
subjects using the CPP-ACFP product could be one of the reasons why no advantage was detected. 
A limitation of these clinical trials is that a single bacterial species (usually S. mutans) was used as 
the surrogate marker to evaluate changes in the salivary/plaque microbial profile. However, 
assessing the dental plaque numbers of a range of cariogenic and health-associated bacteria would 
be more relevant. Clearly, more well-designed RCTs are required to establish whether the reported 
anti-adhesion effects of CPP-ACP can translate into altering the plaque microbial composition to one 
associated with health and not disease. 
 
Buffering Effects 
 A sustained low pH environment in dental plaque not only favours enamel demineralization 
but also allows acidogenic/aciduric bacteria to gain an ecological advantage over health-associated 
oral bacterial species [Nascimento, 2018]. The buffering effects of CPP-ACP can alkalize the plaque 
biofilm and possibly prevent the detrimental microbial ecological shift from occurring. RCTs in 
orthodontic patients have shown that CPP-ACP crèmes could elevate plaque/salivary pH levels and 
improve the oral hygiene index [Heshmant et al., 2014a; Marchisio et al., 2010]. Prior application of 
CPP-ACP products was also seen to reduce the fall in plaque pH following a sucrose challenge, with 
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CPP-ACFP capable of keeping the pH high for up to 96 h compared to 48 h for CPP-ACP [Caruana et 
al., 2009; Heshmant et al., 2014]. 
 
 The mechanisms by which the buffering influences of CPP-ACP are mediated may be varied. 
CPP-ACP does not necessarily impede bacterial acid production per se but rather acts as a reservoir 
of peptides and phosphate ions which offset any drop in pH [Reynolds, 1997]. While the enzymatic 
breakdown of CPPs by plaque peptidases and phosphatases reduces their capacity to stabilize 
calcium and phosphate ions [Cross et al., 2005], the plaque pH rise that results from this hydrolysis 
is beneficial in favourably tilting the de-/remineralization equilibrium [Cochrane et al., 2010]. For 
instance, the glutaminyl and asparaginyl residues of CPPs have been shown to be non-arginine 
sources of nitrogen for oral commensal bacteria to catabolize and effect a pH rise through the 
production of ammonia [Reynolds and Riley, 1989]. The CPP phosphoseryl sequences are relatively 
more resistant to hydrolysis but readily accept protons and neutralize plaque acids [Reynolds, 1987]. 
Evidently, CPPs and their breakdown products can have a positive impact on plaque biofilm 
homeostasis and thus provide a selective ecological advantage to non-aciduric microorganisms. This 
could, over time, increase the proportion of amino acid utilizing commensal bacteria in dental 
plaque while reducing the numbers of cariogenic bacteria. 
 
Biofilm Disruption 
 Dental caries is the most common biofilm-mediated disease afflicting humans. The 
exopolysaccharide glucan-rich matrix of cariogenic plaque biofilms offers substantial protection 
against the inimical influences of remineralizing agents and antimicrobials. Cariostatic agents that 
can potentially delay biofilm development and disrupt its structural organisation should be 
beneficial in caries prevention. A recent in vitro study demonstrated that a glass ionomer cement 
containing 3% CPP-ACP significantly inhibited biofilm development by over 50% [Dashper et al., 
2016]. A single 10 min treatment with aqueous 1% CPP-ACP was also shown to significantly reduce 
biomass and thickness of established S. mutans biofilms, while severely disrupting the structural 
architecture of these biofilms [Dashper et al., 2016]. This was consistent with an in situ study that 
showed treatment with CPP-ACP delayed intraoral biofilm formation [Rahiotis et al., 2008]. The 
ability of CPP-ACP to mask pellicle and bacterial cell surface macromolecules possibly prevents the 
cell to cell adhesion essential for biofilm development. The CPP-ACP mediated disruption to the 
biofilm structural architecture would render it less capable of maintaining an acidic pH at the 
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attachment surface and allow diffusion of fluoride, calcium and phosphate ions to the plaque-tooth 
interface for remineralizing any incipient lesions. 
 
Bacteriostatic/Bactericidal Effects 
 There have been suggestions that CPP-ACP by forcing the maintenance of high free calcium 
concentrations in dental plaque may indirectly have additional biocidal or bacteriostatic effects. 
Calcium concentrations greater than 1 mmol/L have been found to induce streptococcal membrane 
permeability and partial lysis [Trombe et al., 1992], while the ATP-dependent calcium export system 
may also be unable to cope with high calcium concentrations [Kobayashi et al., 1978]. Whether 
these mechanisms actually play a role in CPP-ACP reducing bacterial counts in dental plaque/saliva 
needs further elucidation.  
 
CONCLUSIONS 
 CPP-ACP is a natural non-toxic anti-cariogenic agent that can safely be added to dentifrices, 
chewing gums, and food products to lower caries experience in high-risk individuals. The evidence 
presented in this paper does indicate that CPP-ACP may possibly have multiple modes of cariostatic 
action (inhibition of demineralization, enhanced remineralization, reduced bacterial adhesion, 
buffering action, biofilm disruption, and bacteriostatic/bactericidal effects). While there is a high-
level of evidence supporting the remineralization potential of CPP-ACP, further research is needed 
on whether the suggested ecological mechanisms can effectively translate into beneficial microbial 
changes in dental plaque. Molecular techniques, based on the 16S rRNA real-time quantitative 
polymerase chain reaction or next-generation sequencing, can be used to confirm bacterial profile 
changes in dental plaque after using CPP-ACP oral care products. Three RCTs are currently registered 
on the Australian New Zealand Clinical Trials Registry (ACTRN12618000095268, 
ACTRN12615001227583, ACTRN12617000148370), evaluating whether dentifrices and chewing 
gums containing CPP-ACP can influence microbial compositional changes in dental plaque. Results 
from these clinical trials should provide more definitive evidence on the potential ecological effects 
of CPP-ACP. 
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2.4 LITERATURE GAPS 
The following gaps have been identified from the review of the literature: 
 
1. There have been no studies that have assessed whether natural products with antimicrobial 
activity can selectively inhibit the growth of caries-associated bacterial species without 
affecting the viability of health-associated bacterial species. 
 
2. While isolated phytochemical compounds have exhibited potent activity against cariogenic 
virulence factors, there is a paucity of studies on whether commercially available 
standardized plant or fruit extracts can have similar influence. 
 
3. The literature is lacking studies on whether the synergistic virulence of Streptococcus 
mutans-Candida albicans dual-species biofilms, implicated in contributing to the severity of 
early childhood caries, can be disrupted using antimicrobial natural products. 
 
4. There is are no reports in literature on whether any of the natural products suggested to 
have cariostatic effects can influence beneficial microbial ecological changes. 
 
5. The large majority of studies of CPP-ACP have been on its remineralizing effects, and there 
is a need for more research into its ecological effects. 
 
6. The few clinical studies on the ecological effects of CPP-ACP have focussed on a single 
bacterial species in saliva. There is a need to study its ecological effects on a range of caries- 
and health-associated bacteria in dental plaque. 
 
7. There is a need for well-designed randomised controlled trials to investigate the ecological 
effects of natural products and CPP-ACP. 
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3. HYPOTHESIS AND AIMS 
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3.1  RESEARCH HYPOTHESIS 
The overarching hypothesis for this thesis is that natural products and casein phosphopeptide-
amorphous calcium phosphate (CPP-ACP) can attenuate virulence in cariogenic biofilms and 
influence beneficial microbial ecological changes in the dental plaque. 
 
3.2  RESEARCH AIMS 
This research project has the following aims: 
 
1. Identify natural products with growth inhibitory or virulence attenuating activity that could 
translate into beneficial microbial ecological effects against cariogenic biofilms. 
 
2. Assess the virulence inhibitory and ecological effects of CPP-ACP on polymicrobial biofilms 
and the dental plaque microbiome. 
 
3. Evaluate whether the addition of a cariostatic natural product to a CPP-ACP oral care product 
can enhance beneficial plaque ecological effects. 
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4. SCIENTIFIC PAPERS 
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4.1  SCIENTIFIC PAPER 1 
 
Growth Inhibitory Effects of Antimicrobial Natural Products against Cariogenic 
and Health-associated Oral Bacterial Species  
 
This study investigated whether selected natural products could specifically target the 
growth of a caries-associated bacterial species (Streptococcus mutans) without affecting 
the viability of a health-associated oral bacterial species (Streptococcus sanguinis). The 
study also determined the minimum inhibitory concentrations of the natural products 
that exhibited bacterial growth inhibitory effects. 
 
The paper was accepted on 8th January 2019 for publication in Oral Health and 
Preventive Dentistry, the official publication of the European Society for Preventive 
Dentistry. It is currently being prepared for print. 
 
This chapter is comprised of the publication as accepted. 
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ABSTRACT 
Purpose: This study investigated whether selected natural products could specifically target the 
growth of a caries-associated bacterial species (Streptococcus mutans) without affecting the viability 
of a health-associated oral commensal bacterial species (Streptococcus sanguinis).  
 
Materials and Methods: Agar diffusion assays were used to screen the natural products for bacterial 
growth inhibitory effects and the diameters of the inhibitory zones for the two bacterial species 
were compared. The minimum inhibitory concentrations (MIC) of the natural products that showed 
growth inhibitory effects were then determined using the broth microdilution method.  
 
Results: Except for the fruit berry extracts (cranberry, wild blueberry, and strawberry), all the other 
selected natural products (peppermint, cinnamon, ginger, cinnamon, rosemary, liquorice, 
xanthorrrhizol, tt-farnesol, guaijaverin, and macelignan) exhibited varying degrees of bacterial 
growth inhibition. The MIC values ranged from as low as 4 µg/mL for xanthorrrhizol to 1000 µg/mL 
for guaijaverin. All the growth inhibitory natural agents tested showed similar inhibition for both S. 
mutans and S. sanguinis.  
 
Conclusions: Although several natural products exerted significant antibacterial effects, none had 
selective inhibitory action on the growth of S. mutans. 
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INTRODUCTION 
Dental caries remains among the most widespread global oral health problems, affecting 
quality of life and imposing a costly burden on health services [Kassebaum et al., 2015]. An 
additional concern is that recent epidemiological surveys are indicating that dental caries 
prevalence may be increasing again even in developed countries [AIHW, 2018; Dye et al., 2015]. 
Furthermore, the disease is not uniformly distributed with multiple population groups, including 
children and the elderly, at increased risk of developing the disease [Featherstone et al., 2018]. 
 
In addition to the established caries preventive methods, adjunctive measures 
commensurate to individual caries-risk, are often needed to control the disease in high-risk 
populations. With dental caries known to be a disease of microbiome dysbiosis, preventive 
strategies that ecologically modify the dental plaque biofilm are being increasingly recommended 
[Philip et al., 2018]. Health-associated microbiomes can deliver small but relevant benefits over a 
prolonged period and could be particularly useful for long-term dental caries control [Burne, 2018; 
Marsh, 2018]. With the aim of reducing levels of mutans streptococci (MS), a range of biocides (e.g. 
chlorhexidine, triclosan, cetylpyridinium chloride) and antibiotics (e.g. vancomycin) have been used 
in the past [Chen et al., 2010; De Paola et al., 1974; Holbeche et al., 1976; Ribeiro et al., 2007]. 
However, a concern with conventional antimicrobial agents is that they usually exert a broad-
spectrum of antibacterial action, suppressing even health-associated oral microbial communities, 
and thus disrupting key health benefits of the resident oral microbiome [Yoo et al., 2011]. 
Furthermore, the side-effects associated with synthetic antimicrobials limit their acceptability and 
the duration for which they can be used. Once the chemotherapeutic intervention stops, susceptible 
tooth surfaces are often repopulated with the same disease-associated microbiome that was 
eliminated. 
 
Plant-derived natural products with bacterial growth inhibitory effects are an attractive 
alternative to traditional oral biocides for long-term caries prevention. Phytochemicals have been 
shown to reduce the development of dental plaque, influence bacterial adhesion, and reduce 
symptoms of oral diseases [Palombo, 2011]. For caries prevention, such natural agents should 
ideally suppress the growth of MS without significantly inhibiting the commensal health-associated 
plaque microflora. There is comparatively little information in the literature on whether any of the 
reported antimicrobial natural products can selectively inhibit the growth of cariogenic bacteria 
without affecting health-associated bacteria. Therefore, the aim of this study was to compare the 
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growth inhibitory effects of a range of natural products on the caries-associated Streptococcus 
mutans and the health-associated Streptococcus sanguinis bacterial species. 
 
MATERIALS AND METHODS 
Test Agents 
The selection of test agents was based on a literature review that identified potential 
cariostatic natural products. High-quality supercritical CO2 extracts of peppermint, cinnamon, 
ginger, rosemary, liquorice, and xanthorrrhizol were sourced from Flavex Naturextrakte (Rehlingen, 
Germany). Water soluble molecular extracts of cranberry, wild blueberry, and strawberry were 
sourced from Diana Food (Champlain, QC, Canada). In addition, phytochemicals found in bee-hive 
propolis (tt-farnesol) (Sigma-Aldrich, St. Louis, MO, USA), and those isolated from guava leaves 
(guaijaverin) and nutmeg (macelignan) (Seebio Biotech, Shanghai, China) were also selected. Stock 
solutions of all the natural products were prepared, with the berry extracts dissolved in phosphate 
buffered saline (PBS), while the other test agents were suspended in 2% dimethyl sulfoxide (DMSO, 
Sigma-Aldrich). Both PBS and the 2% DMSO were used as vehicle controls in the different 
experiments.  
 
Bacterial Strains 
Bacterial cultures were obtained from the American Type Culture Collection (ATCC; 
Manassas, VA, USA). S. mutans ATCC 25175 and S. sanguinis ATCC 10556 were revived from freeze-
dried vials and cultured on trypticase soy agar plates (Becton Dickinson, San Jose, CA, USA) 
supplemented with 5% defibrinated sheep blood and incubated in a 5% CO2 atmosphere at 37°C for 
72 h. The bacterial colonies were then subcultured in brain heart infusion (BHI, Merck, Darmstadt, 
Germany) and incubated overnight at 37°C The resulting bacterial cultures were centrifuged at 4000 
x g for 5 min, washed twice with PBS, and resuspended in BHI. The bacterial cell count in the culture 
medium was spectrophotometrically adjusted to approximately 2 x 108 CFU/mL just before each 
assay.  
 
Agar Diffusion Assay 
A standard agar diffusion assay was used for the initial screening of growth inhibitory effects 
against S. mutans and S. sanguinis [Evans et al., 2015].  Briefly, five wells of 5 mm diameter were 
punched into pre-prepared Mueller-Hilton agar petri dishes (MH agar, Thermo Fisher, Rockford, IL, 
USA). The wells were placed 30 mm apart and 20 mm from the outer edge of the petri dish. Each 
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well was loaded with a fine spiral of sterile filter paper (90 mm x 4 mm). Aliquots (50 µL) of the 
respective test agent solutions/controls were the carefully pipetted onto the filter paper. Each plate 
had three test agents, plus 0.2% chlorhexidine (CHX) as a positive control, and the appropriate 
vehicle control. For each plate, 5 mL aliquots of the standardized bacterial suspension was added to 
5 mL of melted MH agar at 45°C, mixed thoroughly and poured evenly over the surface of the agar 
plates containing the wells loaded with test agents/controls. After incubation at 37°C for 24 h, the 
plates were assessed for bacterial growth or inhibition. The zones of inhibition were measured 
directly at their minimum diameter (Fig. 5). All experiments were performed in triplicate on three 
independent occasions. 
 
 
Figure 5. Agar diffusion assay with arrows pointing to zones of bacterial growth inhibition 
 
Broth Microdilution Assay 
 The minimum inhibitory concentration (MIC) of the test agents was determined using the 
broth microdilution method as specified by the Clinical and Laboratory Standards Institute [CLSI, 
2015]. Briefly, twofold serial dilutions of the test agent stock solutions were prepared and pipetted 
into separate wells of 96-well microtiter plates (Costar 3596, Sigma-Aldrich, New York, NY, USA). 
The wells were then inoculated with the bacterial suspensions such that the final bacterial 
concentration in each well was approximately 5 x 105 CFU/mL. Triplicate samples were prepared for 
each concentration of the agent being tested (Fig. 6). Appropriate solvent control, growth control, 
and sterility control wells were also maintained in each microtiter plate. After incubation for 24 h at 
37°C, the optical density (O.D.) was determined at 600 nm wavelength in a microplate 
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spectrophotometer (Tecan Infinite 200 Pro, Grodig, Austria) after correcting for the background 
absorbance of the test agent solutions. The MIC of each test agent against S. mutans and S. sanguinis 
was calculated from the adjusted O.D. values obtained from three independent experiments. 
 
 
Figure 6. Microdilution assays for minimum inhibitory concentration determination 
 
Statistical Analysis 
 After data sets were assessed for normality, an independent sample t-test was used to 
evaluate differences in the zones of growth inhibition between S. mutans and S. sanguinis bacterial 
species for each test agent. The level of significance was set at 5%. Statistical software SPSS version 
24 (IBM, NY, USA) was used to perform the analysis.  
 
RESULTS 
Growth inhibitory effects 
Except for the three berry extracts, all the other natural products inhibited the growth of 
both S. mutans and S. sanguinis in the agar diffusion assay. The highest inhibition of bacterial growth 
was seen for xanthorrrhizol, followed by macelignan and tt-farnesol (Table 5). The diameters of the 
zones of inhibition for S. mutans were not significantly different from that for S. sanguinis for any of 
the growth inhibitory natural products tested (P > 0.05). 
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Table 5. Growth inhibitory effects of natural products against S. mutans and S. sanguinis 
 
 
 
Test Agent (concentration) 
 
Zone of inhibition diameter (mm) 
 
 
 
P-value (SM vs. SS) 
 
Streptococcus mutans (SM) 
 
Streptococcus sanguinis (SS) 
 
Xanthorrrhizol (200 µg/mL) 
 
13.2 ± 0.55 
 
13.1 ± 0.64 
 
N.S 
 
Macelignan (200 µg/mL) 
 
11.8 ± 0.43 
 
12.2 ± 1.11 
 
N.S 
 
tt-Farnesol (200 µg/mL) 
 
11.6 ± 0.82 
 
11.3 ± 0.35 
 
N.S 
 
Liquorice (1 mg/mL) 
 
10.8 ± 0.48 
 
11.0 ± 0.77 
 
N.S 
 
Cinnamon (1 mg/mL) 
 
9.8 ± 0.97 
 
9.9 ± 0.71 
 
N.S 
 
Peppermint (1 mg/mL) 
 
9.2 ± 0.60 
 
9.4 ± 0.72 
 
N.S 
 
Ginger (1 mg/mL) 
 
8.4 ± 0.69 
 
8.3 ± 0.46 
 
N.S 
 
Rosemary (1 mg/mL) 
 
8.1 ± 0.61 
 
7.8 ± 0.52 
 
N.S 
 
Guaijaverin (1 mg/mL) 
 
7.2 ± 0.34 
 
7.2 ± 0.16 
 
N.S 
 
Cranberry (16 mg/mL) 
 
0 
 
0 
 
- 
 
Wild Blueberry (16 mg/mL) 
 
0 
 
0 
 
- 
 
Strawberry (16 mg/mL) 
 
0 
 
0 
 
- 
 
Vehicle control (2% DMSO/PBS) 
 
0 
 
0 
 
- 
 
Positive Control (0.2% CHX) 
 
17.7 ± 0.62 
 
18.0 ± 0.89 
 
N.S 
Diameter of inhibitory zones (mean ± S.D) from three independent triplicate experiments (n = 9). DMSO: dimethyl sulfoxide;  
PBS: phosphate buffered saline; CHX: chlorhexidine. N.S: no significant differences between S. mutans and S. sanguinis inhibition 
using the independent sample t-test (P > 0.05). 
 
Minimum inhibitory concentrations  
The MICs of the natural products that exhibited bacterial growth inhibition are presented in Table 
6. The MIC values obtained from the microdilution assays followed the bacterial growth inhibitory 
pattern seen in the agar diffusion assay, with xanthorrrhizol showing the lowest MIC (4 µg/mL) 
against both S. mutans and S. sanguinis among all the natural products tested. 
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Table 6. MIC of natural products with bacterial growth inhibitory effects in µg/mL 
 
Test Agent 
Streptococcus mutans Streptococcus sanguinis 
 
Xanthorrrhizol 
 
4 
 
4-8 
 
Macelignan 
 
8 
 
4 
 
tt-Farnesol 
 
8 
 
8 
 
Liquorice 
 
80 
 
100 
 
Cinnamon 
 
340 
 
175 
 
Peppermint 
 
375 
 
340 
 
Ginger 
 
275 
 
475 
 
Rosemary 
 
800 
 
800 
 
Guaijaverin 
 
1000 
 
1000 
 
CHX (control) 
 
1 
 
1 
MIC: minimum inhibitory concentration calculated from three independent triplicate experiments (n = 9). CHX: chlorhexidine. 
 
DISCUSSION 
The results of this study provide insights into the growth inhibitory effects of selected natural 
products against S. mutans and S. sanguinis bacteria. S. mutans is one of the primary bacterial 
culprits responsible for caries pathogenesis due to its acidogenic, aciduric, and glucan synthesis 
properties. On the other hand, S. sanguinis can use its arginine deaminase system to neutralize acids 
and slow caries lesion progression. These bacterial species were thus chosen as being representative 
of those associated with dental caries and health.  
 
None of the fruit berry extracts (cranberry, blueberry, and strawberry) demonstrated 
bacterial growth inhibitory effects against either S. mutans or S. sanguinis despite their high 
polyphenol content. This suggests that the bioactive phytochemicals present in these berry extracts 
may lack bactericidal effects at the concentrations tested. In contrast, all the other selected natural 
products inhibited the growth of both S. mutans and S. sanguinis with varying degrees of potency. 
Xanthorrrhizol, the bioactive compound in Javanese turmeric (Curcuma xanthorrhiza) showed the 
highest bacterial growth inhibition, followed closely by macelignan from nutmeg (Myristica 
fragrans), and tt-farnesol, a sesquiterpene isolated from bee-hive propolis. The MICs of the tested 
natural agents ranged from 4 µg/mL for xanthorrrhizol, up to 1000 µg/mL for the guaijaverin 
compound found in guava (Psidium guajava). 
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There were no significant differences observed between S. mutans and S. sanguinis growth 
inhibition for any of the natural products tested. Considering oral streptococci have common 
structural properties [Banas and Vickerman, 2003; Hamada et al., 1980], it will be challenging to find 
an antimicrobial agent that can selectively suppresses the growth of cariogenic MS without also 
affecting health-associated oral streptococci such as S. sanguinis, Streptococcus gordonii or 
Streptococcus mitis/oralis. It would be worthwhile to investigate whether non-streptococcal health-
associated plaque microflora (e.g. Neisseria flavescens or Corynebacterium durum), can remain 
relatively unaffected to the antimicrobial effects of these natural products. While previous studies 
have shown that plant-derived essential oils present in mouthrinses can reduce MS levels and total 
plaque [Fine et al., 2000; Ouhayoun, 2003; Overholser et al., 1990], their ability to discriminate 
between disease- and health-associated microflora requires further study.  
 
The MICs of xanthorrrhizol and macelignan against S. mutans (4 µg/mL and 8 µg/mL 
respectively) found in this study were consistent with earlier reports on these phytochemicals 
[Chung et al., 2006; Hwang et al., 2000]. While MIC values of these phytochemicals may seem only 
slightly higher than the reported 1 µg/mL MIC of CHX, it is important to consider the molecular 
weight of these compounds when comparing the antimicrobial potency of various agents. For 
example, the 4 µg/mL MIC of xanthorrrhizol corresponds to 18.3 µmol/mL based on its molecular 
weight (MW) of 218.3 g/mol, while the similar MIC of CHX (MW 897.8 g/mol) is only 1.1 µmol/mL. 
Evidently, CHX is at least 16-fold more potent than xanthorrrhizol against these bacterial species. 
However, the demonstrated MICs of xanthorrrhizol (18.3 µmol/mL) and macelignan (24.4 µmol/mL) 
were much lower than the reported MICs of essential oils like menthol (3200 µmol/mL) and thymol 
(3329 µmol/mL) that are commonly used in mouthrinses for antibacterial effects. This suggests their 
excellent potential for incorporation into oral care products as alternatives to the currently used 
antibacterial essential oils in conditions where broad antimicrobial action is required. For the other 
natural extracts tested in this study, identification and isolation of their bioactive antimicrobial 
compounds could further improve their antibacterial effects. 
 
CONCLUSIONS 
Recent reports have underlined the symbiotic benefits a healthy oral microbiome affords 
the host [Devine et al., 2015; Kilian et al., 2016]. This has led to clinical recommendations for 
adopting ecological strategies as part of modern caries management [Philip et al., 2018a]. Clearly, 
long-term control of caries risk should be based on successful “stewardship” of the plaque biofilm, 
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rather than simply focussing on eliminating it. This will allow health-associated microbial 
communities to dominate the dental plaque biofilm, and thereby lower its virulence potential. From 
an ecological perspective, it may thus be more beneficial to use natural products that disrupt 
cariogenic virulence properties (e.g. acidogenicity or glucan synthesis), rather than those that 
broadly affect bacterial viability and growth [Jeon et al., 2011]. For example, specific phytochemicals 
like apigenin and cranberry proanthocyanidins were able to modulate virulence properties and 
inhibit dental caries in vivo despite lacking significant biocidal activity [Koo et al., 2010; Koo et al., 
2005]. While this screening study could not identify antimicrobial natural products that specifically 
targeted the growth of cariogenic bacteria, further studies using natural agents with potential for 
inhibiting plaque virulence properties are needed. The vast therapeutic potential of phytodentistry 
in lowering caries-risk and preventing oral diseases remains to be fully exploited. 
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RAW DATA 
Study 1: Agar diffusion assay  
Zone of bacterial inhibition (mm) 
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4.2  SCIENTIFIC PAPER 2 
 
Inhibitory Effects of Fruit Berry Extracts on Streptococcus mutans Biofilms  
 
This study compared the influence of standardized extracts of polyphenol-rich fruit 
berry extracts on virulence properties and microbial viability of Streptococcus mutans 
biofilms.  
 
The paper was published on 12th March 2019 in the European Journal of Oral Sciences, 
the official publication of the International Association of Dental Research Scandinavian 
Division (IADR-NOF).  
 
Eur J Oral Sci 2019 127(2): 122-129. 
 
This chapter is comprised of the publication as it stands in print. 
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ABSTRACT 
Dark-coloured fruit berries are a rich source of polyphenols that could provide innovative bioactive 
molecules as natural weapons against dental caries. High-quality extracts of cranberry, blueberry, 
strawberry, and a combination of the three berry extracts (Orophenol) were used to treat 24 h old 
Streptococcus mutans biofilms. The grown biofilms were treated with the berry extracts at 
concentrations ranging from 62.5 to 500 µg/mL. Treated biofilms were assessed for metabolic 
activity, acidogenicity, biovolumes, structural organisation, and bacterial viability. The biofilms 
treated with the cranberry and Orophenol extracts exhibited the most significant reductions in 
metabolic activity, acid production, and bacterial/exopolysaccharide (EPS) biovolumes, while their 
structural architecture appeared less compact than the control treated biofilms. The blueberry 
extract produced significant reductions in metabolic activity and acidogenicity only at the highest 
concentration tested, without significantly affecting bacterial/EPS biovolumes or biofilm 
architecture. Strawberry extracts had no significant effects on S. mutans biofilms. None of the berry 
extracts were bactericidal for S. mutans. The results indicate that the cranberry extract was the most 
effective in disrupting S. mutans virulence properties without significantly affecting bacterial 
viability. This suggests a potential ecological role for cranberry phenols as non-bactericidal agents 
capable of modulating pathogenicity of cariogenic biofilms. 
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INTRODUCTION 
Dental caries is a polymicrobial disease caused by dysbiosis in the resident microbiome that 
can lead to progressive demineralization of dental hard tissues [Marsh, 2018]. The 
acidogenic/aciduric bacteria responsible for this multifactorial disease are best described as 
pathobionts, as they are present in low numbers even in the dental plaque of caries-free individuals 
[Simon-Soro and Mira, 2015]. Local environmental stresses, such as frequent exposure to sugar in 
the diet or reduced saliva flow, can allow these pathobionts to gain an ecological advantage over 
commensal bacteria leading to microbiome dysbiosis and subsequent initiation of the caries lesion.  
 
Modern molecular techniques have shown that the microbial consortia associated with the 
caries process are remarkably diverse, with Streptococcus mutans accounting for only a small 
fraction of the bacterial community implicated in disease pathogenesis [Gross et al., 2012; Simon-
Soro and Mira, 2015; Tanner et al., 2016]. However, S. mutans is still regarded as a key contributor 
to the caries process based on its extraordinary ability to produce both soluble and insoluble glucans 
from dietary sucrose using glucosyltransferases (Gtfs) [Paes Leme et al., 2006]. Among the different 
exopolysaccharides (EPS), the insoluble glucans are considered to be the prime building blocks of 
cariogenic biofilms, influencing adherence and the physical and biochemical virulence properties of 
dental plaque [Bowen and Koo, 2011]. Recent reviews have stressed that mutans streptococci (MS) 
are largely responsible for insoluble glucan synthesis, with relatively few of the other cariogenic 
bacteria capable of glucan production [Hajishengallis et al., 2017; Klein, 2013]. S. mutans, even when 
present in low numbers, appears to play the major role in orchestrating the initial assembly of the 
cariogenic biofilm matrix. This paves the way for the other relevant resident aciduric bacteria (e.g., 
bifidobacteria, some lactobacilli, and Scardovia spp.) to become dominant as the biofilm matures 
[Burne, 2018; Hajishengallis et al., 2017]. Hence, S. mutans still remains a suitable indicator 
organism for exploring cariogenic virulence properties, and how they may be affected by novel 
antimicrobial agents. 
 
Traditional chemotherapeutic approaches to oral diseases are falling out of favour due to 
adverse effects often associated with commonly used synthetic oral biocides like chlorhexidine 
(CHX) and concerns about the emergence of microbial resistance to these agents. Furthermore, the 
recognition of the key health benefits of a symbiotic oral microbiome has resulted in virulence-
targeted therapies being preferred over broad-spectrum antimicrobials [Marsh, 2015; Marsh et al., 
2015]. This is especially vital for biofilm-mediated diseases like dental caries where reversing the 
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microbiome dysbiosis responsible for caries pathogenesis is more important than simply eliminating 
the dental plaque biofilm [Philip et al., 2018]. Natural products with subtle antimicrobial effects are 
an attractive alternative to conventional chemotherapeutics, offering the promise of a “controlled” 
ecological approach to dental caries prevention [Jeon et al., 2011]. 
 
 Dark-coloured fruit berries are among the best dietary sources of polyphenols and are used 
globally as functional food ingredients. A large body of research has firmly established that the 
dietary intake of berry fruits has a positive impact on human health [Seeram, 2008]. Regarding oral 
health, specific phytochemicals isolated from cranberry have demonstrated inhibitory effects on 
virulence factors of S. mutans virulence factors such as hydrophobicity-mediated adhesion, acid 
production, aciduricity, and glucan synthesis [Duarte et al., 2006; Gregoire et al., 2007; Koo et al., 
2010; Yamanaka et al., 2004]. Besides cariostatic effects, polyphenol molecules from cranberry and 
wild blueberry have also shown the potential to prevent periodontal diseases by inhibiting bacterial 
proteolytic enzymes and the host-inflammatory response [Ben Lagha et al., 2015; Bodet et al., 2008; 
Feghali et al., 2012]. 
 
The extraction and isolation of specific bioactive phytochemicals from berry fruits is a time-
consuming and costly process. An alternative would be to use commercially available berry extracts 
that have standardized polyphenol concentrations. Such extracts have the advantage of having 
consistent phytochemical concentrations, overcoming the problem of compositional variability 
often associated with natural products. Moreover, being a blend of different polyphenol classes of 
varying sizes and molecular weights, they should ideally be able to exert multi-target biological 
effects. Until now, there have been no reports examining the influence of standardized extracts of 
three commonly used fruit berries (cranberry, wild blueberry, and strawberry) on virulence 
properties of S. mutans biofilms. Therefore, the null hypothesis of the study was that none of the 
selected berry extracts had inhibitory effects against S. mutans biofilms.  
 
 
MATERIALS AND METHODS 
Natural Product Extracts 
High-quality, organic extracts of cranberry, wild blueberry, strawberry, and a combined 
product of the three berry extracts (Orophenol) were sourced from Diana Food (Champlain, QC, 
Canada). The total phenolic content of the berry extracts were 40% for cranberry and Orophenol, 
and 20% for the wild blueberry and strawberry extracts as determined by the Folin-Ciocalteu assay 
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[Ainsworth and Gillespie, 2007]. As per the manufacturer’s data sheet, 80% of the polyphenols were 
proanthocyanidins (PACs), with modest amounts of different flavonols (e.g. quercetin, myricetin), 
anthocyanins, and phenolic acids making up the remainder. Serial dilutions of berry extracts were 
made in phosphate buffered saline (PBS; Gibco, Thermo Fisher Scientific, Paisley, UK) before each 
experiment in concentrations ranging from 62.5 to 500 µg/mL. The final pH of the berry extract 
solutions was in the range of 7.1 to 7.3. 
 
Biofilm Model and Substrate 
The well-established Amsterdam Active Attachment (AAA) biofilm model was used to grow 
the S. mutans biofilms [Exterkate et al., 2010]. Hydroxyapatite (HA) discs (9.5mm diameter x 2mm 
thick; Himed, New York, NY, USA) were attached to nylon clamps of the custom-made stainless steel 
lid of the AAA model (Fig. 7), such that each disc fits into one well of a standard polystyrene 24-well 
microtiter plate (Costar 3526; Sigma-Aldrich, New York, NY, USA).           
 
Figure 7. AAA biofilm model with the mounted HA discs 
           
                        
Saliva Collection and HA Disc Conditioning 
Institutional ethics approval was obtained from the University of Queensland Human 
Research Ethics Committee (approval number 2017000519) for the collection of parafilm-
stimulated whole saliva from a single adult donor, who was asked to abstain from food/drink for at 
least 2 h before saliva collection. The collected saliva was clarified by centrifugation (4000 g, 4°C, 20 
min), filter-sterilized (polyethersulphone low-protein binding filter with 0.22 μm-diameter pore size; 
Millipore, Burlington, MA, USA), dispensed into aliquots, and stored at -80°C. Prior to biofilm 
formation, 2 mL of the thawed saliva was pipetted into each well of a 24-well plate. The HA discs 
mounted on the AAA model lid were then transferred to the saliva containing plate and incubated 
for 1 h at 37°C. 
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Biofilm Preparation 
Biofilms of S. mutans (ATCC 25175) were grown for 24 h on the saliva-coated HA (sHA) discs 
as previously described [Exterkate et al., 2010] with some modifications. Briefly, the inoculation 
medium was an overnight culture of S. mutans adjusted spectrophotometrically (Infinite 200 Pro; 
Tecan, Grödig, Austria) to a standard cell count (1 X 107 colony forming units (CFU)/mL) in brain 
heart infusion both (BHI; Merck, Darmstadt, Germany). Immediately after the saliva conditioning, 
the sHA discs were transferred to a 24-well plate containing the inoculation medium and incubated 
for 1.5 h at 37°C in an orbital shaker at 80 rpm to allow adhesion of bacteria. After this initial 
inoculation period, the discs were transferred to a new plate containing fresh BHI supplemented 
with 0.2% sucrose and incubated for a further 22.5 h under similar conditions. 
 
Biofilm Rinsing and Treatment 
At the end of the 24 h growth period, the AAA model lid with the biofilm bearing HA discs was rinsed 
by moving the lid up and down 5 times into sterile PBS and repeating this rinsing procedure twice 
with fresh PBS to ensure the removal of all non-adherent cells. The biofilms were then treated by 
transferring them to a 24-well plate containing 2 mL/well of the berry extracts or the vehicle control 
and incubated for 1 h at 37°C. For assessing the effect of the berry extracts on biofilm metabolic 
activity and acid production, four concentrations of each extract (ranging from 62.5 to 500 µg/mL), 
were compared with their respective control-treated biofilms. The berry extracts that showed 
inhibitory effects against biofilm metabolic activity/acidogenicity were further selected at their 
highest concentration (500 µg/mL) to examine their influence on bacterial viability, biofilm 
biovolumes and structural organisation. After treatment, and prior to any assays, the HA discs with 
the treated biofilms were dip-rinsed with sterile PBS to remove any excess of treatment solutions. 
 
Biofilm Assays 
The effects of the fruit berry extracts on the treated S. mutans biofilms were evaluated for biofilm 
metabolic activity (XTT reduction assay), acid production (using a standard curve colorimetric assay), 
biovolumes/structural organisation (assessed by confocal microscopic imaging) and bacterial 
viability (based on CFU counts). Each assay was carried out in triplicate and repeated in at least three 
independent experiments. 
 
1. Biofilm Metabolic Activity: XTT Reduction Assay 
An indirect quantification of the metabolic activity of biofilm cells was obtained from a colorimetric 
assay that is based on the bioreduction of a tetrazolium salt 2,3-bis (2-methoxy-4-nitro-5-
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sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) to a coloured formazan 
product, the absorbance of which can be measured spectrophotometrically [Bandara et al., 2016]. 
Briefly, XTT (Sigma, St. Louis, MI, USA) salt solution (1 mg/mL in PBS) was prepared, filter-sterilized 
(0.22 μm pore-size filter), and stored at -80°C until required. Immediately before each assay, a 
solution of 0.4 mM menadione (Sigma) was freshly prepared. XTT reaction solution was prepared 
by mixing PBS, XTT stock, and menadione solution in a 79:20:1 volume ratio. The treated biofilm-
coated HA discs were transferred to a new 24-well plate containing the reaction solution and 
incubated in the dark for 3 h at 37°C. Thereafter, 100 µl of the solution from each well was pipetted 
into separate wells of a 96-well plate and absorbance at 492 nm measured with a microplate reader 
(Infinite 200 Pro, Tecan). 
  
2. Acid Production Assay 
At the end of the biofilm growth period and subsequent treatment, the AAA model lid with the 
biofilm bearing HA discs were placed in a new 24-well plate containing 2 mL/well of buffered 
peptone water (Merck) supplemented with 0.2% sucrose. The model was then incubated 
anaerobically for 3 h at 37°C to allow acid formation. The amount of lactic acid formed during this 
period was calculated using a standard curve colorimetric assay by measuring the absorbance at 
340 nm [Exterkate et al., 2014; Janus et al., 2015].       
 
3. Biofilm Biovolumes and Structural Organisation: Confocal Microscopic Imaging 
A novel in situ labeling technique [Klein et al., 2011] that allows simultaneous visualization and 
quantification of EPS and bacterial cells within intact biofilms was followed with minor 
modifications. Briefly, 1 µM Alexa Fluor 647-dextran conjugate (10,000 MW; 
absorbance/fluorescence emission maxima 647/668 nm; Thermo Fisher Scientific, Scoresby, 
Australia) was added to the 0.2% sucrose supplemented BHI culture medium. This fluorescence-
labeled dextran acts as a primer for Gtfs and becomes incorporated into newly formed glucans over 
the course of biofilm development without staining the bacterial cells at these concentrations. The 
biofilm bacterial components were labeled at the end of biofilm treatment using 1 µM SYTO 9 
(480/500 nm; Thermo Fisher Scientific). Imaging of the bacterial and EPS components was done 
using a spectral spinning disc confocal microscope (Nikon, Tokyo, Japan) with argon-ion and helium 
neon lasers tuned to 488 and 637 nm respectively. Each biofilm was scanned at 5 randomly selected 
positions and the z series generated by optical sectioning (2.5 µm intervals) at each of these 
positions. Three independent biofilm experiments were performed and 5 image stacks per 
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experiment were collected. The image-processing software IMARIS (Bitplane, Concord, MA, USA) 
was used to quantify and characterize the 3D structure of the biofilms. Biovolumes (volume of 
biomass/substratum surface area) of the bacterial and EPS biofilm components were quantified 
separately and structural architecture assessed qualitatively. 
 
4. Biofilm Bacterial Viability: Colony Forming Unit (CFU) Determination 
The treated biofilm bearing HA discs were gently detached from the AAA model clamps and 
placed into sterile tubes containing 1 mL PBS and dispersed by uniform vortexing at maximum speed 
for 1 min as described previously [Bandara et al., 2009]. The resultant suspension containing the 
detached biofilm cells was serially diluted (101-104) and a 50 µL aliquot from each suspension was 
plated in duplicate onto BHI agar by means of an automatic spiral plater (Autoplate; Advanced 
Instruments, Norwood, MA, USA). A 0.12% chlorhexidine (CHX) positive control was included in this 
assay. The plates were incubated in a 5% CO2 incubator at 37°C for 48 h. Subsequently, the number 
of CFUs was counted with a digital colony counter and the CFU values were Log10 transformed prior 
to analysis. 
 
Statistical Analysis 
After normality of data distribution was checked using the Shapiro-Wilk test, either the one-
way ANOVA or the Kruskal-Wallis H-test was chosen to look for statistical differences between each 
berry extract treatment and their respective control treatment. For parametric data, a Dunnett’s 
post hoc test was performed for multiple comparisons of the treatment groups with the control 
group. For non-parametric data, the Dunn-Bonferroni post hoc test for multiple comparisons was 
used. The level of significance was set at 5%. Statistical software SPSS version 25 (IBM, New York, 
NY, USA) was used to perform the analyses. 
 
RESULTS  
Metabolic activity 
The effects of the different berry extracts on metabolic activity of 24 h S. mutans biofilms 
are summarized in Table 7. When compared to the control-treated biofilms, the highest reduction 
in metabolic activity was seen in biofilms treated with the cranberry extract at concentrations of 
500 µg/mL (32% reduction, P < 0.001) and 250 µg/mL (29% reduction, P < 0.001), with the 125 µg/mL 
cranberry extract effecting a more modest decrease (14% reduction, P = 0.005) in metabolic activity 
of the S. mutans biofilms. Wild blueberry extracts significantly suppressed metabolic activity only at 
the 500 µg/mL concentration (14% reduction, P = 0.038), while none of the strawberry extract 
111 
 
concentrations appeared to have significant inhibitory effects on biofilm metabolism. The 
combination of the three berry extracts (Orophenol) showed significant reduction in metabolic 
activity at the 500 µg/mL (25% reduction, P < 0.001), 250 µg/mL (22% reduction, P < 0.001), and 125 
µg/mL concentrations (18% reduction, P = 0.001).  
 
Acid production 
Significant reductions in lactic acid production were seen when the S. mutans biofilms were 
treated with the 500 µg/mL of cranberry (46% reduction, P = 0.001) and Orophenol extracts (40% 
reduction, P < 0.001) when compared to their respective control-treated biofilms (Table 7). 
Significant reductions in lactic acid production were also observed for biofilms treated with 125-250 
µg/mL concentrations of the cranberry and Orophenol extracts, while only the 500 µg/mL 
concentration of the wild blueberry extract was able to effect a significant decrease in lactic acid 
synthesis (24% reduction, P < 0.001). The strawberry extract did not elicit any significant effect on 
acid production. The decrease in acid production largely corresponded with the reduced metabolic 
activity shown in the XTT assays for all the test agents.  
 
Table 7. Berry extract effects on metabolic activity and acid production of S. mutans biofilms 
 
Treatment group 
Concentration 
    (µg/mL) 
Metabolic activity (% change) 
           (OD492) 
Lactic acid production (% change) 
           (mM/L) 
Cranberry 500 
250 
125 
62.5 
Control 
0.186 ± 0.027 (-32)* 
0.194 ± 0.035 (-29)* 
0.234 ± 0.029 (-14)* 
0.261 ± 0.454 (-4) 
0.272 ± 0.030 
 
6.4 ± 2.7 (-46)* 
8.3 ± 2.9 (-29)* 
9.1 ± 2.4 (-23)* 
10.4 ± 2.7 (-12) 
11.8 ± 2.7 
Wild blueberry 500 
250 
125 
62.5 
Control 
0.303 ± 0.048 (-14)* 
0.329 ± 0.050 (-6) 
0.340 ± 0.051 (-3) 
0.355 ± 0.041 (+1) 
0.352 ± 0.044 
 
9.3 ± 1.2 (-24)* 
10.6 ± 1.1 (-13) 
11.6 ± 1.1 (-6) 
11.9 ± 1.8 (-3) 
12.3 ± 2.2 
Strawberry 500 
250 
125 
62.5 
Control 
0.319 ± 0.038 (-1) 
0.332 ± 0.056 (+3) 
0.344 ± 0.042 (+7) 
0.339 ± 0.047 (+6) 
0.321 ± 0.036 
 
13.0 ± 1.6 (-4) 
13.4 ± 1.8 (-1) 
14.0 ± 1.2 (+3) 
15.0 ± 1.6 (+10) 
13.6 ± 1.8 
Orophenol 500 
250 
125 
62.5 
Control 
0.271 ± 0.028 (-25)* 
0.281 ± 0.041 (-22)* 
0.296 ± 0.049 (-18)* 
0.337 ± 0.064 (-7) 
0.361 ± 0.057 
6.3 ± 0.6 (-40)* 
7.6 ± 0.9 (-27)* 
9.0 ± 0.8 (-14)* 
9.4 ± 0.6 (-10) 
10.5 ± 1.8 
Metabolic activity represents mean XTT absorbance values ± SD from five independent triplicate experiments (n = 15) at optical 
density absorbance of 492 nm. Lactic acid production of biofilms in mM/L (mean ± S.D) is from three independent triplicate 
experiments (n = 9). Values given in round brackets after mean ± SD represent percentage change of metabolic activity/acid 
production compared to respective controls. * indicates significant difference (P < 0.05) compared to control-treated biofilms. 
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Biovolumes and structural organisation 
Analysis of the confocal imaging data revealed that the cranberry and Orophenol extracts 
produced both quantitative (Table 8) and qualitative alterations (Fig. 8) in the S. mutans biofilms. 
The cranberry treated biofilms exhibited significant reductions in biovolumes of both bacterial (P = 
0.03) and EPS (P = 0.007) components compared to the control-treated biofilms, while the biofilms 
treated with Orophenol also showed significantly lower biovolumes of bacteria (P = 0.04) and EPS 
(P = 0.015). The wild blueberry extract did not exert significant effects on EPS or bacterial 
biovolumes. Qualitatively, treatments with cranberry and Orophenol resulted in biofilms that were 
less compact, with the biofilm structure interspersed with areas of porosity (Fig. 8). 
 
Table 8. Quantitative analysis of S. mutans biofilm confocal images 
 
Treatment group 
Biovolumes of biofilm components (µm3/µm2) 
EPS Bacteria 
Cranberry 
 
1.3 ± 0.4* 1.9 ± 0.4* 
Wild blueberry 
 
1.9 ± 0.8 2.4 ± 0.4 
Orophenol 
 
1.4 ± 0.2* 2.0 ± 0.6* 
Control 
 
2.5 ± 1.5 3.0 ± 1.9 
Biovolumes of bacterial cells and exopolysaccharides (EPS) are given as mean ± SD. 
* Significant difference compared to control-treated biofilms. 
 
Bacterial counts 
The test agents did not significantly impact bacterial viability of the treated S. mutans biofilms as 
indicated by CFU counts (Fig. 9). The population of bacterial colonies recovered from the biofilms 
treated with the berry extracts showed slightly lower numbers of recoverable viable cells compared 
with the vehicle control, however none of them appeared to be bactericidal for S. mutans in the 
biofilms. In contrast, CHX severely affected the viability of S. mutans (> 3 Log decrease in CFU/mL). 
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Figure 8. Representative 3D confocal image stacks of S. mutans biofilms 
Structural organisation of 24 h S. mutans biofilms following treatment with (A) vehicle control, (B) cranberry, (C) Orophenol, 
and (D) wild blueberry. The structures depicted in green (SYTO 9; left column) are metabolically active bacterial cells, while 
the structures in red (Dextran, Alexa Fluor; middle column) represent the extracellular polymeric substances. Third column 
represents merged images of EPS and bacterial biofilm components. The biofilms treated with cranberry and Orophenol 
appear less compact than the control biofilms with areas of porosity. 
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Figure 9. Average number of CFUs recovered from 24 h S. mutans biofilms 
No significant differences were found between the berry extracts and the control-treated biofilms, in contrast to the CHX-
treated biofilm which significantly affected viability of S. mutans.* indicates significant difference between CHX- and control-
treated biofilms. 
 
DISCUSSION 
The results of this study indicate that certain dark-coloured berry extracts may have useful 
biofilm-inhibitory effects by reducing virulence of S. mutans without significantly affecting its 
viability. The organic berry extracts used in this study were standardized in terms of their polyphenol 
content, overcoming problems of compositional variation often associated with phytochemical 
extraction and geographic or seasonal influences. The high content of PACs in these extracts can be 
particularly advantageous, as PACs are known to be the most effective flavonoids against S. mutans 
virulence factors. Furthermore, because of the natural origin of these extracts, they may be more 
readily accepted for long-term control of biofilm-mediated diseases, such as dental caries. These 
water soluble sugar-free molecular extracts are thus ideal for a potential incorporation into oral care 
products for daily use.  
 
The AAA biofilm model used in this study has been recommended for the initial screening of 
new anti-caries agents [Maltz and Beighton, 2012]. Important advantages of this model are that the 
biofilm formation is highly reproducible, there is active attachment of bacteria to the substrate, it 
allows high-throughput screening of multiple compounds and concentrations in a single experiment, 
and the treatment and rinsing steps can be consistently controlled [Exterkate et al., 2010; ten Cate, 
2015]. Although the monospecies biofilm used in the present study does not reflect the complex 
nature of dental plaque, it is useful for investigating specific effects of the test agents on S. mutans 
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metabolism, growth, and biofilm architecture, as a prelude to later studies using polymicrobial 
biofilms. 
 
The XTT assay results indicate that the cranberry and Orophenol extracts effected the most 
significant reductions in biofilm metabolic activity. The influence of the different berry extracts on 
bacterial metabolism largely corresponded with their effects on acid production and EPS 
biovolumes. The difference in the inhibitory effects between the test agents can be attributed to 
the higher phenolic content in the cranberry and Orophenol extracts than in the blueberry and 
strawberry extracts, and, more importantly, to the different types of phytochemicals present in 
these extracts. For instance, the double interflavan A-linked proanthocyanidins (A-PACs) are found 
in high concentrations only in cranberry, with the PAC subunits in other berries and fruits usually 
linked via a single B-type bond [Cunningham et al., 2004]. The A-PACs have been shown to have the 
most potent effects against S. mutans glycolytic enzymes and Gtfs when compared with other berry 
flavonoids [Duarte et al., 2006; Gregoire et al., 2007; Koo et al., 2010]. As the inhibitory effects of 
the combined Orophenol extract was not significantly better than the cranberry extract alone, its 
biological activity could predominantly also be attributed to the cranberry phenols, rather than 
potential synergism between the three extracts present in it. 
 
Considering that the production of lactic acid is an important characteristic of cariogenic 
biofilms, it is noteworthy that the biofilms treated with cranberry and Orophenol extracts showed 
significantly reduced acidogenicity. This is consistent with previous reports showing cranberry 
flavonoids inhibiting S. mutans glycolytic activity. These studies suggested that the polyphenols 
responsible for inhibitory activity against bacterial acid production were mainly the quercetin 
flavonols and a low molecular weight PAC dimer called procyanidin A2 [Duarte et al., 2006; Gregoire 
et al., 2007]. It is unlikely that the larger PAC oligomers can directly affect intracellular bacterial 
glycolytic enzymes, though they may still have deleterious effects on membrane components of the 
glycolytic pathway [Yoo et al., 2011]. Quercetin is also known to be a non-competitive inhibitor of 
the proton-translocating F1-F0 ATPase activity that is critical to the survival of acidogenic bacteria in 
the low pH biofilm environment they create [Zheng and Ramirez, 2000]. Suppressing dental plaque 
acidogenicity and aciduricity can potentially create a more favourable environment for commensal 
bacteria to grow and dominate the biofilm microbial community.  
 
Post-treatment confocal images indicate that bioactive phytochemicals present in the 
cranberry and Orophenol extracts disrupted biofilm integrity and structural architecture. This 
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qualitative assessment was consistent with the quantitative data that showed biovolumes of both 
the EPS and bacterial components were significantly reduced (Table 8). Like acidogenicity, EPS are 
critical to S. mutans virulence as they provide structural integrity and bulk to dental biofilms, 
enhance bacterial adherence and co-aggregation, and can act as a substrate for sustained 
acidogenesis [Bowen and Koo, 2011]. The polyphenols responsible for the reduced EPS are believed 
to be the flavonols and A-PAC oligomers. Flavonol-mediated Gtf inhibition has been related to its 
unsaturated double bond between C2 and C3, as anthocyanins that lack the C2-C3 double bond 
exhibited only modest inhibitory activity against glucan synthesis [Duarte et al., 2006]. For the PACs, 
those with degrees of polymerization between 4 and 12 were considered optimal for interaction 
and inhibition of Gtfs, as a higher degree of polymerization actually diminished inhibitory effects 
[Yoo et al., 2011]. It is reasonable to infer that the polyphenol-mediated inhibition of glucan 
synthesis (particularly of the insoluble glucans) would result in a debilitated biofilm structure and 
disturbed dynamics. This could potentially result in cariogenic biofilms becoming more susceptible 
to inimical influences of remineralizing agents and antimicrobials.  
 
The anti-Gtf effects of berry phenols could also indirectly be responsible for the decrease in 
bacterial biovolumes observed in the study. A drop in the EPS content not only reduces overall 
biofilm bulk and volume, but also affects bacterial biomass (especially in the hydrated stage) by 
limiting the binding sites available for bacterial adhesion and co-aggregation. Besides disrupting Gtf-
mediated bacterial adhesion, a high molecular-weight non-dialyzable fraction of cranberry has been 
shown to inhibit bacterial cell surface hydrophobicity, further affecting bacterial adhesion to tooth 
surfaces [Steinberg et al., 2005; Yamanaka et al., 2004]. The inhibitory effects of cranberry 
polyphenols on bacterial adhesion could largely be responsible for the reduced bacterial biomass 
seen in the confocal 3D images, rather than any bactericidal effects. Further investigation is required 
to corroborate the anti-adhesion effects of cranberry phenols. 
 
The CFU data confirms that none of the berry extracts had a significant effect on the 
population of viable bacterial cells in contrast to the CHX control. The ability of berry phenols to 
target cariogenic virulence properties without significantly affecting microbial viability is an 
important advantage over the broad bactericidal effects of traditional oral biocides. The use of 
agents like CHX for caries prevention in high-risk patients often results in susceptible tooth surfaces 
being repopulated with the same disease-causing microbiome that was eliminated, once the 
chemotherapeutic intervention stops [Burne, 2018]. On the other hand, natural products that can 
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disrupt biofilm acidogenicity, glucan synthesis, and structural architecture are more likely to exert 
an ecological pressure that favours health-associated microbial plaque communities. Animal model 
studies have confirmed that natural products with virulence-targeting properties can reduce caries 
incidence and severity despite lacking bactericidal activity [Koo et al., 2010; Koo et al., 2005]. 
 
 It is possible that berry phenols will have both short-term and long-term effects on bacterial 
biofilms. Cranberry A-type PACs are known to bind irreversibly to proteins, forming protein-
polyphenol complexes that can impair the activity of glycolytic and Gtf enzymes over a period of 
time [Duarte et al., 2006; Gregoire et al., 2007]. Furthermore, the binding of cranberry PACs to 
salivary proteins may confer improved substantivity beyond their brief period of exposure in the 
mouth [Koo et al., 2006]. PACs in other fruit berries lack the rigidity conferring A-type linkage partly 
explaining their lower biological effects observed in this study.  
 
Prevention of dental caries has traditionally been dependent on limiting exposure to dietary 
sugars and on meticulous oral hygiene using fluoride dentifrices. With dental caries now recognized 
as a disease of stress-induced microbiome dysbiosis, there is an increased focus on ecological 
preventive measures that can shift the dental plaque biofilm from a state of dysbiosis to a state of 
symbiosis [Featherstone et al., 2018]. While fluoride will remain the cornerstone of caries 
prevention, its cariostatic effects are primarily physiochemical, exhibiting only short-term reversible 
biological effects against biofilm metabolism even at high concentrations [Dang et al., 2016]. 
Provision of non-fluoride biofilm-modifying interventions, that are designed to repopulate teeth 
with health-associated microbiomes, can deliver small but relevant benefits over a prolonged period 
of time, and these could be particularly useful for caries control in high-risk populations [Burne, 
2018; Marsh, 2018]. Cariogenic virulence-targeting natural products are one of the several 
ecological caries preventive approaches currently under investigation [Philip et al., 2018]. Among 
the potential cariostatic natural products, dark-coloured berry fruits hold particular promise 
because of their high phytochemical content, wide consumption, and proven effects on systemic 
health and disease. There is a growing body of evidence that suggests biological activities of berry 
phenols extend beyond their anti-oxidant effects to include regulating metabolic enzymes, gene 
expression, and subcellular signaling pathways [Seeram, 2008], all actions that can potentially play 
a role in reducing virulence of S. mutans.  
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CONCLUSIONS 
Prudency is required when interpreting the presented data to avoid over evaluation of the 
cariostatic effects. Our in vitro monospecies biofilms clearly do not reflect the complex 
polymicrobial, ecological, and environmental interactions taking place in the oral cavity. However, 
we have demonstrated that the cranberry extract used in this study is particularly effective in 
inhibiting S. mutans pathogenicity without necessarily killing the target bacteria, and is thus a 
promising candidate for development as an ecological caries preventive agent. It could act possibly 
by modulating dental plaque virulence properties, while retaining the benefits of the symbiotic 
resident oral microbiome. Further studies using polymicrobial biofilm models and pilot clinical trials 
with the cranberry extract incorporated into oral care products are currently underway to elucidate 
whether the biological effects shown can actually result in a favourable microbial ecological change 
in dental plaque. 
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4.3  SCIENTIFIC PAPER 3 
 
Polyphenol-rich Cranberry Extracts Modulate Virulence of Streptococcus mutans-
Candida albicans Biofilms Implicated in the Pathogenesis of Early Childhood 
Caries 
 
This study investigated the effects of polyphenol-rich cranberry extracts on cariogenic 
virulence properties of dual-species Streptococcus mutans-Candida albicans biofilms.  
 
The paper was published on 16th February 2019 in Pediatric Dentistry, the official 
publication of the American Academy of Pediatric Dentistry (AAPD) and the College of 
Diplomates of the American Board of Pediatric Dentistry.  
 
Pediatr Dent 2019 41(1): 56-62. 
 
The study images were featured on the cover of the journal issue. 
 
This chapter is comprised of the publication as it stands in print. 
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ABSTRACT 
Purpose: A synergistic alliance between Streptococcus mutans and Candida albicans has been 
implicated in contributing to the severity of early childhood caries. The purpose of this study was to 
investigate the effects of polyphenol-rich cranberry extracts on dual-species S. mutans-C. albicans 
biofilms.  
 
Methods: S. mutans-C. albicans biofilms were grown on saliva-coated hydroxyapatite discs (s-HA) 
mounted on the high-throughput Amsterdam Active Attachment model. The s-HA discs were 
treated with the cranberry extracts/vehicle control for 5 min just before biofilm growth, and 
subsequently, for similar exposure times, after 12 h and 24 h of biofilm growth. The treated 24 h-
old biofilms were then assessed for acidogenicity, metabolic activity, exopolysaccharide 
(EPS)/microbial biovolumes, structural organisation, and colony forming unit (CFU) counts.  
 
Results: Treatment with 500-1000 µg/mL of the cranberry extracts produced highly significant 
reductions in acidogenicity and metabolic activity (P < 0.001) compared to the control-treated 
biofilms. A significant decrease in biovolumes of the EPS (P = 0.003) and microbial (P = 0.007) biofilm 
components was also seen. Qualitative assessment of confocal biofilm images revealed that the 
cranberry extract disrupted biofilm structural architecture. Finally, significantly fewer S. mutans (P 
= 0.006) and C. albicans (P = 0.036) CFUs were recovered from the cranberry-treated biofilms than 
from the control-treated biofilms.  
 
Conclusions: Cranberry extracts inhibited cariogenic virulence properties of S. mutans-C. albicans 
dual-species biofilms in an in vitro model. 
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INTRODUCTION 
Early childhood caries (ECC) is among the most common childhood diseases, 
disproportionately afflicting underprivileged and socially disadvantaged children, both in the U.S 
and globally [Dye et al., 2015a; Kassebaum et al., 2015]. The disease implications extend well beyond 
orofacial functions, as it can negatively affect the child’s physical growth, education, socialization 
and overall well-being [Hajishengallis et al., 2016]. Even after treatment, and despite a variety of 
preventive measures, there remains a high risk of future lesion recurrences, placing significant 
economic costs on patients and their families. While the existing paradigm of encouraging the early 
establishment of a “dental home” has met with limited success, there is clearly a need to consider 
additional measures to effectively tackle the ECC epidemic [Douglass and Clark, 2015]. 
 
Streptococcus mutans is considered the keystone bacterial pathogen in ECC, often exceeding 
30% of the cultivable plaque biofilm flora in severe forms of the disease [Falsetta et al., 2014]. S. 
mutans-derived glucosyltransferase (Gtf) exoenzymes assemble the exopolysaccharide (EPS) 
glucan-rich matrix scaffold, which confers structural integrity and bulk to plaque biofilms, enhances 
microbial adhesion and co-aggregation and provides a readily metabolizable carbohydrate source 
for sustained acid production [Bowen et al., 2018]. Other acidogenic and aciduric bacteria such as 
lactobacilli, bifidobacteria, and Scardovia species also contribute to lesion development as the 
plaque biofilm matures, but these bacterial species lack the specific Gtfs that synthesize insoluble 
glucans [Hajishengallis et al., 2017]. 
 
The fungus Candida albicans has also been frequently isolated from the dental plaque of 
children with ECC [de Carvalho et al., 2006; Marchant et al., 2001; Raja et al., 2010; Yang et al., 
2012]. A recent systematic review and meta-analysis indicated that children colonized with oral C. 
albicans have >5 times higher odds of having ECC compared to those without C. albicans [Xiao et 
al., 2018]. Mothers of children with severe ECC were also found to be infected with similar strains 
of C. albicans, suggesting that the parent is the likely primary source for C. albicans acquisition in 
these children [Xiao et al., 2016]. C. albicans was initially regarded to neither bind well with S. 
mutans nor to effectively colonize teeth on its own. Rather, this opportunistic fungus was known to 
interact with commensal viridans streptococci and to form biofilms on mucosal/acrylic surfaces 
[Jenkinson et al., 1990]. However, recent studies have demonstrated an extraordinary synergistic 
alliance between S. mutans and C. albicans mediated primarily through the influence of the bacterial 
Gtf exoenzymes [Falsetta et al., 2014; Gregoire et al., 2011; Kim et al., 2017]. The symbiotic 
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relationship between these microorganisms is expressed in a number of ways. The ability of S. 
mutans to rapidly breakdown sucrose allows the fungus to utilize sucrose break-down products, 
with enhanced fructose metabolism known to promote C. albicans hyphal morphogenesis [Kim et 
al., 2017]. Equally, the large surface area of C. albicans provides an increased number of binding 
sites for S. mutans to adhere to within dual-species biofilms. The S. mutans-derived Gtfs (particularly 
GtfB) also bind avidly to C. albicans cell surfaces, converting them into de facto glucan producers in 
the presence of sucrose [Gregoire et al., 2011]. This significantly enhances virulence-enhancing 
insoluble glucans in the biofilm and assembles an EPS-rich matrix scaffold that is critical for further 
S. mutans accumulation [Falsetta et al., 2014]. A contrary finding to this was a study that showed S. 
mutans–C. albicans biofilms suppressed EPS production by S. mutans [Sztajer et al., 2014]. However, 
this was likely to be due to sucrose depletion in the co-culture rather than any inhibitory effect of 
C. albicans on S. mutans. Overall, the majority of the studies indicate that the mutualistic bacterial-
fungal relationship amplifies biofilm virulence and led to rampant caries under in vivo experimental 
conditions conducive for ECC [Falsetta et al., 2014; Gregoire et al., 2011; Kim et al., 2017]. 
 
The available evidence has prompted the suggestion of incorporating anti-Candida therapy 
into preventive programs that are designed to reduce the severity of ECC [Koo and Bowen, 2014]. 
While chlorhexidine (CHX) is bactericidal for S. mutans and fungicidal for C. albicans, susceptible oral 
niches are often repopulated with the same disease-associated microorganisms once the 
chemotherapeutic intervention with CHX stops, resulting in lesion recurrence and therapeutic 
failure. To avoid this, ecological caries preventive approaches that lower plaque virulence are being 
increasingly preferred over broad-spectrum antimicrobials for long-term caries control [Philip et al., 
2018]. In this regard, natural products that can disrupt cariogenic virulence properties and 
potentially reverse the microbiome dysbiosis are an attractive alternative to synthetic biocides such 
as CHX. Cariostatic natural products will also find better acceptance among the general public as 
they are less likely to be associated with adverse effects or emergence of resistant strains often seen 
with synthetic biocides and antifungals. 
 
We have recently demonstrated that a highly-purified polyphenol-rich cranberry extract was 
able to significantly disrupt acidogenicity, metabolic activity, EPS/microbial biovolumes and 
structural organisation of S. mutans biofilms, without affecting bacterial viability [Philip et al., 
2019a]. Specific cranberry flavonoids, especially the A-linked proanthocyanidins (A-PACs), have 
been shown to be potent inhibitors of bacterial glycolysis and GtfB-mediated glucan synthesis in S. 
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mutans biofilms and were shown to prevent dental caries development in vivo [Duarte et al., 2006; 
Gregoire et al., 2007; Koo et al., 2010; Koo et al., 2006]. However, there have been no studies that 
have examined the effects of natural cranberry extracts on virulence properties of dual-species S. 
mutans-C. albicans biofilms. Hence, this study aimed to investigate the influence of polyphenol-rich 
cranberry extracts on the bacterial-fungal biofilms, given the critical role these microbes play in ECC 
pathogenesis.  
 
MATERIALS AND METHODS 
Cranberry Extracts 
High-quality organic extracts of cranberry were sourced from Diana Food (Champlain, QC, 
Canada), and used to treat S. mutans-C. albicans biofilms. As per the manufacturer’s data sheet, 
80% of the polyphenols in these extracts were A-PACs, with modest amounts of different flavonols 
(e.g. quercetin, myricetin), anthocyanins, and phenolic acids making up the remainder. The 
cranberry extract was fully soluble in water, and was serially diluted in 0.15 M phosphate buffered 
saline, pH 7.2 (PBS; Gibco, Thermo Fisher, Paisley, UK) in concentrations ranging from 1000 to 125 
µg/mL. 
 
Biofilm Inoculum 
Overnight cultures of S. mutans (ATCC 25175) and C. albicans (SC5314) were grown 
separately in brain heart infusion (BHI; Merck, Darmstadt, Germany). Cells were harvested, 
resuspended in BHI containing 0.2% (w/v) sucrose, and microbial counts adjusted to approximately 
2 X 106 colony forming units (CFU)/mL for S. mutans, and 2 X 104 CFU/mL for C. albicans. This 
proportion of the microorganisms is similar to that found in saliva samples of children with ECC  [de 
Carvalho et al., 2006; Kim et al., 2017]. 
 
Biofilm Preparation and Treatments 
In order to mimic the biofilm formation on smooth surfaces of teeth, the S. mutans-C. 
albicans dual-species biofilms were grown on hydroxyapatite (HA) discs (9.5mm diameter x 2mm 
thick; Himed, New York, NY, USA). The HA discs were mounted on the high-throughput Amsterdam 
Active Attachment (AAA) model [Exterkate et al., 2010]. To partially replicate the salivary pellicle, 
the HA discs were initially coated with filter-sterilized clarified whole human saliva for 1 h at 37°C 
as described previously.[Philip et al., 2019a] The saliva coated HA discs (s-HA) were then moved to 
a flat-bottomed 24-well microtiter plate (Costar 3526, Sigma-Aldrich, New York, NY, USA) containing 
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2 mL/well of the different cranberry extract concentrations and treated for 5 min. The lid with the 
pre-treated s-HA discs was then gently shaken to remove any excess of treatment/control solutions 
and transferred to a 24-well plate containing 2 mL/well of the microbial inoculum and incubated at 
37°C in an orbital shaker at 80 rpm. Subsequent treatments took place after 12 h and 24 h of biofilm 
growth, with the growth medium (0.2% sucrose-BHI) refreshed after the 12 h treatment period. All 
treatment exposures were for 5 min, with the biofilm-laden discs dip-rinsed 5 times in sterile PBS 
just before and after the 12 and 24 h treatments to remove non-adherent cells and any residual 
treatment solutions. 
 
Biofilm Analyses  
After the final treatment, the influence of the cranberry extracts on the 24 h-old S. mutans-
C. albicans dual-species biofilms were assessed using different assays to estimate acidogenicity, 
metabolic activity, EPS/microbial biovolumes, structural organisation and CFU counts. All the biofilm 
assays were performed in triplicate and repeated in 3 independent experiments. 
 
1. Lactic Acid Concentrations: Acid Production Assay 
The treated biofilm-bearing HA discs were transferred to a 24-well plate containing 2 
mL/well of buffered peptone water (BPW, Merck, Darmstadt, Germany) supplemented with 0.2% 
(w/v) sucrose and incubated anaerobically at 37°C. Acid formation was allowed to continue for 3 h 
under anaerobic conditions. The optical density (O.D) values of the BPW solutions were then 
measured at 340 nm and their lactate concentrations determined from lactic acid standard curves 
using an enzymatic (lactate dehydrogenase) method [Exterkate et al., 2010]. 
 
2. Biofilm Metabolic Activity: XTT Reduction Assay 
A standard XTT reduction assay was performed as previously described.[Philip et al., 2018a] 
Briefly, 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) salt solution 
(1 mg/mL in PBS) was filter-sterilized and stored at -80°C until required. Immediately before each 
assay, the reaction solution was prepared by mixing PBS, XTT solution, and freshly prepared 0.4mM 
menadione in a 79:20:1 volume ratio. The treated biofilm-coated HA discs were transferred to a 24-
well plate containing the reaction solution and incubated in the dark for 3 h at 37°C. Thereafter, 100 
µl of the cell-free supernatant from each well was pipetted to a 96-well microtiter plate and 
absorbance measured at a wavelength of 492 nm. 
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3. Biofilm Biovolumes and Structural Organisation: Confocal Microscopy 
The biofilm treated with the 500 µg/mL cranberry extract was selected for confocal 
microscopic imaging to assess its EPS and microbial components. A novel in situ labelling technique 
that allows simultaneous visualization and quantification of EPS and microbial cells within intact 
biofilms was used [Klein et al., 2011]. Briefly, 1 µM Alexa Fluor 647-dextran conjugate (647/668 nm; 
Thermo Fisher, Scoresby, Australia) was added to the sucrose-BHI growth medium to allow its 
incorporation into glucans during biofilm development. The microbial cells were labeled at the end 
of the biofilm treatment using 1 µM SYTO 9 (480/500 nm; Thermo Fisher). Imaging of the intact 
biofilm was done with a spectral spinning disc confocal microscope (Nikon, Tokyo, Japan). The 
biofilm was scanned at 5 randomly selected positions, with the z-series (512 by 512-pixel resolution) 
created by optical sectioning at 2.5 µm intervals. Three independent biofilm experiments were 
performed, generating a 15 image stacks each for the cranberry and control treated biofilms. The 
image-processing software IMARIS (Bitplane, Concord, MA, USA) was used to construct 3D 
renderings of the biofilm structural components (EPS and microorganisms). Biovolumes (volume of 
biomass/substratum surface area) of the EPS and microbial biofilm components were quantified 
separately. Structural architecture of the biofilms was assessed qualitatively based on the 
compactness of the biofilm components. 
 
4. Microbial Counts 
After treatment with 500 µg/mL cranberry extract, the dual-species biofilms were dispersed 
in 1 mL PBS by uniform vortexing at maximum speed for 1 min. The resulting microbial suspension 
was then serially diluted in PBS and a 50 µL aliquot of it plated separately on BHI agar plates 
supplemented with antifungal caspofungin (0.5 µg/mL) and sabouraud dextrose agar plates 
supplemented with antibacterial tetracycline (1 µg/mL) using a spiral plater. The plates were 
incubated in a 5% CO2 incubator at 37°C for 48 h. The number of CFUs were totaled individually for 
S. mutans and C. albicans with a digital colony counter and the CFU values Log10 transformed prior 
to analysis. 
 
Statistical Analysis 
The normality of data distribution was checked with the Shapiro-Wilk test. For the non-
parametric acid production assay data, the Kruskal-Wallis H-test and the Dunn-Bonferroni post hoc 
test was used for the multiple comparisons of the different cranberry concentrations to the control 
group. For the parametric XTT assay data, the one-way ANOVA and Dunnett’s post hoc test was 
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applied for the multiple comparisons. The independent sample t-test was used for the parametric 
microbial biovolume confocal data, while the Mann-Whitney U-test was applied to the non-
parametric EPS biovolume confocal data and CFU assay data. The level of significance was set at 5%. 
Statistical software SPSS version 25 (IBM, New York, NY, USA) was used to perform the analyses. 
 
RESULTS 
Biofilm acidogenicity and metabolic activity 
 Effects of cranberry extract on lactic acid production and metabolic activity of the S. mutans-
C. albicans biofilms are shown in Table 9. The results of the acid production and XTT metabolic 
assays were consistent with each other for the different cranberry concentrations tested. Biofilm 
treatment with 500 - 1000 µg/mL of the cranberry extracts produced highly significant reductions 
in acidogenicity and metabolic activity (P < 0.0001) compared to the control-treated biofilms, while 
no significant effects were seen after treatment with the 125-250 µg/mL cranberry extract 
concentrations (P > 0.05). The increased reduction of acidogenicity and metabolic activity with 
higher concentrations of the cranberry extract suggests a dose-response relationship. 
 
Table 9. Effects of polyphenol-rich cranberry extracts on acid production and metabolic activity of S. 
mutans-C. albicans dual-species biofilms 
Cranberry extract concentration 
(µg/mL) 
 
Lactic acid production (% change) 
(mM/L) 
  
 
Metabolic activity (% change) 
(OD492) 
1000 
 
6.2 ± 1.5 (-45)* P < 0.0001 0.277 ± 0.031 (-29)* P < 0.0001 
500 
 
8.1 ± 1.8 (-28)* P < 0.0001 0.314 ± 0.042 (-20)* P < 0.0001 
250 
 
10.5 ± 1.5 (-7) P = 1.000 0.362 ± 0.034 (-7) P = 0.093 
125 
 
11.1 ± 1.5 (-2) P = 1.000 0.380 ± 0.020 (-3) P = 0.528 
Control 
 
11.3 ± 2.4 0.390 ± 0.025 
Lactic acid production of biofilms in mM/L (mean ± S.D) is from three independent triplicate experiments (n = 9). Metabolic activity 
represents mean XTT absorbance values ± S.D from three independent triplicate experiments (n = 9) at 492 nm optical density 
(OD) absorbance. Values given in round brackets represent percentage change of acid production/metabolic activity compared to 
respective controls. * indicates significant difference compared to control-treated biofilms. The Kruskal-Wallis H-test (with Dunn-
Bonferroni post hoc) was applied for the lactic acid production data, while the one-way ANOVA (with Dunnett’s post hoc) was 
applied for the  XTT metabolic activity data. 
 
Biofilm biovolumes and structural organisation 
Confocal microscopic imaging revealed that topical treatment with the 500 µg/mL cranberry 
extract produced both qualitative and quantitative alterations within the dual-species biofilms. The 
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fluorescence images showed disruption of the architecture of the biofilms, with the cranberry-
treated biofilms appearing less compact than the control biofilms (Fig. 10). There appeared to be 
less EPS (depicted in red) surrounding the bacterial-fungal microcolonies (depicted in green) in the 
cranberry-treated biofilms compared to the control-treated biofilms.  Quantitative data confirmed 
significant reductions in the biovolumes of both the EPS (P = 0.003) and microbial (P = 0.007) 
components of the cranberry-treated biofilms (Table 10). 
 
 
Figure 10. Representative 3D confocal image stacks of S. mutans-C. albicans biofilms 
Structural organisation of dual-species S. mutans-C. albicans dual-species biofilms following topical treatment with A) vehicle 
control and B) 500 µg/mL of the cranberry extract. Microbial cells are depicted in green (SYTO 9) and EPS in red (Dextran, 
Alexa Fluor), with 20x magnification. 
 
Table 10. Quantitative analysis of dual-species S. mutans-C. albicans biofilm confocal images 
 
 
Treatment Group 
Biovolumes of Biofilm Components (µm3/µm2) 
 
EPS 
 
Microbial Cells 
Cranberry 
 
2.3 ± 1.0* P = 0.003 4.8 ± 0.8* P = 0.007 
Control 
 
3.3 ± 1.4 6.3 ± 1.7 
Biovolumes (mean ± S.D) of both EPS and total microbial cells (S. mutans and C. albicans) was quantified using 
IMARIS. The data are from 3 independent biofilm experiments (n = 15). * indicates statistically significant 
reduction of EPS/microbial biovolumes compared to control. The Mann-Whitney U-test (for EPS biovolumes) and 
the independent sample t-test (for microbial biovolumes) were used to test for significance. 
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Microbial counts 
Pre-treatment of the sHA discs followed by treatment of the growing biofilms with the 500 
µg/mL cranberry extract significantly reduced S. mutans (P = 0.006) and C. albicans (P = 0.036) 
populations in the dual-species biofilms (Fig. 11). The mean S. mutans cell numbers recovered from 
cranberry-treated biofilms were 1.1 x 108 CFU/mL compared to 1.6 x 108 CFU/mL for the control-
treated biofilms. The C. albicans counts were 4 x 106 CFU/mL and 5.1 x 106 CFU/mL for cranberry 
and control-treated biofilms respectively.  
 
 
Figure 11. Box-plots of microbial colonies recovered from S. mutans-C. albicans biofilms 
* indicates significantly different CFU values (P < 0.05) for the cranberry-treated biofilm compared to control-treated biofilms 
using the Mann-Whitney U-test (n = 9). 
  
DISCUSSION 
 The results of the study demonstrate that polyphenols present in the cranberry extract can 
inhibit virulence properties and disrupt the structure of S. mutans-C. albicans dual-species biofilms. 
The polyphenols present in the cranberry extract are not only potent inhibitors of bacterial glycolytic 
and Gtf exoenzymes but can also affect microbial adhesion to pellicle-coated tooth surfaces, 
mechanisms that may impede the synergistic relationship between the bacterial keystone pathogen 
and the opportunistic fungus often seen at sites of ECC infection. An approach that involves 
targeting biofilm virulence factors with polyphenol-rich cranberry extracts could facilitate action of 
remineralizing agents and result in better control over aggressive cases of ECC. Such measures are 
in keeping with recent reviews that have highlighted the need for multi-targeted therapeutic 
strategies to disrupt the “pathogenic niche” by targeting the complex biofilm microenvironment 
[Koo et al., 2017; Liu et al., 2018]. 
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In the present study, the reduction observed in the metabolism of the dual-species biofilm 
metabolism corresponded with a decrease in the biofilm acidogenicity. Both S. mutans and C. 
albicans have the ability to produce and tolerate acids, allowing them to outcompete non-cariogenic 
commensal species under low pH conditions [Metwalli et al., 2013]. A low pH environment at the 
biofilm-tooth interface promotes enamel demineralization, leading to the clinical onset of dental 
caries. We had earlier shown that treating S. mutans biofilms with cranberry extracts at 
concentrations between 125-500 µg/mL resulted in significant reductions in metabolic activity and 
lactic acid production [Philip et al., 2019a]. The same cranberry extract showed inhibitory activity 
against dual-species S. mutans-C. albicans biofilms, reducing metabolism and acidogenicity, 
although higher concentrations (500-1000 µg/mL) were required for significant effects. The greater 
biomass of EPS and microorganisms in dual-species S. mutans-C. albicans biofilms compared to 
monospecies S. mutans biofilms possibly explains why higher concentrations of the cranberry 
extract were needed to exert inhibitory effects. The anti-acidogenic mechanism of cranberry is 
possibly due to a low molecular-weight PAC dimer (procyanidin A2) that has been shown to directly 
inhibit intracellular glycolytic enzymes, while larger PAC oligomers may have deleterious effects on 
membrane components of the glycolytic pathway [Gregoire et al., 2007; Yoo et al., 2011]. 
 
A 3D reconstruction of the confocal images revealed a partial impairment of the structural 
architecture of the cranberry-treated biofilms compared to the control-treated biofilms. This 
disruption to the biofilm structural organisation could render it less capable of maintaining acidic 
pH conditions at the attachment surface. An overall decrease in both EPS and microbial biovolumes 
was also observed in the confocal quantitative data, further corroborating the disruptive effect 
cranberry extracts had on biofilm structure. The biofilm disruptive effects of the cranberry extracts 
are believed to be related to specific flavonoids present in them. Cranberry phenols (especially the 
A-PACs) have pronounced inhibitory activity against the S. mutans Gtf exoenzymes responsible for 
glucan synthesis and EPS matrix assembly [Duarte et al., 2006; Feng et al., 2013].  The precise 
mechanisms by which A-PACs inhibit Gtf activity are not clear but are likely to be related to its unique 
rigidity conferring A-type linkages, as PACs from non-cranberry fruits that lack the double interflavan 
A-type linkages do not affect Gtfs [Koo et al., 2010]. Inhibition of bacterial α-glucan synthesis not 
only affects the EPS biofilm matrix, but can also disrupt the bacterial-fungal interaction and 
accumulation in S. mutans-C. albicans biofilms. While C. albicans can also independently contribute 
to the biofilm matrix through the production of extracellular β-glucans, it is not known whether 
cranberry flavonoids affect fungal β-glucan production. 
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In the current study, there was a significant decrease in the numbers of bacterial and fungal 
cells recovered from the cranberry-treated biofilms. Previous studies have established that 
cranberry extracts and their purified compounds had no effect on growth and viability of either S. 
mutans [Duarte et al., 2006; Feng et al., 2013; Gregoire et al., 2007; Koo et al., 2010; Koo et al., 
2006; Philip et al., 2019a] or C. albicans [Feldman et al., 2012; Girardot et al., 2014]. However, 
cranberry phenols are known to exert anti-adhesion effects against both S. mutans [Feng et al., 
2013; Weiss et al., 2004; Yamanaka et al., 2004] and C. albicans [Feldman et al., 2012; Girardot et 
al., 2014] which could account for the lower microbial populations observed in this study. The 
cranberry extracts may have exerted anti-adhesion effects in multiple ways. The exposure of the 
sHA discs to the cranberry extracts prior to biofilm growth could have impeded microbial adhesion 
at the early stages of biofilm growth, as cranberry polyphenols are known to irreversibly bind to 
proline-rich salivary proteins affecting pellicle-mediated adhesion [Bennick, 2002; Girardot et al., 
2014]. Moreover, cranberry A-PACs have been shown to markedly modify cell surfaces of both S. 
mutans [Weiss et al., 2004; Yamanaka et al., 2004] and C. albicans [Feldman et al., 2012] from being 
highly hydrophobic to hydrophilic, thereby affecting their initial adhesion to pellicle-coated 
surfaces. However, the predominant anti-adhesion effects of cranberry phenols are likely to be 
mediated through their effective inhibition of the bacterial GtfB and GtfC exoenzymes. The Gtf-
derived α1,6-linked glucans not only provide sites to which S. mutans cells can adhere to avidly but 
are also largely responsible for the physical interaction between S. mutans and C. albicans in dual-
species biofilms [Falsetta et al., 2014; Gregoire et al., 2011]. It is reasonable to infer that anti-
adhesion effects of the cranberry extract, rather than any biocidal activity, accounts for the decrease 
in the microcolonies recovered from the biofilms in the CFU assay, and the reduction in microbial 
biovolumes observed in the confocal imaging data.  
 
Bioactive cranberry polyphenols have shown therapeutic potential against urinary tract 
infections, gastric ulcers, cardiovascular disease, and cancer cell proliferation [Pappas and Schaich, 
2009]. They are now increasingly being advocated in preventing or managing dental caries and 
periodontal disease [Bonifait and Grenier, 2010; Feghali et al., 2012; Koo et al., 2010]. Among the 
different cranberry flavonoids, the unique A-PACs have shown the most potent effect against 
bacterial glycolytic, Gtf, and F1F0-ATPase enzymes that are critical to cariogenic virulence [Duarte et 
al., 2006; Gregoire et al., 2007]. The fact that the cranberry extract used in this study were rich in 
A-PACs (making up more than 80% of the total phenols) possibly explains the demonstrated 
inhibitory effects against virulence properties of S. mutans-C. albicans biofilms. Other advantages 
135 
 
of these sugar-free water soluble cranberry extracts are that they have standardized phytochemical 
concentrations, thereby overcoming the problem of compositional variability often associated with 
natural products. 
 
Newer approaches are needed to tackle ECC especially with recent data from the National 
Health and Nutrition Evaluation Survey (NHANES) indicating that the disease remains the most 
common infectious disease among preschool children in the United States [Dye et al., 2015]. While 
fluoride remains the gold standard among anti-caries agents, its cariostatic effects are 
predominantly due to its physicochemical influences on the de-/remineralization equilibrium [ten 
Cate and Cummins, 2013]. Recent studies have demonstrated that even high fluoride 
concentrations could not sustain antimicrobial activity against biofilm metabolism [Dang et al., 
2016; Souza et al., 2018]. Moreover, considering that children at risk to ECC are often not able to 
use high concentration fluoride products (due to the risk of dental fluorosis), additional caries 
preventive measures are warranted in this high-risk population group. The present study indicates 
that polyphenol-rich cranberry extracts have the potential to disrupt the synergistic S. mutans-C. 
albicans alliance and can thus potentially play a role in influencing ECC pathogenesis. These 
commercially available natural extracts can possibly be incorporated into daily use oral care 
products to supplement the remineralizing effects of fluoride. However, our in vitro biofilm model 
clearly does not reflect the complex polymicrobial, ecological, and environmental influences 
encountered in the oral cavity. Well-designed clinical trials are warranted to demonstrate whether 
the beneficial properties shown under our assay conditions can translate into efficacious 
therapeutic approaches to control ECC. 
 
CONCLUSIONS 
The following conclusions can be made from this in vitro study: 
1. Polyphenol-rich cranberry extracts significantly reduced the metabolic activity and lactic acid 
production of S. mutans-C. albicans dual-species biofilms. 
2. Topical treatment of S. mutans-C. albicans biofilms with the cranberry extracts disrupted 
their structural architecture and lowered EPS/microbial biovolumes. 
3. There was a significant reduction in the numbers of S. mutans and C. albicans microbial 
colonies recovered from the cranberry-treated S. mutans-C. albicans dual-species biofilms. 
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RAW DATA 
Study 3: XTT reduction assay on 24 h S. mutans-C. albicans biofilms 
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Study 3: Lactic acid production assay on 24 h S. mutans-C. albicans biofilms 
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Study 3: Colony Forming Unit (CFU) assay on 24 h S. mutans-C. albicans biofilms 
 
CFU/mL 
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Study 3: CLSM quantitative assay on 24 h S. mutans-C. albicans biofilms 
 
Biofilm biovolumes (µm3/µm2) 
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4.4  SCIENTIFIC PAPER 4 
 
Effect of Polyphenol-rich Cranberry Extracts on Cariogenic Biofilm Properties and 
Microbial Composition of Polymicrobial Biofilms 
 
This study investigated the effects of polyphenol-rich cranberry extracts on saliva-
derived polymicrobial biofilms growing in a cariogenic environment. 
 
The paper was published on 30th March 2019 in the Archives of Oral Biology.  
 
Arch Oral Biol 2019; 102:1-6. 
 
This chapter is comprised of the publication as it stands in print. 
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ABSTRACT 
 
Purpose: To investigate the effect of cranberry extracts on saliva-derived polymicrobial biofilms with 
regards to biofilm biomass, acidogenicity, exopolysaccharide (EPS)/microbial biovolumes, colony 
forming unit (CFU) counts, and the relative abundance of specific caries- and health-associated 
bacteria. 
 
Methods: Saliva-derived polymicrobial biofilms were grown for 96 h in a cariogenic environment 
and treated for 2 min every 12 h over the entire biofilm growth period with 500 µg/mL cranberry 
extract or vehicle control. The effect of the cranberry extract on biofilm behaviour was evaluated 
using different assays and its influence on key cariogenic and health-associated bacterial 
populations was assessed with a microarray real-time quantitative PCR method. 
 
Results: Cranberry-treated biofilms showed significant drops in biomass (38% reduction, P < 0.001), 
acidogenicity (44% reduction, P < 0.001), EPS/microbial biovolume ratios (P = 0.033), and CFU counts 
(51% reduction, P = 0.001). Furthermore, the cranberry extracts effected a significantly lower 
relative abundance of caries-associated Streptococcus sobrinus (fold change 0.004, P = 0.002) and 
Prevotella denticola (0.002, P < 0.001), and a significantly higher relative abundance of the health-
associated Streptococcus sanguinis (fold change 90.715, P = 0.001). 
 
Conclusions: The cranberry extract lowered biofilm biomass, acidogenicity, EPS/microbial 
biovolumes, CFU counts, and modulated a beneficial microbial ecological change in saliva-derived 
polymicrobial biofilms. 
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INTRODUCTION 
Dental caries is a biofilm-mediated disease characterized by a highly dynamic, polymicrobial, 
and diet-driven pathologic process [Bowen et al., 2018]. Local environmental stresses (e.g. frequent 
sugar exposures, poor oral hygiene, xerostomia) induce dysbiosis in the resident microbiome 
resulting in microbial community shifts that ensues dominance of acidogenic/aciduric 
microorganisms over health-associated commensal species [Marsh, 2018]. If the microbiome 
dysbiosis is not reversed, the assembled virulent plaque biofilms will cause enamel 
demineralization, eventually leading to the clinical onset of cavitation [Burne, 2018]. The ecological 
antagonism between commensal and cariogenic bacteria is thus a major factor shaping the 
composition and virulence of dental biofilms [Huang et al., 2016]. When in equilibrium, a symbiotic 
oral microbiome can not only control the growth of cariogenic bacteria but can also play a positive 
role in maintaining oral health by delivering important benefits like immunologic priming and down-
regulation of excessive pro-inflammatory responses [Marsh et al., 2015]. 
 
 One consequence of the evolution of caries etiological paradigms is the realization that 
current caries preventive approaches do not fully address the microbiome dysbiosis that is 
fundamental to the disease process [Philip et al., 2018a]. Fluoride, which is regarded as the gold 
standard among anti-caries agents, has only limited antimicrobial actions, and is often not able to 
cope with the massive bacterial challenge encountered in high-risk individuals [ten Cate and 
Cummins, 2013]. On the other hand, commonly used biocides are likely to indiscriminately eradicate 
oral microflora, including those beneficial to health [Philip et al., 2018]. Once the chemotherapeutic 
intervention stops, susceptible tooth surfaces are often repopulated with a microbiome similar in 
composition to one that was eliminated, resulting in the continuation of the disease process [Burne, 
2018]. This suggests the need to develop additional measures that can reverse the dental plaque 
dysbiosis and complement the cariostatic effects of fluoride on the de-/remineralization 
equilibrium. 
 
 Plant-derived natural products may be better able to modulate the behaviour of dental 
biofilms, in line with the concept of targeting virulence rather than broadly affecting microbial 
growth or viability [Cegelski et al., 2008]. Among the several cariostatic natural products studied, 
cranberry polyphenols hold particular promise as they can disrupt critical cariogenic virulence 
factors such as bacterial adhesion, acidogenicity, aciduricity, glucan synthesis, and biofilm structural 
architecture without affecting microbial viability [Duarte et al., 2006; Feng et al., 2013; Gregoire et 
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al., 2007; Koo et al., 2010; Philip et al., 2019a]. Furthermore, microbial resistance is less likely to 
develop against such natural flavonoids as they are chemically diverse and have multiple modes of 
antimicrobial action [Koehn and Carter 2005]. This potentially makes it an ideal agent to reduce 
overall biofilm virulence and ecologically modify the dental plaque microbial community. 
 
 Most previous studies of cranberry polyphenols have focussed on its effects on monospecies 
Streptococcus mutans biofilms [Duarte et al., 2006; Feng et al., 2013; Gregoire et al., 2007; Philip et 
al., 2019a]. To date, its influence on polymicrobial biofilms growing in a sucrose-rich environment 
has not been examined. There is also a need to ascertain whether cranberry phenols could promote 
beneficial microbial ecological changes in the biofilm. Thus, the present study was undertaken to 
explore whether standardized polyphenol-rich cranberry extracts could inhibit the cariogenic 
virulence properties of saliva-derived polymicrobial biofilms and the relative abundance of certain 
health- and caries-associated bacterial species. The null hypothesis of this study was that the 
cranberry extracts did not did not influence biofilm behaviour or its microbial composition. 
 
MATERIALS AND METHODS 
Cranberry Extracts 
High-quality organic extracts of cranberry were sourced from Diana Food (Champlain, QC, 
Canada), and used to treat the polymicrobial biofilms. As per the manufacturer’s data sheet, > 80% 
of the polyphenols in these cranberry extracts were A-linked proanthocyanidins (A-PACs), with 
modest amounts of different flavonols (e.g. quercetin, myricetin), anthocyanins, and phenolic acids 
making up the remainder. The polyphenol concentrations in these water-soluble, sugar-free 
cranberry extracts have been standardized by the manufacturer, ensuring uniform therapeutic 
effects. Based on previous studies of the same extracts against S. mutans biofilms, a concentration 
of 500 µg/mL was chosen [Philip et al., 2019a]. The cranberry extract was diluted in 0.15 M 
phosphate buffered saline (PBS; Gibco, Thermo Fisher Scientific, Paisley, UK) just prior to each 
treatment. The final pH of the treatment solution was in the range of 7.1-7.2. PBS was used as the 
vehicle control in the different assays. 
 
Saliva Collection 
With approval of the institutional ethics committee (approval number 2017001492), 
parafilm-stimulated whole saliva was collected from 16 caries-free healthy adult donors who had 
not used antibiotics/mouthwashes in the previous 3 months. The donors did not brush their teeth 
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the morning before saliva donation and abstained from food for 2 h prior to saliva donation. The 
saliva was pooled, diluted 2-fold with 60% sterile glycerol, dispensed into aliquots and stored at -
80°C as described previously [Exterkate et al., 2010; Huang et al., 2017]. 
 
Polymicrobial Biofilm Formation and Treatments 
 Saliva-derived polymicrobial dental biofilms were grown for 96 h on hydroxyapatite (HA) 
discs (9.5mm diameter x 2mm thick; Himed, New York, NY, USA) in the high-throughput Amsterdam 
Active Attachment (AAA) model [Exterkate et al., 2010]. Briefly, the HA discs were fitted to the 
custom-made AAA model lid such that each HA disc fitted into one well of a polystyrene 24-well flat-
bottomed microtiter plate. Prior to biofilm formation, and in order to partly replicate the salivary 
pellicle, the HA discs were coated with cell-free clarified human saliva as described previously [Philip 
et al., 2019a]. The saliva-coated HA discs (sHA) were moved to a 24-well plate containing 2 mL/well 
of the 500 µg/mL cranberry extract solution as a pre-treatment for 2 min. The pre-treated sHA discs 
were shaken gently to remove excess treatment solutions and transferred to a new 24-well plate 
containing the 2 mL/well of the biofilm inoculum.  The inoculation medium for the polymicrobial 
biofilms was a 50-fold dilution of the pooled saliva-glycerol mixture in the mucin-rich McBain 
medium [McBain et al., 2005] supplemented with 1% (w/v) sucrose.  The AAA model was then 
incubated anaerobically at 37°C in an orbital shaker at 80 rpm. The sucrose-containing growth 
medium was replenished every 8 h, while subsequent biofilm treatments took place every 12 h, until 
the end of the 96 h growth period. All treatment exposures were for 2 min, with the biofilm-laden 
HA discs dip-rinsed 5 times in PBS before each treatment to remove non-adherent cells. The biofilms 
were also rinsed post-treatment with PBS to remove any residual treatment solutions. 
 
Biofilm Analyses  
After the final treatment, the influence of the 500 µg/mL cranberry extract on the 96 h-old 
polymicrobial biofilms was assessed using different assays to estimate biofilm biomass, 
acidogenicity, exopolysaccharide (EPS)/microbial biovolumes, structural organization, and colony 
forming unit (CFU) counts. All the biofilm assays were performed in triplicate and repeated in 3 
independent experiments. The relative abundance of specific caries- and health-associated bacteria 
was estimated from duplicate biofilms obtained from 3 separate experiments using a real-time 
quantitative polymerase chain reaction (qPCR) assay. The assay procedures are briefly described 
below. 
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1. Biofilm biomass: Crystal violet (CV) assay 
 The CV assay was used to quantify biofilm biomass at 96 h. The biofilms were carefully rinsed 
in PBS three times and stained with 0.1% CV solution for 15 min at 25°C without shaking. After 
staining, the cells were again washed in PBS to remove excess stain and air-dried at room 
temperature. The discs with the stained biofilms were then transferred to a 24-well plate containing 
2 mL/well of 10% (v/v) acetic acid and incubated for 30 min at 25°C. At the end of the incubation 
period, 100 µL of the acetic acid solution was transferred to a 96-well plate and its absorbance 
measured at wavelength of 570 nm [Bandara et al., 2016].  
 
2. Acidogenicity: Acid production assay 
The biofilm bearing HA discs were transferred to a 24-well plate containing 2 mL/well of 
buffered peptone water (BPW, Merck, Darmstadt, Germany) supplemented with 0.2% sucrose and 
incubated anaerobically at 37°C for 3 h under anaerobic conditions. Lactic acid concentrations 
formed by the biofilms during this period was then determined using the lactate dehydrogenase 
assay [Exterkate et al., 2010].  
 
3. EPS/Microbial biovolumes and structural organization: Confocal microscopy 
 The effect of the cranberry extract on structure of the polymicrobial biofilms was evaluated 
by confocal microscopic imaging as described previously [Klein et al., 2011]. Briefly, 1 µM Alexa Fluor 
647-labeled dextran conjugate (647/668 nm; Thermo Fisher Scientific, Scoresby, Australia) was 
added to the culture medium to label the EPS component of the biofilm during the biofilm growth 
phase. Biofilm microbial components were labeled at the end of the growth period using 1 µM SYTO 
9 (480/500 nm; Thermo Fisher Scientific). The images were obtained using a spectral spinning disc 
confocal microscope (Nikon, Tokyo, Japan) at 5 randomly selected positions for each biofilm. Three 
dimensional (3D) renderings of biofilms and the quantification of EPS/microbial biovolumes was 
assessed with IMARIS 8.0 (Bitplane, Concord, MA, USA). The biovolume was defined as the volume 
of the biomass (µm3) divided by substratum surface area (µm2). The effect of the treatment and 
control solutions on biofilm structural architecture was assessed qualitatively from the confocal 3D 
images. 
 
4. Microbial counts 
The treated biofilms were dispersed in 1 mL sterile PBS by uniform vortexing at maximum 
speed for 1 min and serially diluted as previously described [Philip et al., 2019a]. Briefly, 50 µL 
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aliquots of the microbial suspensions were plated on tryptic soy agar blood plates and incubated 
anaerobically at 37°C for 48 h. Microbial colonies were counted from the dilution that allowed 
visualization of distinct isolated colonies. The CFU/mL values were calculated after correcting for 
the relevant dilution factor. 
 
5. Ecological effects: DNA extraction and real-time quantitative PCR (qPCR) 
The treated polymicrobial biofilms were dispersed as described previously for the CFU assay. 
Bacterial DNA was then extracted from the microbial suspension using the MO BIO Power Soil DNA 
Isolation Kit (MO BIO Laboratories, Carlsbad, CA, USA) following manufacturer’s instructions. RNA 
was removed using RNAse A (Thermo Fischer Scientific) and the amount of isolated DNA was 
quantified spectrophotometrically.  
 
The bacterial load of each of the 14 bacterial species of interest were determined using a 
custom-made qPCR array (16 x 24 format; Qiagen, Hilden, Germany). The bacteria selected included 
8 caries-associated bacterial species (Actinomyces gerensceriae, Lactobacillus gasseri, Streptococcus 
mutans, Streptococcus sobrinus, Streptococcus parasanguinis, Scardovia wiggsiae, Prevotella 
denticola and Veillonella parvula) and 6 health-associated commensal bacterial species 
(Streptococcus sanguinis, Streptococcus mitis/oralis, Steptococcus salivarius/thermophilus, 
Corynebacterium durum, Rothia aeria/dentocariosa and Neisseria flavescens). The target was the 
16S rRNA gene of the relevant bacterium, with probes designed using the GreenGene database for 
16S sequences. The DNA sample was mixed with a proprietary master mix and robotically dispensed 
into a 384-well plate (10µL/well, 7 ng DNA/well) containing freeze-dried primers and fluorogenic 
probes for each of the bacterial 16S rRNA genes tested. Arrays also contained a positive PCR control 
to test for inhibitors in the sample, and a non-template control to account for assay background. 
Reactions were performed with the 384-well plate QuantStudio™ 6 Flex Real-Time PCR sequence 
detection system (Thermo Fisher Scientific) with the following cycling conditions: enzymatic 
activation at 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec, and 60°C for 2 min. Data was 
analysed using the sequence detection system software (QuantStudio v1.3; Thermo Fisher 
Scientific). 
 
Statistical Analysis 
Depending on the normality of data distribution, either an independent sample t-test or the 
Mann-Whitney U-test was chosen to compare the cranberry- and control-treated biofilms for the 
biomass, acid production, EPS/microbial biovolumes, and CFU counts. Data was considered 
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statistically significant if the 2-tailed P-value was < 0.05. For the qPCR assay, the fold change of each 
bacterial amplicon in cranberry- versus control-treated biofilms was calculated using the 
comparative cycle threshold method (ΔΔCt). Briefly, for each sample, the Ct value of the individual 
bacterial species was normalized to the mean Ct value of all bacterial species (ΔCtbacteria species = 
Ctbacteria species – Ctmean of all bacterial species). The ΔΔCt for cranberry- versus control-treated biofilms was 
then calculated for each bacterial species as follows: ΔΔCt = ΔCtbacterial species (cranberry) – ΔCtbacterial species 
(control). Fold increase, or decrease, in abundance was calculated based on the formula 2- ΔΔCt. For each 
bacterial species, independent t-tests were performed to test for differences between the 
cranberry- and control-treated biofilms using the ΔCt values [Yuan et al., 2006]. P-values were 
considered significant only if they were less than the Simes critical P-value [Simes,1986]. Statistical 
software SPSS version 25 (IBM, New York, NY, USA) was used to perform the analyses. 
 
RESULTS 
Cranberry extract reduces biomass of polymicrobial biofilms 
The cranberry extract significantly inhibited (P < 0.001) the biomass of the 96 h polymicrobial 
biofilms, with the cranberry-treated biofilms showing 38% mean reduction in biomass compared to 
the control-treated biofilms (Table 11). 
 
Cranberry extract inhibited polymicrobial biofilm lactic acid production  
The cranberry extract caused a 44% reduction in lactic acid production (Table 11). Lactic acid 
concentrations of 6.2 ± 1.9 mM/L were produced from the cranberry-treated biofilms compared to 
the 11.2 ± 3.8 mM/L lactic acid generated from the control-treated biofilms (P < 0.001).  
 
Table 11. Inhibitory effects of polyphenol-rich cranberry extracts on biomass and acid production of 
polymicrobial biofilms 
 
Treatment Group 
Biofilm biomass (% change) 
(OD570) 
Lactic acid production (% change) 
(mM/L) 
Cranberry 
 
Control 
0.089 ± 0.01 (-38)* 
 
0.144 ± 0.02 
6.2 ± 1.9 (-44)* 
 
11.2 ± 3.8 
Biomass represents mean crystal violet absorbance values ± standard deviation (SD) at optical density (OD) of 570 nm. 
Lactic acid production of biofilms is in mM/L (mean ± SD). Data for both assays were obtained from three independent 
triplicate experiments (n = 9). Values in brackets represent percentage reduction of biofilm biomass/acid production 
compared to control. * indicates significant difference compared to vehicle control using independent sample-t-
test/Mann-Whitney U-test at confidence interval of 95% 
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Cranberry extract reduced EPS/microbial biovolumes and disrupted biofilm structure 
 The cranberry-treated biofilms showed significantly lower biovolumes for both the EPS and 
microbial biofilm components (Table 12), with the EPS/microbial biovolume ratios significantly 
lower than that of the control-treated biofilms (P = 0.033). 
 
The architecture of the cranberry-treated biofilms also appeared less compact, with distinct 
areas of porosity seen within the biofilm structure (Fig. 12). The 3D confocal images indicated that 
the cranberry extract altered the biofilm structural organization, with microcolonies (depicted in 
green) appearing more closely interspersed within the EPS matrix (depicted in red) in the control-
treated biofilms than in the cranberry-treated biofilms. 
 
Table 12. Quantitative analysis of biovolumes of polymicrobial biofilms from confocal images 
 
Treatment Group 
EPS biovolume 
(µm3/µm2) 
Microbial biovolume 
(µm3/µm2) 
Total biofilm biovolume 
(µm3/µm2) 
Cranberry 
 
Control 
1.14 ± 0.15* 
 
2.64 ± 0.56 
 
2.05 ± 0.55* 
 
3.82 ± 0.73 
3.19 ± 0.63* 
 
6.46 ± 1.19 
Biovolume data was quantified using IMARIS and represents mean values ± SD (n = 15) from 3 independent 
experiments. * indicates significant difference (P < 0.05) in cranberry-treated biofilms compared to control 
using independent sample t-test. 
 
 
 
 
Figure 12. Representative 3D confocal image stacks of polymicrobial biofilms 
Structural organisation of polymicrobial biofilms after treatment with A) 500 µg/mL of the cranberry extract and B) PBS 
control. Microbial colonies are depicted in green (SYTO 9) and EPS in red (Dextran, Alexa Fluor), with 20x magnification.  
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Cranberry extract lowered CFUs recovered from polymicrobial biofilms 
 Significantly fewer microbial colonies were recovered from the cranberry-treated biofilms 
compared to the control-treated biofilms (51% reduction, P = 0.001). The CFU/mL counts (mean ± 
S.D) were 4.9 x 107 ± 1.2 x 107 and 1.0 x 108 ± 3.2 x 107 for the cranberry- and control-treated biofilms 
respectively (Fig. 13). 
 
Figure 13. Box-plots of microbial colonies recovered from polymicrobial biofilms 
* indicates significantly lower CFU counts (P < 0.05) for the cranberry-treated biofilm compared to control-treated biofilms 
using the Mann-Whitney U-test (n = 9). 
 
Cranberry extract beneficially modulated microbial ecology of polymicrobial biofilms 
 The qPCR analysis demonstrated that compared to the control-treated biofilms, the 
cranberry-treated biofilms had significantly lower abundance of the caries-associated S. sobrinus 
(fold change 0.004, P = 0.002) and P. denticola (fold change 0.002, P < 0.001) (Fig. 14A), and 
significantly greater abundance of the health-associated S. sanguinis (fold change 90.715, P = 0.001) 
(Fig.14B). Two bacterial species (L. gasseri and S. parasanguinis) were not detected in any of the 
treated biofilms and hence were not included in the comparisons. For the other bacterial species, 
there was a consistent trend towards a reduction in caries-associated bacterial species (except for 
A. gerensceriae) and a fold increase for all the health-associated bacteria, however these changes 
were not statistically significant (Fig. 14). 
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Figure 14 (A and B). Fold change of bacterial species in cranberry- vs. control-treated biofilms 
A ratio below 1 indicates lower relative abundance; a ratio above 1 indicates higher relative abundance. * indicates statistically 
significant results after the Simes adjustment for multiple comparisons. P-values in brackets are from independent t-tests. 
 
DISCUSSION 
The results of the study indicate that the A-PAC-rich cranberry extract inhibited cariogenic 
virulence behaviour of polymicrobial biofilms and promoted a beneficial change in the microbial 
ecological balance of the biofilm. Such extracts could have value for inclusion into daily use oral care 
products to complement the remineralizing effects of fluoride, as part of a long-term caries 
management strategy. In the present study, saliva-derived polymicrobial biofilms were grown on 
HA discs in sugar-rich conditions to partly mimic the complexity of dental plaque developing under 
cariogenic environments. Pooled saliva from multiple donors ensured microbial diversity of the in 
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vitro polymicrobial biofilms. To maintain a cariogenic environment, the growth medium was 
replenished regularly with the sucrose supplemented growth medium.  
 
The CV assay results demonstrated that the cranberry extract reduced the biomass of the 
saliva-derived polymicrobial biofilms, consistent with the significant decreases observed in the 
biovolumes of EPS and microbial components. These changes likely reflect the inhibitory effects 
cranberry flavonols and A-PACs have on the S. mutans-derived glucosyltransferase (Gtf) 
exoenzymes. While the presence of sucrose in the biofilm growth environment enable Gtfs to 
rapidly assemble a glucan-rich EPS matrix, cranberry phenols can disrupt this process and thereby 
affect biofilm bulk and structural integrity. 3D confocal images confirmed that the cranberry extract 
altered the biofilm structural architecture. The cranberry polyphenol-mediated disruption to biofilm 
structural organization may render the biofilm less capable of maintaining acidic pH conditions at 
the tooth-biofilm interface. 
 
S. mutans, as the main producer of insoluble glucans among oral bacteria, plays the key role 
in orchestrating the EPS biofilm matrix. The glucan-rich EPS matrix resets the biofilm 
microenvironment for other “heavyweight” acidogenic-aciduric bacteria (e.g. certain lactobacilli, 
bifidobacteria, and some Scardovia spp.) to thrive and become established [Bowen et al., 2018; 
Burne, 2018; Hajishengallis et al., 2017]. Furthermore, the glucan-rich EPS scaffold also makes it 
difficult to mechanically remove plaque biofilms from tooth surfaces, while its physiochemical 
properties protect the embedded bacteria by reducing drug access and triggering antimicrobial 
tolerance [Bowen et al., 2018]. Previous studies have shown that cranberry A-PACs inhibited Gtf-
mediated glucan synthesis in S. mutans monospecies biofilms [Duarte et al., 2006; Feng et al., 2013; 
Gregoire et al., 2007; Philip et al., 2019a]. The current study indicates that polyphenol-rich cranberry 
extract lowered EPS biovolumes in polymicrobial biofilms too, and this could potentially result in a 
less pathogenic biofilm environment. 
 
Acidogenicity is another important characteristic of cariogenic biofilms. Sustained biofilm 
acid production not only favours enamel demineralization, but also results in microbial dysbiosis in 
the dental plaque biofilm. The present study demonstrated a significant decrease in lactic acid 
concentrations from the polymicrobial biofilms treated with the cranberry extract. Specific 
cranberry flavonoids like the low molecular weight A-PAC dimer (called procyanidin A2) have been 
shown to affect intracellular bacterial glycolytic enzymes, while larger A-PAC oligomers can have 
deleterious effects on membrane components of the glycolytic pathway [Duarte et al., 2006; 
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Gregoire et al., 2007]. These mechanisms could account for the reduced lactic acid concentrations 
produced from the cranberry-treated biofilms. Curbing bacterial acid production would result in a 
more homeostatic environment for the optimal functioning of non-aciduric commensal organisms 
thereby preventing the emergence of highly aciduric organisms in the biofilm microbial community. 
 
The reduced microbial counts observed in the CFU assay and confirmed in the lower 
microbial biovolumes from the confocal biofilm images are intriguing observations. Several studies 
have demonstrated that cranberry polyphenols did not have inhibitory effects on microbial growth 
or viability [Duarte et al., 2006; Girardot et al., 2014; Koo et al., 2010; Philip et al., 2019a; Weiss et 
al., 2004]. A likely reason for the present findings is the anti-adhesion effects of flavonoids present 
in the cranberry extract, rather than any biocidal effects. Initial bacterial adhesion to the saliva-
coated HA surfaces may have been impeded since cranberry polyphenols are known to irreversibly 
bind to salivary proteins, thereby affecting pellicle-mediated adhesion [Bennick, 2002; Girardot et 
al., 2014]. In addition, high-molecular weight cranberry fractions can also interact with bacterial cell 
surface proteins, reducing their hydrophobicity, and thus hindering their adhesion to tooth surfaces 
[Weiss et al., 2004; Yamanaka et al., 2004]. The A-PAC-mediated inhibition of glucan synthesis can 
also significantly affect adhesion, as the α1,6-linked glucans are known to provide ample sites for 
microbial adhesion and co-aggregation [Koo et al., 2010].  Together, these mechanisms could have 
impaired bacterial adhesion to saliva-coated HA surfaces and to the developing biofilm, explaining 
the lower CFUs recovered from the cranberry-treated biofilms. 
 
Within the limitations of the experimental conditions used, it is notable that the cranberry 
extract was able to influence the microbial ecology of the polymicrobial biofilms. The selection of 
the bacterial profile for the qPCR analysis was based on previous studies that identified bacterial 
species commonly associated with dental caries or with health [Aas et al., 2008; Becker et al., 2002; 
Gross et al., 2012; Tanner et al., 2016]. The polymicrobial biofilms treated with the cranberry extract 
showed significantly lower relative abundance of two caries associated bacteria (P. denticola and S. 
sobrinus) compared to the control-treated biofilms. P. denticola showed the highest fold decrease 
among all the caries-associated bacteria assessed in the qPCR assay. This Prevotella species has been 
associated both with initial white spot lesions as well as with advanced dentinal lesions [Chhour et 
al., 2005; Tanner et al., 2016; Torlakovic et al., 2012]. S. sobrinus is often found as a co-colonizer 
with S. mutans, and these species are collectively referred to as mutans streptococci [Gross et al., 
2012]. The pathogenic potential of S. sobrinus has been established in several studies and its co-
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colonization with S. mutans has been consistently associated with greater caries risk [Choi et al., 
2009; Okada et al., 2005]. S. sobrinus has also been shown to have higher acidogenic potential than 
S. mutans [de Soet et al., 1989], and this could explain why caries increment in children with both 
S. mutans and S. sobrinus was found to be four times higher than those with S. mutans alone [Okada 
et al., 2005]. Furthermore, unlike S. mutans, S. sobrinus is not detected in plaque of caries-free 
subjects, suggesting it may be a more specific predictor of the disease than S. mutans [Gross et al., 
2012]. The qPCR results did indicate a fold decrease for S. mutans in the cranberry-treated biofilm, 
although its relative abundance in the cranberry- vs. control-treated biofilms was not significant 
(fold change 0.238, P = 0.055). The lack of significance could possibly be due to the fact that S. 
mutans is usually present, albeit in lower numbers, even in health-associated saliva or plaque.  
 
Among the bacteria associated with health, levels of S. sanguinis was found to be 
significantly higher in the cranberry-treated biofilm than in the control-treated biofilm. S. sanguinis 
is known to have a well-established arginine deaminase (ADS) activity that can elevate biofilm pH 
through ammonia and CO2 production from salivary and dietary substrates [Nascimento, 2018]. The 
elevated pH not only neutralizes acids produced from carbohydrate metabolism, but also creates 
an environment that favours growth of health-associated, acid-sensitive bacteria over cariogenic 
aciduric bacteria [Burne, 2018]. Thus, the observed increase in S. sanguinis numbers in the 
cranberry-treated biofilms should be beneficial for the microbiome. All the other health-associated 
bacteria also showed fold increases in the cranberry-treated biofilm, although these changes were 
not statistically significant.  
 
A common problem with using natural products as therapeutic agents is their compositional 
variability due to their geographical location, seasonal influences, and time of harvest. In this regard, 
cranberry is a particularly feasible and sustainable source of standardized bioactive compounds, as 
it is a chemically and genetically well-characterized fruit, with highly standardized methods for 
extracting the biologically active components (Koo et al, 2010).  
 
CONCLUSIONS 
In summary, the inhibitory effects of the cranberry extract on biofilm acidogenicity, EPS 
biovolumes, microbial adhesion, and structure architecture is likely to have also effected a beneficial 
modulation of the microbial populations of polymicrobial biofilms. There is a need for well-designed 
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clinical trials to evaluate whether the proposed cariostatic effects of cranberry phenols can translate 
into reversing the microbiome dysbiosis and preventing dental caries in high-risk patients.  
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4.5  SCIENTIFIC PAPER 5 
 
Casein Phosphopeptide-Amorphous Calcium Phosphate Attenuates Virulence and 
Modulates Microbial Ecology of Saliva-derived Polymicrobial Biofilms  
 
This study investigated the effects of CPP-ACP on saliva-derived- polymicrobial biofilms 
growing in a cariogenic environment. 
 
The paper was published on 4th June 2019 in Caries Research, the official publication of 
the European Organisation for Caries Research (ORCA). 
 
Caries Res 2019; DOI: 10.1159/000499869. 
 
This chapter is comprised of the publication as it stands in print.  
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ABSTRACT 
Background: Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) acts as a salivary 
biomimetic that provides bioavailable calcium and phosphate ions to augment fluoride-mediated 
remineralization of early caries lesions. However, there are indications that it may also have 
virulence attenuating and beneficial ecological effects on the oral microbiome. 
 
Purpose: This in vitro study investigated whether CPP-ACP could influence acidogenicity, microbial 
counts, and relative abundance of specific caries-and health-associated bacterial species in 
polymicrobial biofilms. 
 
Methods: Saliva-derived polymicrobial biofilms were grown for 96 h in a cariogenic environment 
and treated every 12 h with 2% CPP-ACP or vehicle control. Acidogenicity and colony forming units 
(CFUs) and were estimated from the treated biofilms. Microbial ecological effects of CPP-ACP were 
assessed based on the relative abundance of 14 specific caries- and health-associated bacterial 
species using a real-time quantitative PCR assay. 
 
Results: CPP-ACP-treated biofilms showed relatively modest, but significant reductions, in 
acidogenicity (33% reduction, P < 0.001) and microbial CFUs (21% reduction, P = 0.008), compared 
to the control-treated biofilms. The CPP-ACP treated biofilms also exhibited significantly lower 
bacterial loads of cariogenic Scardovia wiggsiae (fold change 0.017, P < 0.001) and Prevotella 
denticola (fold change 0.005, P < 0.001), and higher bacterial loads of commensal Streptococcus 
sanguinis (fold change 30.22, P < 0.001), Streptococcus mitis/oralis (fold change 9.66, P = 0.012), 
and Steptococcus salivarius/thermophilus (fold change 89.35, P < 0.001) than the control-treated 
biofilms. 
 
Conclusions: The results indicate that CPP-ACP has cariogenic virulence-attenuating attributes that 
can influence a beneficial microbial ecological change in the biofilm.  
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INTRODUCTION 
A symbiotic oral microbiome delivers important health benefits and plays a critical role in 
preventing dysbiosis-mediated oral diseases like dental caries [Marsh, 2018]. Dental caries is now 
widely recognised as a disease triggered by dysbiosis in the plaque biofilm and maintaining microbial 
ecological balance in dental plaque is critical for long-term control over the disease [Burne, 2018; 
Philip et al., 2018]. While acids produced from bacterial glycolysis of dietary carbohydrates can 
favour the dominance of acidogenic/aciduric bacteria in the plaque biofilm, health-associated 
plaque microflora can re-establish the homeostatic balance by producing alkali metabolites to 
neutralise the acid [Nascimento, 2018]. This evolving view of ecological battles and polymicrobial 
synergies has important implications for developing effective therapeutics against dental caries 
[Bowen et al., 2018]. 
 
Fluoride is without doubt the gold standard among remineralizing agents used for caries 
prevention. However, recent clinical studies have shown that it has minimal effects on the 
microbiome ecology [Adams et al., 2017; Koopman et al., 2015; Reilly et al., 2016; Reilly et al., 2014]. 
This suggests the need for additional ecological measures to supplement the predominantly 
physicochemical cariostatic effects of fluoride, especially in high caries-risk individuals [Philip et al., 
2018]. Although biocides like chlorhexidine have been used in the past for caries control, their 
broad-spectrum of antimicrobial action tend to indiscriminately eliminate even health-associated 
commensals.  A delicate balance has to be achieved to control oral microflora at levels compatible 
with health [Marsh et al., 2015].  
 
Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), a naturally derived milk 
protein-based remineralizing technology, may hold greater promise in effecting a beneficial shift in 
the dental plaque microbial ecology. While there is a growing body of evidence that supports the 
use of CPP-ACP to augment remineralizing effects of fluoride [Philip, 2019], there have also been 
suggestions that it could potentially have ecological effects on dental plaque too [Philip and Walsh, 
2019]. Several clinical trials have shown that regular use of CPP-ACP reduced mutans streptococci 
(MS) levels in saliva [Emamieh et al., 2015; Plonka et al., 2013; Pukallus et al., 2013; Subramanian 
and Naidu, 2009; Yetkiner et al., 2014]. This interference with cariogenic bacteria may beneficially 
modulate the virulence of dental plaque and enable health-associated commensals to thrive. 
However, these previous studies have in general used a single bacterial species (usually 
Streptococcus mutans) as the surrogate marker for dental plaque ecology. For ecological caries 
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control, it is more relevant to know the influence of CPP-ACP on a range of health- and disease-
associated bacteria. Hence, this in vitro study was designed to investigate whether CPP-ACP could: 
1) inhibit acidogenicity and microbial numbers of saliva-derived polymicrobial biofilms growing in a 
cariogenic environment; and 2) effect the relative abundance of specific caries- and health-
associated bacterial species in these polymicrobial biofilms. 
 
MATERIALS AND METHODS 
Test Agent 
A 15% aqueous solution of CPP-ACP was sourced from GC Corporation (Tokyo, Japan) and 
diluted to 2% for testing against the saliva-derived polymicrobial biofilms. The concentration was 
chosen to represent what would be achieved in the oral cavity with the dilution by saliva of a topical 
crème containing 10% CPP-ACP. As the test solution of CPP-ACP contained a sodium benzoate 
preservative, a 0.1% (w/v) sodium benzoate solution was used for control comparisons. 
 
Saliva Collection 
With institutional ethics approval (approval number 2017001492), parafilm-stimulated 
whole human saliva was collected from 16 caries-free healthy adult donors. The study participants 
did not brush their teeth the morning before saliva donation and abstained from food for 2 h prior 
to saliva donation. The donors and had no history of using antibiotics/mouthwashes in the previous 
3 months. The collected saliva was pooled, diluted 2-fold in 60% sterile glycerol, dispensed into 
aliquots, and stored at -80°C.  
 
Polymicrobial Biofilm Formation and Treatments 
 The high-throughput Amsterdam Active Attachment (AAA) model [Exterkate et al., 2010] 
was used to grow the saliva-derived polymicrobial biofilms. The biofilms were grown for a total of 
96 h on hydroxyapatite (HA) discs (9.5mm diameter x 2mm thick; Himed, New York, NY, USA). 
Briefly, the HA discs were fitted to the custom-made AAA model such that each HA disc fitted into 
one well of a 24-well flat-bottomed microtiter plate (Costar 3526, Sigma-Aldrich, New York, NY, 
USA). To partly replicate the salivary pellicle coating, the HA discs were initially conditioned with 
filter-sterilized clarified human saliva for 1 h at 37°C immediately prior to biofilm formation, as 
described previously [Philip et al., 2019a]. The saliva-coated HA discs (sHA) were then moved to a 
24-well plate containing 2 mL/well of 2% CPP-ACP or the vehicle control solution, and treated for 10 
min. The pre-treated sHA discs were shaken gently to remove excess treatment solutions, and 
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transferred to a new 24-well plate containing the 2 mL/well of the biofilm inoculum and incubated 
anaerobically at 37°C in an 80 rpm orbital shaker for a total of 96 h. The inoculation medium was a 
50-fold dilution of the pooled saliva in the mucin-rich McBain medium [McBain et al., 2005] 
supplemented with 1% (w/v) sucrose. The sucrose-containing growth medium was replenished 
every 8 h to provide a constant cariogenic challenge. Subsequent biofilm treatments took place 
every 12 h, until the end of the 96 h growth period. All treatment exposures were for 10 min, with 
the biofilm-laden HA discs dip-rinsed 5 times in phosphate buffered saline (PBS; Gibco, Thermo 
Fisher Scientific, Paisley, UK) prior to treatment to remove non-adherent cells. The biofilms were 
similarly rinsed post-treatment also to remove any residual treatment solutions. 
 
Biofilm Assays 
 At the end of the biofilm growth period, the effect of CPP-ACP on the acidogenicity was 
estimated using a lactic acid production assay, while effects on microbial viability were assessed by 
counting the colony forming units (CFUs) recovered from the treated biofilms. These biofilm assays 
were performed in triplicate and repeated in three independent experiments. The ecological effects 
of CPP-ACP on the polymicrobial biofilms were assessed based on the relative abundance of certain 
specific caries- and health-associated bacteria obtained from three independent duplicate biofilm 
experiments using a real-time quantitative PCR (qPCR) assay. 
 
 For estimating biofilm acidogenicity, the biofilm-bearing HA discs were placed in a 24-well 
plate containing 2 mL/well of buffered peptone water (Merck, Darmstadt, Germany) supplemented 
with 0.2% sucrose. The model was then incubated anaerobically for 3 h at 37°C to allow acid 
formation. The amount of lactic acid generated during this period was calculated by means of a 
standard curve colorimetric assay using a lactate dehydrogenase enzymatic method [Exterkate et 
al., 2010]. 
 
 To assess microbial populations, the HA discs with the biofilms were gently detached from 
the AAA model lid and transferred to sterile tubes containing 1 mL PBS. The biofilms were dispersed 
by uniform vortexing at maximum speed for 1 min and a series of dilutions made. A 50 µL aliquot of 
the microbial suspensions was plated on tryptic soy agar blood plates using an automatic spiral 
plater (Autoplate; Advanced Instruments, Norwood, MA, USA) and incubated anaerobically at 37°C 
for 48 h. Microbial colonies were counted from the dilution that allowed visualization of distinct 
colonies and the CFU/mL values calculated after correcting for the dilution factor. 
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For the qPCR assay, the treated polymicrobial biofilms were dispersed as described 
previously for the CFU assay. Bacterial DNA was then extracted from the microbial suspension using 
the MO BIO Power Soil DNA Isolation Kit (MO BIO Laboratories, Carlsbad, CA, USA) following 
manufacturer’s instructions. RNA was removed using RNAse A (Thermo Fischer Scientific, Scoresby, 
Australia) and the amount of isolated DNA was quantified spectrophotometrically. The bacterial 
load of 14 bacterial species were determined using a custom-made qPCR array (16 x 24 format; 
Qiagen, Hilden, Germany). The bacteria selected included 8 caries-associated bacterial species 
(Actinomyces gerensceriae, Lactobacillus gasseri, Streptococcus mutans, Streptococcus sobrinus, 
Streptococcus parasanguinis, Scardovia wiggsiae, Veillonella parvula, and Prevotella denticola) and 
6 health-associated commensal bacterial species (Streptococcus sanguinis, Streptococcus 
mitis/oralis, Steptococcus salivarius/thermophilus, Corynebacterium durum, Rothia 
aeria/dentocariosa, and Neisseria flavescens). The assay used the 16S rRNA gene of the relevant 
bacterium, with the proprietary probes designed using the GreenGene database for 16S sequences 
[DeSantis et al. 2006]. The DNA sample was mixed with a proprietary master mix and robotically 
dispensed into a 384-well plate (10µL, 7 ng DNA/well) containing freeze-dried primers and 
fluorogenic probes for each of the bacterial 16S rRNA genes tested. Arrays also contained a positive 
PCR control to test for inhibitors in the sample, and a non-template control to account for assay 
background. Reactions were performed with the 384-well plate QuantStudio™ 6 Flex Real-Time PCR 
sequence detection system (Thermo Fisher Scientific) with the following cycling conditions: 
enzymatic activation at 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec, and 60°C for 2 min. 
Data were analysed using the sequence detection system software (QuantStudio v1.3; Thermo 
Fisher Scientific). 
 
Statistical Analysis 
 For the lactic acid assay and CFU counts, depending on the normality of data distribution, an 
independent sample t-test or the Mann-Witney U-test was performed to detect any statistical 
difference between the CPP-ACP and control-treated biofilms. For the qPCR assay, the fold change 
of each bacterial amplicon in CPP-ACP- versus control-treated biofilms was calculated using the 
comparative cycle threshold method (ΔΔCt). Briefly, for each sample, the Ct value of the individual 
bacterial species was normalized to the mean Ct value of all bacterial species (ΔCtbacteria species = 
Ctbacteria species – Ctmean of all bacterial species). The ΔΔCt for CPP-ACP- versus control-treated biofilms was 
then calculated for each bacterial species as follows: ΔΔCt = ΔCtbacterial species (CPP-ACP) – ΔCtbacterial species 
(control). Fold increase, or decrease, in abundance was calculated based on the formula 2- ΔΔCt. For each 
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bacterial species, independent t-tests were performed to test for differences between the CPP-ACP- 
and control-treated biofilms using the ΔCt values [Yuan et al., 2006]. P-values were considered 
significant only if they were less than the Simes critical P-value [Simes, 1986]. Statistical software 
SPSS version 25 (IBM, New York, NY, USA) was used to perform the analyses. 
 
RESULTS 
Biofilm acidogenicity 
The polymicrobial biofilms treated with CPP-ACP demonstrated a significant reduction in 
acidogenicity compared to the control-treated biofilms (33% reduction, P < 0.001), with mean lactic 
acid concentrations of 3.6 ± 1.1 mM/L and 5.3 ± 1.2 mM/L respectively (Table 13).  
 
Table 13. Effect of CPP-ACP on lactic acid production of polymicrobial biofilms 
 
Treatment Group 
Lactic acid production (% change) 
(mM/L) 
CPP-ACP 
 
Control 
3.6 ± 1.1 (-33)* 
 
5.3 ± 1.2 
Lactic acid production data (mean ± SD) is from three independent triplicate experiments. 
Values in brackets represent percentage reduction in acid production compared to control. 
* indicates significant difference using independent sample t-test at 95% confidence interval. 
 
Biofilm microbial counts 
 Total CFUs recovered from the CPP-ACP-treated biofilms were significantly lower (P = 0.008) 
compared to the microbial colonies obtained from the control-treated biofilms. The mean CFU 
counts were 7.9 x 107 ± 1.2 x 107 and 1.0 x 108 ± 1.1 x 107 for the CPP-ACP- and control-treated 
biofilms respectively (Fig. 15). 
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Figure 15. Box-plots of microbial colonies recovered from polymicrobial biofilms 
* indicates significantly different CFU values (P < 0.05) for the CPP-ACP-treated biofilm compared to control-treated biofilms. 
 
 
Biofilm ecological effects 
 Compared to the controls, the CPP-ACP-treated biofilms had significantly lower abundance 
for two caries-associated bacterial species: P. denticola (fold change 0.005, P < 0.001) and S. 
wiggsiae (fold change 0.017, P < 0.001). All the other caries-associated bacteria (except for L. 
gasseri) also showed fold decreases but this did not reach statistical significance (Fig. 16A). Among 
the health-associated commensals, S. sanguinis (fold change 30.22, P < 0.001), S. mitis/oralis group 
(fold change 9.66, P < 0.012), and the S. salivarius/thermophilus group (fold change 89.35, P < 0.001), 
were detected significantly more abundantly in the CPP-ACP-treated biofilms than in the control-
treated biofilms (Fig. 16B). S. parasanguinis was not detected in any of the biofilm samples and was 
not included in the comparison.  
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Figure 16 (A and B). Fold change of bacterial species in CPP-ACP- vs. control-treated biofilms 
A ratio below 1 indicates lower relative abundance; a ratio above 1 indicates higher relative abundance. * indicates statistically 
significant results after the Simes adjustment for multiple comparisons. P-values in brackets are from independent t-tests. 
 
DISCUSSION 
 Dental caries is a polymicrobial biofilm-mediated disease triggered by environmentally-
induced dysbiosis in the resident oral microbiome [Marsh, 2015]. If the dysbiosis is not reversed it 
can lead to bacterial acid-mediated demineralization of the dental hard tissues and ultimately result 
in clinical cavitation. Comprehensive caries prevention protocols should therefore encompass not 
only agents that can affect the de-/remineralization balance, but also include measures that can 
maintain or restore the ecological equilibrium in the oral microbiome. The current study provides 
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evidence of the beneficial ecological effects of CPP-ACP on complex polymicrobial biofilms and 
extends the recent findings of CPP-ACP ecological effects on multispecies biofilm comprised of 6 
bacterial species growing in a highly cariogenic environment [Dashper et al., 2018]. The present 
study also provides in vitro evidence that CPP-ACP can inhibit lactic acid production and microbial 
numbers in saliva-derived polymicrobial biofilms. 
 
 The AAA model used in this study has been shown to maintain reproducible, complex, and 
actively attached microbial biofilms in a habitat similar to dental plaque [Exterkate et al., 2010; ten 
Cate, 2015]. Pooled saliva from several individuals was used as the biofilm inoculum to improve the 
microbial diversity of the in vitro polymicrobial biofilms. A cariogenic environment was created by 
regular replenishment of the sucrose-supplemented growth medium. The 10 min treatment time 
was chosen as CPP-ACP crèmes are intended to remain in the oral cavity until salivary clearance. 
Selection of the bacteria for the qPCR assay was based on profile studies of bacterial species 
commonly associated with dental caries and health [Aas et al., 2008; Becker et al., 2002; Burne and 
Marquis, 2000; Gross et al., 2012; Kianoush et al., 2014; Richards et al., 2017; Takahashi, 2015; 
Tanner et al., 2016].  
 
 The present study demonstrated a significant, though relatively modest, reduction in biofilm 
acidogenicity in the CPP-ACP-treated biofilms compared to the control-treated biofilms. It is possible 
that treating the biofilms for a longer duration than the 96 h of this study could have resulted in 
greater reductions in biofilm lactic acid concentrations.  In fact, several clinical studies have shown 
that regular use of CPP-ACP had pronounced buffering effects on salivary and plaque pH [Caruana 
et al., 2009; Heshmat et al., 2014a; Heshmat et al., 2014b; Marchisio et al., 2010; Ozdas et al., 2015; 
Peric et al., 2015].  The buffering mechanisms of CPP-ACP are likely to be due to its ability to act as 
a reservoir of peptides and phosphate ions which can offset any drop in biofilm pH [Philip and Walsh, 
2019]. The catabolism of certain CPP amino acids (e.g. glutamine, asparagine) by bacterial 
peptidases would buffer against a pH fall through the production of ammonia [Reynolds and Riley, 
1989]. The CPP phosphoseryl residues that are more resistant to hydrolysis readily accept protons 
and neutralize plaque acids [Reynolds, 1987]. Furthermore, the inorganic phosphate (PO43-) and 
organic phosphate (-O-PO32-) ions in the CPP-ACP nanocomplex can also contribute to elevating 
salivary/plaque pH [Dashper et al., 2018]. The buffering influence of CPP-ACP is thus an important 
virulence-attenuating attribute, creating a biofilm microenvironment that provides a selective 
ecological advantage to acid-sensitive commensal organisms. 
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 A small but significant decrease in the total CFUs recovered from the CPP-ACP-treated 
polymicrobial biofilms was also seen in the current study. The lower microbial counts are likely to 
be due to the anti-adhesion effects of CPP-ACP, as the product is not known to have bactericidal or 
bacteriostatic effects. In vitro studies have demonstrated a rapid saturation of saliva-coated 
hydroxyapatite surfaces by casein complexes inhibiting the adherence of S. mutans and S. sobrinus 
[Erdem et al., 2011; Reynolds and Wong, 1983; Schüpbach et al., 1996; Vacca-Smith et al., 1994]. 
CPP-ACP was also shown to bind both to dental plaque (with a strong affinity for S. mutans) and to 
pellicle macromolecules adsorbed on the tooth surface [Reynolds et al., 2003; Rose, 2000b; Rose, 
2000a]. The anti-adhesion effects of CPP-ACP may have a number of mechanisms. CPP-ACP is known 
to compete with free calcium for plaque calcium binding sites, reducing the degree of calcium 
bridging between the pellicle and adhering cells and between the bacterial cells themselves [Rose, 
2000b]. CPP molecules can also mask the bacterial cell surface hydrophobic proteins and thereby 
impede the initial adhesion to pellicle-coated surfaces. The anti-adhesion effects of CPP-ACP could 
be the reason for the reduced levels of MS that have been observed in various clinical trials 
[Emamieh et al., 2015; Plonka et al., 2013; Pukallus et al., 2013; Subramanian and Naidu, 2009; 
Yetkiner et al., 2014]. Disruption of bacterial adhesion can impair the ability of cariogenic bacteria 
to recruit other key players during biofilm formation and prevent the establishment of a cariogenic 
biofilm [Simon-Soro and Mira, 2015].  
 
 The qPCR analysis provides evidence that CPP-ACP beneficially modulated the microbial 
ecology of the CPP-ACP-treated polymicrobial biofilms. In the present study, CPP-ACP was able to 
effect significantly lower relative abundance of S. wiggsiae and P. denticola compared to the 
control-treated biofilm. S. wiggsiae has been associated with severe early childhood caries and 
orthodontic white spot lesions [Tanner et al., 2011; Tanner et al., 2012], while P. denticola has been 
associated with initial enamel lesions [Chhour et al., 2005; Tanner et al., 2016; Torlakovic et al., 
2012].  S. mutans also showed a fold decrease in the CPP-ACP-treated biofilm, but this did not reach 
the threshold for statistical significance. It has been suggested that when “heavyweight” aciduric 
bacteria such as S. wiggsiae begin to dominate, the relative numbers of S. mutans tend to decrease, 
as the biofilm pH is driven to below what can be tolerated by even S. mutans [Burne, 2018]. This 
could be the reason why significant differences in relative abundance of S. mutans were not seen 
between the CPP-ACP- and control-treated biofilms. 
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 The three health-associated bacterial species (S. sanguinis, S. mitis, S. salivarius) that showed 
significant fold increases in the CPP-ACP-treated biofilms possess systems actively engaged in 
biofilm pH homeostasis. S. sanguinis and S. mitis are known to express arginine deaminase system 
(ADS) activity that can effectively neutralize acids produced from carbohydrate metabolism [Burne 
and Marquis, 2000; Nascimento, 2018]. S. salivarius is among the relatively small number of oral 
bacteria that encode urease enzymes that also play a role in elevating resting plaque pH [Burne et 
al., 2012]. Endogenous NH3 production via ADS or ureases also provides bioenergetic advantages to 
health-associated bacterial species that are likely to influence plaque ecology and competitiveness 
of commensals [Burne, 2018].  
  
CONCLUSIONS   
A better understanding of oral microbial ecology, especially the importance of the balance 
between cariogenic and commensal microflora, has highlighted the need to develop strategies to 
modulate the microbial composition of dental plaque for caries prevention [Marsh et al., 2015]. 
Measures that help maintain a symbiotic oral microbiome would be particularly beneficial for long-
term control over dental caries in high caries-risk patients. CPP-ACP may hold particular promise in 
this regard as not only can it boost the remineralizing effects of fluoride, but the results of this study 
indicate that it may have beneficial microbial ecological effects too. Future clinical trials are required 
to ascertain whether these in vitro effects can translate to a clinical environment. 
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Study 5: Colony Forming Unit (CFU) assay on 96 h polymicrobial biofilms 
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Study 5: qPCR assay on 96 h polymicrobial biofilms 
 
Cycle threshold (Ct) values for each bacterial species 
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4.6  SCIENTIFIC PAPER 6 
 
Randomised Controlled Study to Evaluate Microbial Ecological Effects of Casein 
Phosphopeptide-Amorphous Calcium Phosphate and Cranberry on Dental Plaque 
 
This clinical study investigated the microbial ecological effects of dentifrices containing 
CPP-ACP and polyphenol-rich cranberry extracts on dental plaque. 
 
The paper was published in JDR Clinical and Translational Research, the official 
publication of the International Association of Dental Research (IADR).  
 
JDR Clin Trans Res 2019; DOI: 10.1177/2380084419859871. 
 
This chapter is comprised of the publication as it stands in print.  
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ABSTRACT 
Introduction: Ecological approaches to dental caries prevention play a key role in attaining long-
term control over the disease and maintaining a symbiotic oral microbiome. 
 
Objectives: This study aimed to investigate the microbial ecological effects of two interventional 
dentifrices: a casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) dentifrice, and the 
same dentifrice supplemented with a commercial polyphenol-rich cranberry extract. 
 
Methods: The interventional toothpastes were compared with each other and with an active control 
fluoride dentifrice in a double-blinded randomised controlled trial. Real-time quantitative PCR 
(qPCR) analysis was used to determine changes in the bacterial loads of 14 key bacterial species (8 
caries-associated and 6 health-associated) in the dental plaque of trial participants after they used 
the dentifrices for 5-6 weeks.  
 
Results: From the baseline to the recall visit, significant differences were observed between the 
treatment groups in the bacterial loads of two caries-associated bacterial species S. mutans (P < 
0.001) and V. parvula (P < 0.001) and three health-associated bacterial species C. durum (P = 0.008), 
N. flavescens (P = 0.005), and S. sanguinis (P < 0.001). Compared to the fluoride control dentifrice, 
the CPP-ACP dentifrice demonstrated significant differences for S. mutans (P = 0.032), C. durum (P 
= 0.007) and S. sanguinis (P < 0.001), while the CPP-ACP – cranberry combination dentifrice showed 
significant differences with the control dentifrice for S. mutans (P < 0.001), V. parvula (P < 0.001), 
N. flavescens (P = 0.003) and S. sanguinis (P < 0.001). However, no significant differences were seen 
in the bacterial load comparisons between the CPP-ACP and combination dentifrices for any of the 
targeted bacterial species (P > 0.05).  
 
Conclusions: Overall, the results indicate that dentifrices containing CPP-ACP and polyphenol-rich 
cranberry extracts can influence a species level shift in the microbial ecology of dental plaque 
resulting in a microbial community less associated with dental caries.  
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INTRODUCTION 
The oral cavity harbours one of the most diverse microbiomes in the human body with over 
700 different microbial species identified to date. When in equilibrium, the diversity of the 
endogenous oral microbial community not only prevents outgrowth of any single species or 
colonisation by exogenous pathogens, but also contributes to critical metabolic, physiological and 
immunological functions [Marsh, 2018]. Despite daily physical and chemical perturbations, a normal 
healthy microbiome exhibits remarkable long-term stability and is characterised by commensalism 
and mutualism with the host [Zaura et al., 2014]. However, adverse local environmental conditions 
(e.g. frequent exposure to dietary sugars, poor oral hygiene or salivary dysfunction) can result in the 
breakdown of this symbiotic relationship and onset of diseases like dental caries. 
 
Dental caries is a polymicrobial disease caused by dysbiosis in the dental plaque biofilm, with 
microbial community shifts driven by environmental acidification [Takahashi and Nyvad, 2008, 
2011].  If the environmental acidic stress persists, acidogenic and aciduric bacteria will outcompete 
health-associated commensals and create multiple low-pH niches within the biofilm 
microenvironment. Health-associated commensal microorganisms can counter the acidic conditions 
through the production of alkaline compounds that attempt to maintain plaque pH values near 
neutrality [Bowen et al., 2018; Nascimento, 2018]. The ecological battles between the opportunistic 
cariogenic pathogens and the health-associated commensals will determine whether incipient 
lesions caused by acid-induced mineral loss from susceptible tooth surfaces will progress to 
cavitation or can be remineralized. 
 
Fluoride will continue to remain the gold standard for caries prevention. However, the 
cariostatic effects of fluoride are principally due its physiochemical effects on the de-
/remineralization equilibrium, suggesting the need for additional ecological measures to 
complement fluoride effects on hard dental tissues. Mechanical plaque control using fluoride 
dentifrices alone is not likely to reverse the plaque dysbiosis responsible for the disease. Recent 
studies have shown that even high fluoride concentrations could not sustain antimicrobial activity 
against plaque biofilm metabolism [Dang et al., 2016; Souza et al., 2018]. Clinical trials have 
confirmed that fluoride alone was not able to effect significant changes in dental plaque microbial 
composition [Adams et al., 2017; Koopman et al., 2015; Reilly et al., 2016; Reilly et al., 2014]. This 
could be one of the reasons why caries persists in high-risk individuals and population groups 
despite the widespread use of fluoride products.  
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A variety of antimicrobial agents have also been used in the past for caries prevention. 
However, the use of broad-spectrum biocides (e.g. chlorhexidine) indiscriminately eradicates even 
commensal bacteria that are beneficial to health. Moreover, because of their adverse side-effects, 
such agents may not be suitable for daily use. Once the chemotherapeutic intervention stops, 
susceptible tooth surfaces are often repopulated with a microbiome similar in composition to the 
one that was eliminated [Burne, 2018]. Strategies that target cariogenic virulence properties within 
a pathogenic biofilm, rather than broadly affecting microbial viability, would thus be preferable to 
conventional antimicrobials for beneficially modulating and maintaining a healthy microbiome. 
 
Comprehensive caries management protocols should therefore encompass agents that can 
influence the de-/remineralization balance as well as measures that have a moderating influence on 
acidogenic oral bacteria. In this regard, casein phosphopeptide-amorphous calcium phosphate (CPP-
ACP) is of interest as not only can it augment the remineralizing effects of fluoride, but it can also 
potentially exert a beneficial effect on the microbial ecology of dental plaque [Philip and Walsh, 
2019]. Recent in vitro studies have demonstrated that CPP-ACP treatment was able to effect a 
decrease in the abundance of caries-associated bacteria and a concomitant increase in the 
abundance of health-associated bacteria in multi-species biofilms grown in a cariogenic 
environment [Philip et al. 2019; Dashper et al., 2018]. Although majority of the clinical studies on 
CPP-ACP have been on its remineralizing effects, several clinical studies have also reported that that 
regular use of CPP-ACP reduced mutans streptococci (MS) levels in saliva [Emamieh et al., 2015; 
Plonka et al., 2013; Pukallus et al., 2013; Subramanian and Naidu, 2009; Yetkiner et al., 2014]. This 
interference with cariogenic bacteria may inhibit the virulence of dental plaque and enable health-
associated commensals to thrive. However, the previous studies have mostly used salivary levels of 
a single bacterial species (usually Streptococcus mutans) as the surrogate marker. Of greater 
relevance is the possible influence of CPP-ACP on a range of health- and disease-associated bacteria 
in dental plaque.  
 
In addition, the potential exists for synergism between the milk-derived CPP-ACP and other 
cariogenic virulence inhibiting natural agents. Cranberry flavonoids are of particular interest as its 
A-linked proanthocyanidins (A-PACs) have been shown to be potent disruptors of several cariogenic 
virulence factors without affecting bacterial viability [Duarte et al., 2006; Feng et al., 2013; Gregoire 
et al., 2007; Philip et al., 2019a, b]. The virulence attenuating effects of cranberry polyphenols have 
translated into reduced incidence and severity of carious lesions in an animal caries model [Koo et 
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al., 2010]. While cranberry phenols exhibit inhibitory effects against bacterial acidogenicity, 
aciduricity and glucan synthesis, CPP-ACP is known for its buffering and anti-adhesion effects. This 
suggests potential synergism if CPP-ACP and polyphenol-rich cranberry extracts are combined in a 
single oral care product. Hence, the objective of this study was to investigate the microbial 
ecological effects of a CPP-ACP dentifrice and a combination CPP-ACP – cranberry dentifrice with 
regards to species level changes of specific caries- and health-associated bacteria in the dental 
plaque of a high caries-risk group. 
 
MATERIALS AND METHODS 
Study Design and Sample Size  
This parallel three-group double-blinded randomised controlled trial (RCT) was designed in 
accordance with the CONSORT guidelines. A study flow diagram based on the CONSORT guidelines 
is shown in Fig. 17. The trial was registered with the Australian New Zealand Clinical Trial Registry 
(ANZCTR 12618000095268). A clinical trial notification for using the interventional products of the 
study was obtained from the Australian Therapeutic Goods Administration (TGA, CT-2017-CTN-
05069-1). As described previously (Lipták et al 2018), the G-POWER program tool was used to 
determine the sample size needed for a three-group one-way ANOVA test, assuming an alpha of 
0.05, power of 80% and large effect size (f = 0.4). Based on these assumptions, the power analysis 
showed that a total sample size of 66 was needed. To ensure there was enough statistical power in 
case some of the aforementioned assumptions were not met, and to account for attrition (from 
drop-outs or poor compliance), 30 subjects were recruited into each of the three trial groups.  
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Figure 17. Study flow diagram 
 
Trial Products 
Except for the active agents (CPP-ACP and cranberry extract) in the interventional 
toothpastes, all the trial toothpastes had same ingredients and a standard 1100 ppm fluoride 
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concentration. The interventional toothpastes were compared with each other and with an active 
control fluoride dentifrice. Details of the three treatment groups are as follows: 
• CPP-ACP group: dentifrice containing 10% (w/v) CPP-ACP (MI Paste® ONE, GC Corporation, 
Tokyo, Japan). 
• All-in-One group: 0.25% (w/w) cranberry extract (Diana Food, Champlain, QC, Canada) was 
incorporated into the CPP-ACP dentifrice. The polyphenol-rich cranberry extract was a highly 
purified, organic, sugar-free natural extract that contained more than 80% A-PACs. 
• Active control group:  standard fluoride dentifrice (GC Corporation), which had the same 
vehicle and flavour as the interventional dentifrices. 
 
Blinding and Randomisation 
The trial dentifrices were coded and had the same external packaging, and their content was not 
known to the participants or the enrolling investigator. The dentifrice product codes were known 
only to the chief supervisor of the study (L.J.W) who was not involved in participant enrolment, 
product allocation or data analysis. The product codes were retained by the supervisor and broken 
only after final analysis of the study results. The randomisation allocation list was made by a single 
investigator (N.P) in SPSS version 25 (IBM, New York, NY, USA) using the random number generation 
function that equally distributed a third of the 90 trial subjects to each of the three coded trial 
groups. The same investigator enrolled participants and allocated the trial interventions to the study 
participants, without being aware of which dentifrice the individual trial participants had received. 
 
Participants and Eligibility Criteria 
The study protocol was approved by the institutional human research ethics committee 
(HREC/18/QPCH/7). The participants were child/teenage patients recruited from the orthodontic 
clinics of the University of Queensland School of Dentistry from July 2018 to October 2018.  
 
The inclusion criteria for study participants were: (i) minimum of 10 years of age with at least 
4 fully erupted permanent maxillary teeth; (ii) undergoing fixed orthodontic treatment in both 
arches with treatment having been underway for at least 1 month; (iii) not currently using 
antibiotics/antimicrobial mouth rinses; and (iv) available to attend a recall appointment in 5-6 
weeks. The exclusion criteria were: (i) any medical condition or disability preventing self-tooth 
brushing; (ii) allergy to milk casein proteins or benzoate preservatives present in the CPP-ACP 
toothpaste; (iii) unwillingness to use a fluoridated toothpaste; and (iv) untreated periodontal 
disease or clinical evidence of active caries. All the study participants were given standardized oral 
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hygiene instructions and encouraged to use the allocated toothpaste for routine twice-daily tooth 
brushing throughout the trial period. Participant compliance with using the dentifrice was assessed 
based on the weight of the toothpaste tube at the end of the trial. 
 
Dental Plaque Sample Collection 
 Dental plaque samples were collected from the study subjects at two time points - at a 
baseline visit just before the participants started using the trial toothpastes, and then at a recall visit 
scheduled after 5-6 weeks of using the allocated toothpastes. The plaque samples were collected 
by using a sterile microbrush to swab the labial and gingival third of the upper and lower anterior 
teeth. Sample were collected without removing any orthodontic modules, chain or ligature-ties. The 
microbrush tips were placed in 0.01% thiomersal (Sigma-Aldrich, St. Louis, MO, USA) solution and 
stored at -80°C until microbial analysis. 
 
Microbial Analysis 
The bacterial load of 14 selected bacterial species was determined using real-time 
quantitative PCR (qPCR) analysis. The bacterial panel included 8 caries-associated bacterial species 
(Actinomyces gerensceriae, Lactobacillus gasseri, Streptococcus mutans, Streptococcus sobrinus, 
Streptococcus parasanguinis, Scardovia wiggsiae, Veillonella parvula and Prevotella denticola), and 
6 health-associated commensal bacterial species (Streptococcus sanguinis, Streptococcus 
mitis/oralis, Steptococcus salivarius/thermophilus, Corynebacterium durum, Rothia 
aeria/dentocariosa and Neisseria flavescens) 
 
DNA extraction 
 DNA was extracted from the plaque samples using the MO BIO Power Soil DNA Isolation Kit 
(MO BIO Laboratories, Carlsbad, CA, USA) according to manufacturer’s instructions. RNA was 
removed using RNAse A (Thermo Fischer Scientific, Scoresby, Australia) and the amount of isolated 
DNA quantified spectrophotometrically. 
 
16S rRNA sequencing 
 The bacterial load of the 14 selected bacterial species was determined using a custom-made 
qPCR array (16 x 24 format; Qiagen, Hilden, Germany). The assay used the 16S rRNA gene of the 
relevant bacterium, with the proprietary probes designed using the GreenGene version 13.8 
database [DeSantis et al. 2006] for 16S sequences. Each DNA sample was mixed with a proprietary 
master mix and robotically dispensed into a 384-well plate (10µL, 7 ng DNA/well) containing freeze-
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dried primers and fluorogenic probes for each of the bacterial 16S rRNA genes tested. Arrays also 
contained a positive PCR control to test for inhibitors in the sample, and a non-template control to 
account for assay background. Reactions were performed with the 384-well plate QuantStudio™ 6 
Flex Real-Time PCR sequence detection system (Thermo Fisher Scientific) with the following cycling 
conditions: enzymatic activation at 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec, and 
60°C for 2 min. Data was analysed using the sequence detection system (QuantStudio v1.3). 
 
Statistical Analysis 
The fold change of each bacterial amplicon was calculated using the comparative cycle 
threshold method (ΔΔCt). Briefly, for each sample, the Ct value of each bacterial target was 
normalized to the mean Ct value of all bacterial species (ΔCtbacteria species = Ctbacteria species – Ctmean of all 
bacterial species). The trial group ΔΔCt for each bacterial species was then calculated as follows: ΔΔCttrial 
group = ΔCtbacterial species (recall visit) – ΔCtbacterial species (baseline visit). Fold increase, or decrease, in bacterial 
abundance from the baseline to recall visit for each trial group was calculated based on the formula: 
2-ΔΔCt. For each bacterial species, one-way ANOVA was used to test for differences among the three 
trial groups using the ΔΔCt values [Yuan et al. 2006]. To adjust for the multiple bacterial 
comparisons, P-values were considered significant only if they were less than the Simes critical P-
value [Simes 1986]. For bacterial species that showed significant ANOVA results, paired t-tests were 
performed, and the Bonferroni correction was used to assess for any significant differences between 
the treatment group pairs. 
 
RESULTS 
Age and gender distribution were comparable among the three trial groups (Table 14). At 
the baseline visit, there was no significant differences in the prevalence of any of the bacterial 
species across the treatment groups (P > 0.05). Except for 4 bacterial species (L. gasseri, S. sobrinus, 
S. parasanguinis and S. wiggsiae), all the other 10 bacterial species were highly prevalent in all 
groups at the baseline visit (Table 15). 
 
Table 14. Demographic characteristics of the study population 
  
CPP-ACP Group 
 
All-in-One Group 
 
Control Group 
 
P-values 
Mean Age ± S.D  14.33 ± 1.64 14.0 ± 1.55 14.03 ± 1.79 0.696 
 
Female n (%) 19 (63%) 16 (53%) 19 (63%) 0.458 
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Table 15. Bacterial prevalence at the baseline visit across the three treatment groups 
 
 
Bacterial Species 
All Samples  
(n = 71) 
CPP-ACP 
(n = 22) 
All-in-One 
(n = 23) 
Control 
(n = 26) 
 
P-value 
 
Actinomyces gerensceriae 
 
70 (99%) 
 
21 (96) 
 
23 (100%) 
 
26 (100%) 
 
0.32 
 
Corynebacterium durum 
 
70 (99%) 
 
21 (96) 
 
23 (100%) 
 
26 (100%) 
 
0.32 
 
Lactobacillus gasseri 
 
13 (18%) 
 
2 (9%) 
 
4 (17%) 
 
7 (27%) 
 
0.28 
 
Neisseria flavescens 
 
63 (89%) 
 
19 (86%) 
 
22 (96%) 
 
22 (85%) 
 
0.44 
 
Prevotella denticola 
 
56 (79%) 
 
17 (77%) 
 
18 (78%) 
 
21 (81%) 
 
0.95 
 
Rothia aeria/dentocariosa 
 
71 (100%) 
 
22 (100%) 
 
23 (100%) 
 
26 (100%) 
 
δ 
 
Streptococcus mitis/oralis 
 
71 (100%) 
 
22 (100%) 
 
23 (100%) 
 
26 (100%) 
 
δ 
 
Streptococcus mutans 
 
54 (76%) 
 
16 (73%) 
 
18 (78%) 
 
20 (77%) 
 
0.90 
 
Streptococcus parasanguinis 
 
5 (7%) 
 
0 (0%) 
 
1 (4%) 
 
4 (15%) 
 
0.09 
 
Streptococcus salivarius/ thermophilus 
 
71 (100%) 
 
22 (100%) 
 
23 (100%) 
 
26 (100%) 
 
δ 
 
Streptococcus sanguinis 
 
71 (100%) 
 
22 (100%) 
 
23 (100%) 
 
26 (100%) 
 
δ 
 
Streptococcus sobrinus 
 
2 (2.8%) 
 
0 (0%) 
 
0 (0%) 
 
2 (8%) 
 
0.17 
 
Scardovia wiggsiae 
 
42 (59%) 
 
13 (59%) 
 
13 (57%) 
 
16 (62%) 
 
0.94 
 
Veillonella parvula 
 
71 (100%) 
 
22 (100%) 
 
23 (100%) 
 
26 (100%) 
 
δ 
Baseline prevalence data showing number of samples in which the bacterial species was detected and values in brackets representing % 
prevalence. No significant differences between the treatment groups at the baseline visit (P > 0.05; chi-square test). δ: no statistics 
computed because bacterial prevalence was a constant. 
 
The relative abundance of cariogenic and health-associated bacterial species at the baseline 
and recall visit, and the subsequent fold change in bacterial loads over time, are presented in the 
Tables 16 and 17 respectively. From the baseline to the recall visit, the treatment groups differed 
significantly in the mean changes in bacterial loads of two caries-associated species V. parvula (P < 
0.001) and S. mutans (P < 0.001) (Table 18, Fig. 18A) and three health-associated bacterial species 
C. durum (P = 0.008), N. flavescens (P = 0.005), and S. sanguinis (P < 0.001) (Table 18, Fig. 18B). 
Bacterial loads of V. parvula and S. mutans decreased over time, both in the CPP-ACP group (mean 
fold decreases of 0.31 and 0.52 respectively) and in the All-in-One group (mean fold decreases of 
0.11 and 0.23 respectively), and increased over time in the control group (mean fold increases of 
1.10 and 2.51 respectively) (Table 18, Fig. 18A). Conversely, bacterial loads of N. flavescens and S. 
sanguinis increased over time in the CPP-ACP group (mean fold increases of 2.05 and 2.92 
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respectively) and in the All-in-One group (mean fold increases of 12.27 and 3.44 respectively), and 
decreased over time in the control group (mean fold decreases of 0.64 and 0.46 respectively). For 
C. durum, there were fold increases of 14.45, 6.11, and 1.92 in the CPP-ACP, All-in-One, and control 
groups respectively (Table 18, Fig. 18B). Mean changes in the loads of the other 9 bacterial species 
assessed did not differ between the treatment groups (P > 0.05) (Table 18). 
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Table 16. Relative abundance of each caries-associated bacterial species at the baseline and recall visits and the subsequent fold change in bacterial load over time 
 ΔCt Baseline Visit ΔCt Recall Visit ΔΔCt Fold change 
Bacterial Species CPP-ACP All-in-One Control CPP-ACP All-in-One Control CPP-ACP All-in-One Control CPP-ACP All-in-One Control 
Veillonella parvula 
 
-9.75 
 
-9.50 
 
-8.32 
 
-8.06 
 
-6.37 
 
-8.46 
 
1.68 
 
3.13 
 
-0.14 
 
0.31 
 
0.11 
 
1.10 
 
Streptococcus mutans 
 
3.51 
 
1.85 
 
2.55 
 
4.45 
 
3.99 
 
1.23 
 
0.94 
 
2.14 
 
-1.33 
 
0.52 
 
0.23 
 
2.51 
 
Actinomyces gerensceriae 
 
-4.33 
 
-5.56 
 
-4.60 
 
-2.75 
 
-4.46 
 
-4.36 
 
1.58 
 
1.10 
 
0.24 
 
0.33 
 
0.47 
 
0.85 
 
Streptococcus parasanguinis 9.55 
 
9.27 
 
7.97 
 
10.40 
 
10.59 
 
9.42 
 
0.85 
 
1.32 
 
1.45 
 
0.56 
 
0.40 
 
0.37 
 
Streptococcus sobrinus 
 
9.55 
 
9.86 
 
9.44 
 
10.26 
 
10.59 
 
9.92 
 
0.71 
 
0.73 
 
0.48 
 
0.61 
 
0.60 
 
0.72 
 
Scardovia wiggsiae 
 
5.37 
 
4.94 
 
5.09 
 
6.18 
 
4.92 
 
4.49 
 
0.81 
 
-0.01 
 
-0.60 
 
0.57 
 
1.01 
 
1.52 
 
Lactobacillus gasseri 
 
9.01 
 
8.63 
 
9.13 
 
9.10 
 
9.04 
 
9.21 
 
0.09 
 
0.41 
 
0.08 
 
0.94 
 
0.75 
 
0.95 
 
Provotella denticola -0.32 
 
0.72 
 
1.28 
 
-1.45 
 
-0.19 
 
-0.96 
 
-1.12 
 
-0.92 
 
-2.25 
 
2.18 
 
1.89 
 
4.74 
 
The Ct value of each bacterial target was normalized to the mean Ct value of all bacterial species (ΔCt = Ctbacteria species – Ctmean of all bacterial species). The ΔΔCt for each bacterial species was then 
calculated as follows: ΔΔCt = ΔCtbacterial species (recall visit) – ΔCtbacterial species (baseline visit). Fold increase, or decrease, in bacterial abundance from the baseline to recall visit for each trial group was 
calculated based on the formula: 2-ΔΔCt. Ratio below 1 indicates lower relative abundance; a ratio above 1 indicates higher relative abundance 
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Table 17. Relative abundance of each health-associated bacterial species at the baseline and recall visits and the subsequent fold change in bacterial load over time 
 ΔCt Baseline Visit ΔCt Recall Visit ΔΔCt Fold change 
Bacterial Species CPP-ACP All-in-One Control CPP-ACP All-in-One Control CPP-ACP All-in-One Control CPP-ACP All-in-One Control 
Corynebacterium durum 
 
0.77 
 
-0.81 
 
-0.86 
 
-3.09 
 
-3.43 
 
-1.80 
 
-3.85 
 
-2.61 
 
-0.94 
 
14.45 
 
6.11 
 
1.92 
 
Neisseria flavescens 
 
-0.06 
 
1.14 
 
1.58 
 
-1.09 
 
-2.48 
 
2.23 
 
-1.03 
 
-3.62 
 
0.65 
 
2.05 
 
12.27 
 
0.64 
 
Streptococcus sanguinis 
 
-7.92 
 
-7.27 
 
-8.31 
 
-9.47 
 
-9.05 
 
-7.19 
 
-1.55 
 
-1.78 
 
1.12 
 
2.92 
 
3.44 
 
0.46 
 
Streptococcus mitis/oralis 
 
-6.60 
 
-6.13 
 
-6.64 
 
-6.34 
 
-6.11 
 
-6.03 
 
0.26 
 
0.02 
 
0.62 
 
0.84 
 
0.98 
 
0.65 
 
Rothia aeria/dentocariosa 
 
-5.63 
 
-4.39 
 
-6.00 
 
-5.59 
 
-5.12 
 
-5.10 
 
0.04 
 
-0.73 
 
0.89 
 
0.97 
 
1.65 
 
0.54 
 
Streptococcus salivarius/ 
thermophilus 
-3.14 
 
-2.74 
 
-2.31 
 
-2.56 
 
-1.93 
 
-2.59 
 
0.59 
 
0.81 
 
-0.27 
 
0.67 
 
0.57 
 
1.21 
 
The Ct value of each bacterial target was normalized to the mean Ct value of all bacterial species (ΔCt = Ctbacteria species – Ctmean of all bacterial species). The ΔΔCt for each bacterial species was then 
calculated as follows: ΔΔCt = ΔCtbacterial species (recall visit) – ΔCtbacterial species (baseline visit). Fold increase, or decrease, in bacterial abundance from the baseline to recall visit for each trial group was 
calculated based on the formula: 2-ΔΔCt. Ratio below 1 indicates lower relative abundance; a ratio above 1 indicates higher relative abundance. 
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Table 18. Comparison of treatment groups with regard to mean fold changes (2-ΔΔCt) in bacterial loads of 
the caries-associated and health-associated bacterial species from baseline to recall visit 
 
 
 
 
Treatment Groups 
 
 
 
Bacterial Species 
 
CPP-ACP 
 
All-in-One 
 
Control 
One-way ANOVA 
P-values 
Caries-associated 
Veillonella parvula 
 
0.31 (0.14, 0.68) 
 
0.11 (0.04, 0.32) 
 
1.10 (0.68, 1.78) 
 
< 0.001* 
 
Streptococcus mutans 
 
0.52 (0.23, 1.20) 
 
0.23 (0.07, 0.71) 
 
2.51 (1.30, 4.83) 
 
< 0.001* 
 
Actinomyces gerensceriae 
 
0.33 (0.13, 0.85) 
 
0.47 (0.22, 0.99) 
 
0.85 (0.41, 1.75) 
 
0.23 
 
Streptococcus parasanguinis 
 
0.56 (0.40, 0.77) 
 
0.40 (0.15, 1.05) 
 
0.37 (0.12, 1.15) 
 
0.79 
 
Streptococcus sobrinus 
 
0.61 (0.45, 0.83) 
 
0.60 (0.36, 1.01) 
 
0.72 (0.42, 1.22) 
 
0.83 
 
Scardovia wiggsiae 
 
0.57 (0.18, 1.81) 
 
1.01 (0.36, 2.86) 
 
1.52 (0.52, 4.43) 
 
0.42 
 
Lactobacillus gasseri 
 
0.94 (0.46, 1.90) 
 
0.75 (0.26, 2.20) 
 
0.95 (0.56, 1.60) 
 
0.89 
 
Prevotella denticola 
 
2.18 (0.42, 11.34) 
 
1.89 (0.44, 8.01) 
 
4.74 (1.46, 15.40) 
 
0.58 
 
Health-associated 
Corynebacterium durum 
 
14.45 (6.59, 31.71) 
 
6.11 (2.55, 14.64) 
 
1.92 (0.66, 5.52) 
 
0.008* 
 
Neisseria flavescens 
 
2.05 (0.71, 5.87) 
 
12.27 (2.16, 69.68)  
 
0.64 (0.23, 1.75) 
 
0.005* 
 
Streptococcus sanguinis 
 
2.92 (1.61, 5.32) 
 
3.44 (1.86, 6.37) 
 
0.46 (0.28, 0.76) 
 
< 0.001* 
 
Streptococcus mitis/oralis 
 
0.84 (0.36, 1.96) 
 
0.98 (0.35, 2.77) 
 
0.65 (0.34, 1.25) 
 
0.77 
 
Rothia aeria/dentocariosa 
 
0.97 (0.51, 1.83) 
 
1.65 (0.60, 4.53) 
 
0.54 (0.37, 0.79) 
 
0.07 
 
Streptococcus salivarius/ 
thermophilus 
 
0.67 (0.28, 1.60) 
 
0.57 (0.27, 1.20) 
 
1.21 (0.63, 2.33) 
 
0.29 
 
Mean fold change (2-ΔΔCt) values (95% confidence intervals) for each bacterial species in the CPP-ACP group (n = 22), All-in-One 
group (n = 23) and control group (n = 26). Ratio below 1 indicates lower relative abundance; a ratio above 1 indicates higher 
relative abundance. * indicates where significant differences were found among the groups. 
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Figure 18 (A and B). Fold change in relative bacterial abundance from baseline to recall visit 
 * indicates significant differences using the one-way ANOVA and Simes adjustment for the multiple bacterial comparisons
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Post-hoc analysis revealed that the CPP-ACP group differed significantly from the control 
group with respect to mean changes in loads of S. mutans (P = 0.032), C. durum (P = 0.007) and S. 
sanguinis (P < 0.001), while the All-in-One group differed from the control group with respect to 
mean changes in loads of S. mutans (P < 0.001), V. parvula (P < 0.001), N. flavescens (P = 0.003) and 
S. sanguinis (P < 0.001) (Table 19). Compared to the CPP-ACP group, the All-in-One group generally 
showed greater mean fold decreases over time in the loads of the caries-associated bacteria, and 
higher mean fold increases over time in the loads of the health-associated bacteria (except for C. 
durum) (Fig. 18). However, these differences were not statistically significant (P > 0.05) (Table 19). 
 
Table 19.  Post-hoc pairwise comparisons between treatment groups 
 P-values 
Bacterial species CPP-ACP versus Control All-in-One versus Control CPP-ACP versus All-in-One 
Caries-associated    
Veillonella parvula 0.061 < 0.001* 0.213 
 
Streptococcus mutans 0.032* < 0.001* 0.555 
 
Health-associated    
Corynebacterium durum 0.007* 0.207 0.579 
 
Neisseria flavescens 0.571 0.003* 0.158 
 
Streptococcus sanguinis < 0.001* < 0.001* 1.00 
Bonferroni correction was used to assess significance. * indicates where significant differences were found between the groups. 
 
DISCUSSION 
This clinical trial provides evidence that a CPP-ACP dentifrice can beneficially influence 
dental plaque microbial composition in a high caries-risk group. Specifically, we demonstrate species 
level changes in dental plaque after using dentifrices containing CPP-ACP with regards to two caries-
associated bacterial species and three health-associated bacterial species. The addition of a highly 
purified polyphenol-rich cranberry extract to the CPP-ACP dentifrice gave a small enhancement to 
the microbial ecological effects of CPP-ACP, with the CPP-ACP – cranberry dentifrice significantly 
reducing V. parvula bacterial loads and significantly increasing N. flavescens bacterial loads 
compared to the fluoride control, effects that were not seen with the dentifrice containing CPP-ACP 
alone. This observation, combined with the fact the CPP-ACP – cranberry dentifrice effected a 
greater fold decrease in S. mutans levels and a higher fold increase in S. sanguinis levels than the 
CPP-ACP dentifrice, suggests the possibility that greater beneficial effects from the combination 
dentifrice could be seen if it was used for longer period, or a higher concentration of cranberry 
extract was used. 
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The proposed mechanisms for the microbial ecological effects of CPP-ACP observed in this 
study could be related to its buffering and anti-adhesion effects [Philip and Walsh, 2019]. Various 
clinical studies have reported that regular use of CPP-ACP topical crèmes had pronounced buffering 
influences on salivary and plaque pH [Caruana et al., 2009; Heshmat et al., 2014a; Heshmat et al., 
2014b; Marchisio et al., 2010; Ozdas et al., 2015; Peric et al., 2015]. The buffering effects of CPP-
ACP are due to its ability to act as a reservoir of peptides and phosphate ions. The catabolism of 
peptides by plaque peptidases would buffer against a pH fall through the production of ammonia 
(Reynolds and Riley 1989). CPP phosphoseryl residues that are more resistant to hydrolysis can 
readily accept protons and neutralize plaque acids (Reynolds 1987). Furthermore, the inorganic 
phosphate (PO43-) and organic phosphate (-O-PO32-) ions in the CPP-ACP nanocomplex also 
contribute to elevating salivary/plaque pH (Dashper et al. 2018). The buffering actions of CPP-ACP 
can result in a homeostatic oral environment that favours the growth of health-associated 
commensals. Besides its buffering effects, CPP-ACP is also known to inhibit bacterial co-aggregation 
and accumulation in dental plaque by binding to bacterial surfaces (with a strong affinity for S. 
mutans) and pellicle macromolecules (Reynolds et al. 2003; Rose 2000). In the present study, the 
CPP-ACP dentifrice effected a decrease in the bacterial load of S. mutans and an increase in bacterial 
loads of C. durum and S. sanguinis. These results can possibly be attributed to the anti-adhesion and 
buffering influences of CPP-ACP on the plaque biofilm. 
 
 Polyphenol-rich cranberry extracts and purified cranberry A-PACs have demonstrated 
potent inhibitory effects against S. mutans glycolytic, F1F0-ATPase, and glucosyltransferase (Gtf) 
enzymes, while also disrupting the structural architecture of in vitro biofilms [Duarte et al., 2006; 
Gregoire et al., 2007; Koo et al., 2006; Philip et al., 2019a, b]. The ability of cranberry polyphenols 
to influence key cariogenic virulence properties without affecting microbial viability make them 
potentially ideal agents to lower cariogenic virulence and improve the microbial ecological balance 
of dental plaque. The fact that the combination dentifrice showed the highest fold decreases in the 
cariogenic S. mutans and V. parvula bacterial species, suggests that the virulence-inhibitory effects 
of the polyphenol-rich cranberry extract extended to a clinical environment too. 
 
 The two bacterial species (S. mutans and V. parvula) that showed significant decreases in 
their bacterial loads have both been strongly associated with dental caries. S. mutans, even when 
present in low numbers, is still considered a keystone pathogen in the disease process as it is largely 
responsible for the initial assembly of the cariogenic glucan-rich biofilm matrix (Bowen et al. 2018). 
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Other acidogenic and aciduric bacteria lack the specific Gtfs to synthesize insoluble glucans that are 
considered the foundational building blocks of cariogenic biofilms (Hajishengallis et al. 2017). The S. 
mutans-derived Gtf exoenzymes orchestrate the virulent glucan-rich exopolysaccharide matrix 
scaffold, paving the way for other resident aciduric bacteria (e.g. lactobacilli, bifidobacteria, 
Scardovia spp. etc.) to dominate the microbiome as the plaque biofilm matures (Bowen et al. 2018; 
Burne 2018). Veillonella, an obligate anaerobic Gram-negative bacterium, is considered a bridge 
organism in the biofilm [Knapp et al., 2017], and is commonly isolated from initial lesions [Aas et al., 
2005; Becker et al., 2002; Gross et al., 2012]. It was earlier perceived that presence of this bacterium 
in plaque may be beneficial as it neutralizes acidic pH by utilizing lactic acid as its nutritional source 
of energy. However, evidence from recent microbiome studies confirm that Veillonella is strongly 
associated with caries lesions [Jiang et al., 2016; Richards et al., 2017; Tanner et al., 2016; Zhou et 
al., 2016]. Veillonella was seen to promote S. mutans growth even in the presence of antagonistic 
Streptococcus gordonii, while the acetic acid produced from Veillonella lactate catabolism can also 
demineralize enamel (Bowen et al. 2018). Metatranscriptomic studies reveal that Veillonella is 
positively stimulated by low-pH conditions and exhibits intracellular pH control mechanisms (Do et 
al. 2015; Edlund et al. 2015). Furthermore, even aciduric organisms show reduced growth when pH 
drops below 4.5, and Veillonella can help the acidogenic microbial community by maintaining a 
relatively more neutral pH (Tanner et al. 2016).  
 
 In the present study, three health-associated bacterial species (S. sanguinis, C. durum and N. 
flavescens) showed significant increases in their bacterial loads from the baseline to the recall visit. 
These commensals have various strategies to foster an oral biofilm environment that discourages 
the emergence and dominance of opportunistic cariogenic pathogens. S. sanguinis belongs to a 
group of oral commensals known to possess the arginine deaminase system (ADS) that can 
neutralize acids produced from carbohydrate metabolism by generating ammonia from prebiotic 
dietary and salivary substrates [Nascimento, 2018]. The ammonia produced not only alkalizes the 
bacterial cytoplasm but also gets released outside the cell promoting an overall elevation in plaque 
pH. This creates an environment that supports the growth of other acid-sensitive commensals. 
Moreover, endogenous ammonia production promotes stability of health-associated biofilms by 
affording bioenergetic advantages to the commensal bacteria [Burne, 2018]. The bacterial species 
C. durum has an established nitrate (NO3-) reductase system which rapidly reduces salivary NO3- to 
nitrite (NO2-) as part of its respiration. In a low pH environment, NO2- dissociates to form a range of 
nitrogen oxides, most notably nitric oxide (NO). The NO3--NO2--NO reduction pathway can limit the 
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growth of cariogenic bacteria because of the antimicrobial effects of NO [Doel et al., 2004]. Neisseria 
is a catalase-positive aerobic species that has been identified as part of the healthy “core 
microbiome” of the human oral cavity [Zaura et al., 2009]. Neisseria flavescens is known to be 
asaccharolytic and has been associated with caries-free status in next-generation sequencing 
studies of saliva and plaque samples [Gross et al., 2012; Richards et al., 2017].  
 
Prudency is required when interpreting the results of this study. Further studies are required 
to know whether the beneficial plaque microbial changes shown here can translate into lowering 
the caries increment in a high-risk population group, which should be the only criteria to judge the 
efficacy of new anti-caries agents. While the microarray and taxon-specific qPCR techniques 
employed in this study allowed quantification of multiple high-interest bacterial species from dental 
plaque, it does not make an evaluation of the numerous other microorganisms present in dental 
plaque. Moreover, the taxonomic composition of plaque samples alone does not give complete 
information about the functional output of plaque microbial communities or their role in health and 
disease [Takahashi, 2015]. Future research using metagenomic and metatranscriptomic analysis 
tools can provide genetic information of the whole microbial community and provide a better 
understanding of the metabolic output and functional profile of oral microbial communities. 
 
 There is now evidence that routine provision of interventions that deliver small but relevant 
benefits can support the maintenance of a symbiotic oral microbiome [Marsh, 2018]. A recent RCT 
demonstrated that that a toothpaste containing enzymes and proteins promoted an overall 
community shift by increasing the relative abundance of bacteria associated with gingival health 
and decreasing those associated with periodontal disease [Adams et al., 2017]. The rationale for 
applying similar ecological approaches to dental caries prevention is apparent, and various 
strategies are currently under investigation [Philip et al., 2018]. This study suggests the possibility 
of using milk-derived CPP-ACP and polyphenol-rich cranberry extracts in daily use oral care products 
to ecologically modulate plaque microbial communities. 
 
CONCLUSIONS 
Overall, the results of this clinical study indicate CPP-ACP delivered in a dentifrice exerts 
useful microbial ecological effects, and this is enhanced somewhat by including a polyphenol-rich 
cranberry extract as well. In the past two decades, CPP-ACP topical crèmes and chewing gums have 
been in use globally for its remineralizing actions. The present study shows that twice-daily brushing 
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with a CPP-ACP dentifrice can provide an additional ecological benefit that could potentially 
translate into lowering caries-risk. Further studies will be needed to resolve whether polyphenol-
rich cranberry extracts or other additives can enhance the ecological effects of CPP-ACP. Finally, it 
should be emphasized that microbial ecology-based therapeutics are only one component within a 
holistic caries preventive strategy that should primarily aim to reverse the environmental stresses 
responsible for the dental plaque dysbiosis. 
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RAW DATA 
Study 6: qPCR Cycle threshold (Ct) Data 
 
Trial Group A Ct data (Baseline and Recall Visit) 
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Study 6: qPCR Cycle threshold (Ct) Data 
 
Trial Group B Ct data (Baseline and Recall Visit) 
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Study 6: qPCR Cycle threshold (Ct) Data 
 
Trial Group C Ct data (Baseline and Recall Visit) 
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5. GENERAL DISCUSSION 
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The purpose of this thesis was to develop natural approaches to attenuate cariogenic biofilm 
virulence and maintain a symbiotic oral microbiome. The previous chapters have reviewed the 
literature and presented results from the in vitro and clinical studies investigating the effects of 
polyphenol-rich natural extracts and milk-derived CPP-ACP on microbial biofilms. The work in this 
thesis has addressed several gaps in the literature and provided insights about the potential of using 
natural products and CPP-ACP to ecologically modulate dental biofilms and thereby lower caries-
risk. This chapter presents an overview of the study in relation to current knowledge, discusses how 
the research gaps identified have been addressed, and proposes recommendations for future 
research. Figure 19 broadly summarizes the gaps in knowledge, results of the thesis and directions 
for future work. 
 
Figure 19. Summary of research gaps, thesis results and future directions 
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RESEARCH OVERVIEW 
Prevention and management of dental caries is remarkably different from other infectious 
diseases. While dental caries is essentially a microbially induced disease caused by bacterial 
metabolites, it cannot be considered an infectious disease in classical terms since its aetiology is 
polymicrobial and the opportunistic pathogens involved are found even in healthy individuals 
[Lopez-Lopez et al., 2017]. Insights from the Human Microbiome Project have revealed that 
maintaining microbial equilibrium is vital for health and preventing disease [Turnbaugh et al., 2007]. 
This is evident in oral diseases like dental caries where plaque dysbiosis, rather than any specific 
microorganism, is the trigger for lesion initiation. Recent paradigms have also emphasised the role 
that health-associated commensals can play in abating disease pathogenesis. This evolving view of 
ecological battles (health- vs. caries-associated bacteria) and polymicrobial synergies within the 
structured heterogeneous biofilm environment has direct implications for developing effective 
modern-day therapeutics against dental caries [Bowen et al., 2018].  
 
Fluoride-based preventive strategies have the strongest and most consistent level of 
evidence supporting their use for caries control and are singularly responsible for the dramatic 
decline in caries prevalence rates over the past 60 years [Fontana et al., 2018]. Yet, the recent Global 
Burden of Diseases report identified dental caries as the most common human disease condition 
worldwide [Kassebaum et al., 2017]. In Australia itself, the 2018 Australian Institute of Health and 
Welfare report highlighted that 42% of Australian children aged between 5 and 10 years of age 
experience dental caries, while 30% of the adults in the 25-40 years age bracket have untreated 
caries lesions [AIHW, 2018]. Recent epidemiological reports from United States and Scandinavian 
nations show similar worrying trends [Agustsdottir et al., 2010; Dye et al., 2017]. This suggests that 
dental caries remains a “silent epidemic”, even in developed countries where there is widespread 
use of fluoride products and good access to dental care [Bowen, 2002]. The persistence of dental 
caries in many high-risk groups even with regular exposure to fluoride could be due to the inability 
of the remineralizing agent to significantly alter microbial composition and reverse the plaque 
dysbiosis. Thus, while fluoride will continue to be the cornerstone of any caries management 
protocol, additional antimicrobial or ecological strategies are needed to supplement the 
physicochemical cariostatic effects of fluoride. 
 
The current antimicrobial approach to preventing dental plaque-related diseases like caries 
is however non-specific, mostly centred on removal of plaque by mechanical and/or chemical means 
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[Zhang et al., 2018]. Eradication of dental plaque is a completely logical approach in a healthy 
mouth, but may not be as effective in caries conducive environments [Liu et al., 2018]. Conventional 
mechanical/chemical plaque control measures do not reverse the microbiome dysbiosis seen in 
high-risk patients, and susceptible tooth surfaces are often repopulated with a microbiome similar 
in composition to the one that was removed [Burne, 2018]. Re-establishing a health oral ecosystem 
and maintaining a symbiotic oral microbiome is thus crucial, not only for long-term control over the 
disease, but also has important metabolic, physiological and immunologic benefits [Marsh, 2018]. 
This has resulted in increasing research interest in therapeutic interventions that modulate and 
restore ecological balance in dental biofilms [Nascimento, 2018]. This thesis has attempted to close 
some of the research gaps identified in the use of natural products and CPP-ACP as ecological agents 
to maintain a healthy plaque microbiome. 
 
RESEARCH GAPS ADDRESSED 
The paradigm shifts in caries aetiology and their implications for the development of 
therapeutic agents against the disease have been the most significant change in cariology research 
over the past couple of decades. As summarized in the introduction to the literature review 
(Chapters 2.1.1 and 2.1.2), the rationale for adopting ecological approaches to caries prevention is 
now evident, from aetiological conceptual perspectives to the important clinical implications it has 
for preventing lesion recurrence in patients. Various iterations of the ecological plaque hypothesis 
have emphasised that dental caries results from a shift in the composition of biofilm microbiota 
driven by local environmental stress [Filoche et al., 2010; Kleinberg, 2002; Marsh, 1994, 2003; 
Takahashi and Nyvad, 2008, 2011]. It is thus vital that preventive measures address the underlying 
ecological basis of the disease in order to achieve long-term control over dental caries. Clinicians 
need to be aware that restorative interventions alone will have no significant effect on the 
microbiome dysbiosis or avoiding the vicious cycle of treatment and retreatment of CARS 
[Domejean et al., 2017; Featherstone and Chaffee, 2018]. 
 
The literature review Chapters 2.2.2 and 2.3.2 discussed the role that cranberry polyphenols 
and CPP-ACP can potentially play as therapeutic ecological agents to reverse dental plaque 
dysbiosis. However, there were significant gaps in the literature on whether natural agents and CPP-
ACP can be used to disrupt cariogenic virulence properties and modify the oral microbiome (Chapter 
2.4). Research on cariostatic natural products has mostly focussed on their growth inhibitory effects 
against cariogenic bacteria, with only few studies examining their virulence inhibitory activity, and 
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no research on any potential biofilm ecological effects. For CPP-ACP, while there have been multiple 
reports on its ability to inhibit bacterial adhesion and buffer biofilm pH, the vast majority of the CPP-
ACP research has been rightly directed towards its remineralizing effects (Chapter 2.3.1). Evidence 
of the dental plaque ecological effects of CPP-ACP has just started emerging, with results from this 
study providing among the earliest confirmation for this. 
 
This research project has attempted to close the aforementioned gaps in the literature on 
virulence inhibitory and ecological effects of natural products and CPP-ACP. A commercially 
available polyphenol-rich cranberry extract was shown to disrupt critical cariogenic virulence factors 
of monospecies S. mutans (Chapter 4.2), dual-species S. mutans-C. albicans biofilms (Chapter 4.3) 
and saliva-derived polymicrobial biofilms (Chapter 4.4). The virulence inhibitory effects resulted in 
beneficial microbial ecological changes in polymicrobial biofilms growing in a cariogenic 
environment (Chapters 4.4). The present study further demonstrated that treating polymicrobial 
biofilms twice-daily with 2% CPP-ACP lowered biofilm acid production and microbial counts, with 
the buffering and anti-adhesion influences of CPP-ACP the likely mechanisms for these effects. The 
CPP-ACP treatment of polymicrobial biofilms growing in a cariogenic environment was also able to 
effect a beneficial microbial ecological change compared to control-treated biofilms (Chapter 4.5). 
This in vitro study on the ecological effects of CPP-ACP on saliva-derived polymicrobial biofilms 
extended and confirmed the results from a recent study on microbial modulatory effects of CPP-
ACP in a 6-species biofilm model [Dashper et al., 2018]. 
 
The randomised controlled trial conducted as part of this project (Chapter 4.6) closed 
another important gap in natural product and CPP-ACP clinical research. The evidence cited in 
previous studies on the cariostatic effects of natural products (Chapter 2.2.1) are almost entirely 
from in vitro studies. A single in vivo study in an animal caries model showed that treatment with 
cranberry A-PACs was able to reduce the incidence and severity of caries lesions [Koo et al., 2010], 
indicating the potential of using natural products for caries prevention. However, there are no 
studies on whether any of the natural products with proposed cariostatic effects could lower caries-
risk in a clinical environment. With regards to CPP-ACP, multiple clinical studies have shown that 
regular use of CPP-ACP lowered salivary counts of S. mutans (Chapter 2.3.2). However, new data 
strongly suggests that saliva may not be an appropriate sample for caries aetiological studies or for 
caries-risk tests [Mira, 2018]. What is more relevant from the therapeutic point of view would the 
effects of CPP-ACP on a range of disease- and health-associated bacteria in dental plaque. The RCT 
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in the current study showed that twice-daily brushing with dentifrices containing CPP-ACP and a 
polyphenol-rich cranberry extract was able to effect significant improvements in the dental plaque 
microbial ecology. The clinical translation of the in vitro virulence inhibitory and ecological effects 
could contribute towards lowered risk of developing new caries lesions, an important goal sought 
by patients, clinicians and policy makers. 
 
FUTURE RESEARCH DIRECTIONS 
 Preventive approaches to dental caries must in future be more logical, focussing not just on 
the remineralizing early hard tissue lesions, but also on reversing the microbiome dysbiosis causing 
the lesions [Zhan, 2018]. Rather than attempting to eliminate entire plaque microflora with short-
term antimicrobial treatment, regular provision of interventions that promote symbiosis and 
prevent dysbiosis could deliver relevant benefits to support the maintenance of a symbiotic oral 
microbiome [Marsh, 2018].  
The science of cariology with regards to microbiome dysbiosis is well-advanced, but the 
challenge is translating mechanistic research into practical solutions for patients and clinicians. 
Based on the results of this study, it is recommended that future research on natural products and 
ecological agents be driven in the following areas: 
1. Bacterial growth inhibitory treatments will generally be unfruitful in preventing oral 
polymicrobial diseases like dental caries. Rather, strategies directed towards modulating 
microbial interactions and their metabolic output should be developed further. 
 
2. Enormous intraspecies gene diversity and plasticity of oral microbes are exhibited by 
commensal and cariogenic bacteria manifesting as phenotypic heterogeneity. Thus, 
function-based, rather than taxonomy-only studies, are needed in the future to 
understand what the plaque microflora are doing regardless of its taxonomic composition. 
 
3. Specific flavonoids in the cranberry extracts like the A-PACs are known to exert the most 
potent virulence disruptive effects. Future in vitro and clinical studies using the isolated 
bioactive phytochemicals in different combinations and concentrations are needed to 
assess whether they can cause greater inhibition of cariogenic virulence properties and 
result in better ecological effects on the dental plaque microbiome. 
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4. The caries preventive efficacy of cranberry extracts and CPP-ACP in low concentration 
fluoride dentifrices (250-500 ppm) requires further investigation. If successful, these 
combination toothpastes could safely be used by infants and children below 6 years for 
enhanced protection against ECC. 
 
5. Further research is also required to evaluate the microbial ecological effects and caries 
preventive efficacy of fluoride-cranberry combinations (without CPP-ACP), in daily use 
mouthwashes and dentifrices. Such combinations may be more cost-effective for low to 
moderate caries-risk patients, while the CPP-ACP-fluoride-cranberry combination could be 
used in patients assessed to be at high risk to dental caries. 
 
6. The recent in vitro demonstration of the enhanced remineralizing and ecological effects of 
CPP-ACP - SnF2 combination [Dashper et al., 2018] suggests the possibility that 
incorporation of the cranberry extract to this combination may further enhance the 
beneficial effects. Additional research needs to be directed towards such CPP-ACP 
combinations. 
 
7. Besides caries prevention, there is a need to investigate whether CPP-ACP or natural 
products can be used against other oral infections and diseases. For example, periodontal 
disease is also known to be triggered by microbiome dysbiosis. It will be of interest to 
evaluate whether the prebiotic effects of CPP-ACP or virulence inhibitory effects of 
cranberry extracts can promote growth of bacteria associated with periodontal health, 
while concomitantly inhibiting those associated with periodontal disease. Furthermore, in 
conditions like oral candidiasis, natural products with antimicrobial effects would be 
preferred over synthetic biocides or antifungals. 
 
8. The ultimate success of any caries preventive agent should be judged only on its 
proficiency to lower caries experience and prevent new lesions from developing. Hence, 
well-designed RCTs, in high-risk population groups, are required to assess the preventive 
effectiveness of the CPP-ACP - cranberry dentifrices suggested in this study. 
 
CONCLUDING REMARKS 
The disease of dental caries can have long-term and broad dental, medical, societal, 
economic and oral health-related quality of life consequences [Fontana et al., 2018a]. Despite 
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significant improvements in dental caries prevalence rates, the disease remains a major public 
health problem, affecting all age groups, and with multiple vulnerable population groups at 
heightened risk. Concerted clinical and research efforts are needed to reduce the scourge of dental 
caries around the world and throughout an individual’s lifespan.  
 
Ecological approaches to dental caries prevention could prove to be the missing link in 
eradicating this ubiquitous and age-old disease. While reducing dietary sugar exposures is the most 
effective way to prevent dental plaque dysbiosis, modifying dietary behaviour is often difficult to 
sustain in the present-day consumerist culture. Clearly, additional ecological measures may be 
required in many high caries-risk individuals and population groups. The work presented in this 
thesis provides evidence to support the possibility of using polyphenol-rich cranberry extracts and 
CPP-ACP as ecological agents to lessen caries-risk and prevent dental caries. 
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Appendix 7.11: CONSORT Checklist for Reporting a Randomised Trial* 
 
Section/Topic 
Item 
No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title 238 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) 239 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale 240-241 
2b Specific objectives or hypotheses 241-242 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 242 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons None 
Participants 4a Eligibility criteria for participants 244 
4b Settings and locations where the data were collected 244 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were 
actually administered 
243-244 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
245-246 
6b Any changes to trial outcomes after the trial commenced, with reasons None 
Sample size 7a How sample size was determined 242 
7b When applicable, explanation of any interim analyses and stopping guidelines - 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence 244 
8b Type of randomisation; details of any restriction (such as blocking and block size) 244 
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 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), 
describing any steps taken to conceal the sequence until interventions were assigned 
244 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to 
interventions 
244 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those 
assessing outcomes) and how 
244 
11b If relevant, description of the similarity of interventions - 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 246 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses - 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
Figure 1 
13b For each group, losses and exclusions after randomisation, together with reasons Figure 1 
Recruitment 14a Dates defining the periods of recruitment and follow-up 244 
14b Why the trial ended or was stopped - 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group Table 1 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was 
by original assigned groups 
Figure 1 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
246-249 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended - 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
- 
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Harms 19 All-important harms or unintended effects in each group (for specific guidance see CONSORT for harms) None 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses 253 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 253 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence 250-253 
Other information 
 
Registration 23 Registration number and name of trial registry 242 
Protocol 24 Where the full trial protocol can be accessed, if available - 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders None 
 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we 
also recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and 
pragmatic trials. Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org. 
